<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":3.520727,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpFDhsSD1wPC1dKF1MXQQ8BDQNATE4fVUhaHEZIUFFXC01UAQsACkpTEw4N","queueTime":0,"ttGuid":"a7af86d1850e06d1"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full">
<meta property="description" name="description" content="Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the human Ether--go-go-Related Gene (hERG), which encodes the  subunit of ch...">
<meta property="og:title" name="title" content="Frontiers | In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome">
<meta property="og:description" name="description" content="Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the human Ether--go-go-Related Gene (hERG), which encodes the  subunit of ch...">
<meta name="keywords" content="arrhythmia,short QT syndrome,Atrial Fibrillation,hERG, potassium channels,class I anti-arrhythmics,human atria">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="9">
<meta name="citation_journal_title" content="Frontiers in Physiology">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Physiol.">
<meta name="citation_issn" content="1664-042X">
<meta name="citation_doi" content="10.3389/fphys.2018.01888">
<meta name="citation_firstpage" content="417422">
<meta name="citation_language" content="English">
<meta name="citation_title" content="In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome">
<meta name="citation_keywords" content="arrhythmia; short QT syndrome; Atrial Fibrillation; hERG, potassium channels; class I anti-arrhythmics; human atria">
<meta name="citation_abstract" content="Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the human Ether--go-go-Related Gene (hERG), which encodes the  subunit of channels carrying rapid delayed rectifier potassium current, IKr. In addition to QT interval shortening and ventricular arrhythmias, SQT1 is associated with increased risk of atrial fibrillation (AF), which is often the only clinical presentation. However, the underlying basis of AF and its pharmacological treatment remain incompletely understood in the context of SQT1. In this study, computational modelling was used to investigate mechanisms of human atrial arrhythmogenesis consequent to a SQT1 mutation, as well as pharmacotherapeutic effects of selected class I drugs  disopyramide, quinidine, and propafenone. A Markov chain formulation describing wild type (WT) and N588K-hERG mutant IKr was incorporated into a contemporary human atrial action potential (AP) model, which was integrated into one-dimensional (1D) tissue strands, idealised 2D sheets, and a 3D heterogeneous, anatomical human atria model. Multi-channel pharmacological effects of disopyramide, quinidine, and propafenone, including binding kinetics for IKr/hERG and sodium current, INa, were considered.Heterozygous and homozygous formulations of the N588K-hERG mutation shortened the AP duration (APD) by 53 and 86 ms, respectively, which abbreviated the effective refractory period (ERP) and excitation wavelength in tissue, increasing the lifespan and dominant frequency (DF) of scroll waves in the 3D anatomical human atria. At the concentrations tested in this study, quinidine most effectively prolonged the APD and ERP in the setting of SQT1, followed by disopyramide and propafenone. In 2D simulations, disopyramide and quinidine promoted re-entry termination by increasing the re-entry wavelength, whereas propafenone induced secondary waves which destabilised the re-entrant circuit. In 3D simulations, the DF of re-entry was reduced in a dose-dependent manner for disopyramide and quinidine, and propafenone to a lesser extent. All of the anti-arrhythmic agents promoted pharmacological conversion, most frequently terminating re-entry in the order quinidine > propafenone = disopyramide. Our findings provide further insight into mechanisms of SQT1-related AF and a rational basis for the pursuit of combined IKr and INa block based pharmacological strategies in the treatment of SQT1-linked AF. ">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2018/12/12">
<meta name="citation_publication_date" content="2019/01/11">
<meta name="citation_author" content="Whittaker, Dominic G. ">
<meta name="citation_author_institution" content="Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, United Kingdom">
<meta name="citation_author" content="Hancox, Jules C. ">
<meta name="citation_author_institution" content="Biological Physics Group, School of Physics and Astronomy, The University of Manchester, United Kingdom">
<meta name="citation_author" content="Zhang, Henggui ">
<meta name="citation_author_institution" content="Biological Physics Group, School of Physics and Astronomy, The University of Manchester, United Kingdom">
<meta name="dc.identifier" content="doi:10.3389/fphys.2018.01888">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome","author":[{"@type":"Person","name":"Dominic G. Whittaker","affiliation":["Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, United Kingdom","Biological Physics Group, School of Physics and Astronomy, The University of Manchester, United Kingdom"]},{"@type":"Person","name":"Jules C. Hancox","affiliation":["Biological Physics Group, School of Physics and Astronomy, The University of Manchester, United Kingdom","Cardiovascular Research Laboratories, Department of Physiology, Pharmacology and Neuroscience, School of Medical Sciences, University of Bristol, United Kingdom"]},{"@type":"Person","name":"Henggui Zhang","affiliation":["Biological Physics Group, School of Physics and Astronomy, The University of Manchester, United Kingdom","School of Computer Science and Technology, Harbin Institute of Technology, China","Space Institute of Southern China, China","Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, China"]}],"datePublished":"2019-01-11","dateModified":"2025-11-26","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2019","isPartOf":{"@type":"PublicationVolume","volumeNumber":"9","isPartOf":{"@type":"Periodical","name":"Frontiers in Physiology"}}},"citation":["https://doi.org/10.3389/fphys.2018.01888"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="red"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/physiology" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Physiology</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=65&amp;specialtyid=0&amp;entitytype=2&amp;entityid=210" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/physiology" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Physiology</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/aquatic-physiology" data-event="iBarJournal-sections-a_id_230">Aquatic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/autonomic-neuroscience" data-event="iBarJournal-sections-a_id_157">Autonomic Neuroscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/avian-physiology" data-event="iBarJournal-sections-a_id_1328">Avian Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/biophysics" data-event="iBarJournal-sections-a_id_667">Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cardiac-electrophysiology" data-event="iBarJournal-sections-a_id_211">Cardiac Electrophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cell-physiology" data-event="iBarJournal-sections-a_id_2468">Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/chronobiology" data-event="iBarJournal-sections-a_id_1393">Chronobiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/clinical-and-translational-physiology" data-event="iBarJournal-sections-a_id_579">Clinical and Translational Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/computational-physiology-and-medicine" data-event="iBarJournal-sections-a_id_212">Computational Physiology and Medicine</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/craniofacial-biology-and-dental-research" data-event="iBarJournal-sections-a_id_214">Craniofacial Biology and Dental Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/developmental-physiology" data-event="iBarJournal-sections-a_id_1346">Developmental Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/environmental-aviation-and-space-physiology" data-event="iBarJournal-sections-a_id_1331">Environmental, Aviation and Space Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/exercise-physiology" data-event="iBarJournal-sections-a_id_215">Exercise Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/gastrointestinal-sciences" data-event="iBarJournal-sections-a_id_216">Gastrointestinal Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/integrative-physiology" data-event="iBarJournal-sections-a_id_218">Integrative Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/invertebrate-physiology" data-event="iBarJournal-sections-a_id_229">Invertebrate Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/lipid-and-fatty-acid-research" data-event="iBarJournal-sections-a_id_444">Lipid and Fatty Acid Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/medical-physics-and-imaging" data-event="iBarJournal-sections-a_id_670">Medical Physics and Imaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/membrane-physiology-and-membrane-biophysics" data-event="iBarJournal-sections-a_id_213">Membrane Physiology and Membrane Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/metabolic-physiology" data-event="iBarJournal-sections-a_id_2071">Metabolic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/mitochondrial-research" data-event="iBarJournal-sections-a_id_232">Mitochondrial Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/physio-logging" data-event="iBarJournal-sections-a_id_1496">Physio-logging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/red-blood-cell-physiology" data-event="iBarJournal-sections-a_id_1386">Red Blood Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/redox-physiology" data-event="iBarJournal-sections-a_id_219">Redox Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/renal-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_222">Renal Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/reproductive-and-mating-physiology" data-event="iBarJournal-sections-a_id_2527">Reproductive and Mating Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/respiratory-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_224">Respiratory Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skeletal-physiology" data-event="iBarJournal-sections-a_id_2275">Skeletal Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skin-physiology" data-event="iBarJournal-sections-a_id_2965">Skin Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/striated-muscle-physiology" data-event="iBarJournal-sections-a_id_221">Striated Muscle Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/vascular-physiology" data-event="iBarJournal-sections-a_id_225">Vascular Physiology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=65&amp;specialtyid=0&amp;entitytype=2&amp;entityid=210" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/physiology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Physiology</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/aquatic-physiology" data-event="iBarJournal-sections-a_id_230">Aquatic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/autonomic-neuroscience" data-event="iBarJournal-sections-a_id_157">Autonomic Neuroscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/avian-physiology" data-event="iBarJournal-sections-a_id_1328">Avian Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/biophysics" data-event="iBarJournal-sections-a_id_667">Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cardiac-electrophysiology" data-event="iBarJournal-sections-a_id_211">Cardiac Electrophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cell-physiology" data-event="iBarJournal-sections-a_id_2468">Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/chronobiology" data-event="iBarJournal-sections-a_id_1393">Chronobiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/clinical-and-translational-physiology" data-event="iBarJournal-sections-a_id_579">Clinical and Translational Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/computational-physiology-and-medicine" data-event="iBarJournal-sections-a_id_212">Computational Physiology and Medicine</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/craniofacial-biology-and-dental-research" data-event="iBarJournal-sections-a_id_214">Craniofacial Biology and Dental Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/developmental-physiology" data-event="iBarJournal-sections-a_id_1346">Developmental Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/environmental-aviation-and-space-physiology" data-event="iBarJournal-sections-a_id_1331">Environmental, Aviation and Space Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/exercise-physiology" data-event="iBarJournal-sections-a_id_215">Exercise Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/gastrointestinal-sciences" data-event="iBarJournal-sections-a_id_216">Gastrointestinal Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/integrative-physiology" data-event="iBarJournal-sections-a_id_218">Integrative Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/invertebrate-physiology" data-event="iBarJournal-sections-a_id_229">Invertebrate Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/lipid-and-fatty-acid-research" data-event="iBarJournal-sections-a_id_444">Lipid and Fatty Acid Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/medical-physics-and-imaging" data-event="iBarJournal-sections-a_id_670">Medical Physics and Imaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/membrane-physiology-and-membrane-biophysics" data-event="iBarJournal-sections-a_id_213">Membrane Physiology and Membrane Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/metabolic-physiology" data-event="iBarJournal-sections-a_id_2071">Metabolic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/mitochondrial-research" data-event="iBarJournal-sections-a_id_232">Mitochondrial Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/physio-logging" data-event="iBarJournal-sections-a_id_1496">Physio-logging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/red-blood-cell-physiology" data-event="iBarJournal-sections-a_id_1386">Red Blood Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/redox-physiology" data-event="iBarJournal-sections-a_id_219">Redox Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/renal-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_222">Renal Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/reproductive-and-mating-physiology" data-event="iBarJournal-sections-a_id_2527">Reproductive and Mating Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/respiratory-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_224">Respiratory Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skeletal-physiology" data-event="iBarJournal-sections-a_id_2275">Skeletal Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skin-physiology" data-event="iBarJournal-sections-a_id_2965">Skin Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/striated-muscle-physiology" data-event="iBarJournal-sections-a_id_221">Striated Muscle Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/vascular-physiology" data-event="iBarJournal-sections-a_id_225">Vascular Physiology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/physiology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Physiology</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/aquatic-physiology" data-event="iBarJournal-sections-a_id_230">Aquatic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/autonomic-neuroscience" data-event="iBarJournal-sections-a_id_157">Autonomic Neuroscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/avian-physiology" data-event="iBarJournal-sections-a_id_1328">Avian Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/biophysics" data-event="iBarJournal-sections-a_id_667">Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cardiac-electrophysiology" data-event="iBarJournal-sections-a_id_211">Cardiac Electrophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cell-physiology" data-event="iBarJournal-sections-a_id_2468">Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/chronobiology" data-event="iBarJournal-sections-a_id_1393">Chronobiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/clinical-and-translational-physiology" data-event="iBarJournal-sections-a_id_579">Clinical and Translational Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/computational-physiology-and-medicine" data-event="iBarJournal-sections-a_id_212">Computational Physiology and Medicine</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/craniofacial-biology-and-dental-research" data-event="iBarJournal-sections-a_id_214">Craniofacial Biology and Dental Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/developmental-physiology" data-event="iBarJournal-sections-a_id_1346">Developmental Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/environmental-aviation-and-space-physiology" data-event="iBarJournal-sections-a_id_1331">Environmental, Aviation and Space Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/exercise-physiology" data-event="iBarJournal-sections-a_id_215">Exercise Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/gastrointestinal-sciences" data-event="iBarJournal-sections-a_id_216">Gastrointestinal Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/integrative-physiology" data-event="iBarJournal-sections-a_id_218">Integrative Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/invertebrate-physiology" data-event="iBarJournal-sections-a_id_229">Invertebrate Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/lipid-and-fatty-acid-research" data-event="iBarJournal-sections-a_id_444">Lipid and Fatty Acid Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/medical-physics-and-imaging" data-event="iBarJournal-sections-a_id_670">Medical Physics and Imaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/membrane-physiology-and-membrane-biophysics" data-event="iBarJournal-sections-a_id_213">Membrane Physiology and Membrane Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/metabolic-physiology" data-event="iBarJournal-sections-a_id_2071">Metabolic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/mitochondrial-research" data-event="iBarJournal-sections-a_id_232">Mitochondrial Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/physio-logging" data-event="iBarJournal-sections-a_id_1496">Physio-logging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/red-blood-cell-physiology" data-event="iBarJournal-sections-a_id_1386">Red Blood Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/redox-physiology" data-event="iBarJournal-sections-a_id_219">Redox Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/renal-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_222">Renal Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/reproductive-and-mating-physiology" data-event="iBarJournal-sections-a_id_2527">Reproductive and Mating Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/respiratory-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_224">Respiratory Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skeletal-physiology" data-event="iBarJournal-sections-a_id_2275">Skeletal Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skin-physiology" data-event="iBarJournal-sections-a_id_2965">Skin Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/striated-muscle-physiology" data-event="iBarJournal-sections-a_id_221">Striated Muscle Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/vascular-physiology" data-event="iBarJournal-sections-a_id_225">Vascular Physiology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=65&amp;specialtyid=0&amp;entitytype=2&amp;entityid=210" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Physiol.</span><span>, 11 January 2019</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Computational Physiology and Medicine</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 9 - 2018 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fphys.2018.01888">https://doi.org/10.3389/fphys.2018.01888</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Cardiac Modeling: Aiming for Optimization of Therapy</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 16 articles" href="https://www.frontiersin.org/research-topics/7807/cardiac-modeling-aiming-for-optimization-of-therapy/magazine" target="_self" data-event="customLink-linkType-a_viewAll16Articles"><span>View all 16 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1><i>In silico</i> Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract">
<a id="h1" name="h1"></a>
<div class="authors"><span class="author-wrapper notranslate">
<a href="https://loop.frontiersin.org/people/462272" class="user-id-462272"><img class="pr5" src="https://loop.frontiersin.org/images/profile/462272/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="
Dominic G. Whittaker,">Dominic G. Whittaker</a><sup>1,2</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/91129" class="user-id-91129"><img class="pr5" src="https://loop.frontiersin.org/images/profile/91129/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Jules C. Hancox,*">Jules C. Hancox</a><sup>2,3</sup><sup>*</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/27383" class="user-id-27383"><img class="pr5" src="https://loop.frontiersin.org/images/profile/27383/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Henggui Zhang,,,*">Henggui Zhang</a><sup>2,4,5,6</sup><sup>*</sup></span></div>
<ul class="notes">
<li><span><sup>1</sup></span>Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom</li>
<li><span><sup>2</sup></span>Biological Physics Group, School of Physics and Astronomy, The University of Manchester, Manchester, United Kingdom</li>
<li><span><sup>3</sup></span>Cardiovascular Research Laboratories, Department of Physiology, Pharmacology and Neuroscience, School of Medical Sciences, University of Bristol, Bristol, United Kingdom</li>
<li><span><sup>4</sup></span>School of Computer Science and Technology, Harbin Institute of Technology, Harbin, China</li>
<li><span><sup>5</sup></span>Space Institute of Southern China, Shenzhen, China</li>
<li><span><sup>6</sup></span>Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China</li>
</ul>
<p>Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the <i>human Ether-&#x000E0;-go-go-Related Gene</i> (<i>hERG</i>), which encodes the &#x003B1; subunit of channels carrying rapid delayed rectifier potassium current, <i>I</i><sub>Kr</sub>. In addition to QT interval shortening and ventricular arrhythmias, SQT1 is associated with increased risk of atrial fibrillation (AF), which is often the only clinical presentation. However, the underlying basis of AF and its pharmacological treatment remain incompletely understood in the context of SQT1. In this study, computational modeling was used to investigate mechanisms of human atrial arrhythmogenesis consequent to a SQT1 mutation, as well as pharmacotherapeutic effects of selected class I drugs&#x02013;disopyramide, quinidine, and propafenone. A Markov chain formulation describing wild type (WT) and N588K-hERG mutant <i>I</i><sub>Kr</sub> was incorporated into a contemporary human atrial action potential (AP) model, which was integrated into one-dimensional (1D) tissue strands, idealized 2D sheets, and a 3D heterogeneous, anatomical human atria model. Multi-channel pharmacological effects of disopyramide, quinidine, and propafenone, including binding kinetics for <i>I</i><sub>Kr</sub>/hERG and sodium current, <i>I</i><sub>Na</sub>, were considered. Heterozygous and homozygous formulations of the N588K-hERG mutation shortened the AP duration (APD) by 53 and 86 ms, respectively, which abbreviated the effective refractory period (ERP) and excitation wavelength in tissue, increasing the lifespan and dominant frequency (DF) of scroll waves in the 3D anatomical human atria. At the concentrations tested in this study, quinidine most effectively prolonged the APD and ERP in the setting of SQT1, followed by disopyramide and propafenone. In 2D simulations, disopyramide and quinidine promoted re-entry termination by increasing the re-entry wavelength, whereas propafenone induced secondary waves which destabilized the re-entrant circuit. In 3D simulations, the DF of re-entry was reduced in a dose-dependent manner for disopyramide and quinidine, and propafenone to a lesser extent. All of the anti-arrhythmic agents promoted pharmacological conversion, most frequently terminating re-entry in the order quinidine &#x0003E; propafenone = disopyramide. Our findings provide further insight into mechanisms of SQT1-related AF and a rational basis for the pursuit of combined <i>I</i><sub>Kr</sub> and <i>I</i><sub>Na</sub> block based pharmacological strategies in the treatment of SQT1-linked AF.</p>
<div class="clear"></div></div>
<div class="JournalFullText">
<a id="h2" name="h2"></a><h2>Introduction</h2>
<p class="mb15">The short QT syndrome (SQTS) is characterized primarily by a short QT interval on the ECG, which corresponds to abbreviated ventricular repolarisation. However, symptomatic atrial fibrillation (AF) has also been reported as a common first clinical presentation of the SQTS (<a href="#B62">Schimpf et al., 2005</a>), suggesting that pathophysiological mechanisms leading to shortening of the QT interval also affect the atria, which can increase susceptibility to AF. The N588K mutation to the <i>human Ether-&#x000E0;-go-go-Related gene (hERG)</i>, which encodes the &#x003B1; subunit of channels carrying rapid delayed rectifier potassium current, <i>I</i><sub>Kr</sub>, underlies a form of SQTS variant 1 (SQT1) (<a href="#B12">Brugada et al., 2004</a>), and has been associated with a high incidence of AF in affected probands&#x02014;as high as 50% (<a href="#B34">Hu et al., 2017</a>). Whilst ventricular arrhythmia substrates in SQT1 have received much attention (<a href="#B78">Zhang and Hancox, 2004</a>; <a href="#B56">Patel and Antzelevitch, 2008</a>; <a href="#B2">Adeniran et al., 2011</a>), there have been comparatively fewer studies investigating mechanisms by which SQT1 mutations promote AF, which can be an important biomarker of the SQTS. Furthermore, effective management of AF remains a challenge, and is incompletely understood in the context of SQT1 (<a href="#B22">Enriquez et al., 2016</a>; <a href="#B31">Hancox et al., 2018</a>).</p>
<p class="mb15">A previous simulation study (<a href="#B44">Loewe et al., 2014b</a>) used the Courtemanche-Ramirez-Nattel (CRN) mathematical model of the human atrial action potential (AP) (<a href="#B17">Courtemanche et al., 1998</a>) to demonstrate shortening of the atrial effective refractory period (ERP) and tissue excitation wavelength (WL) consequent to the N588K-hERG mutation. This was shown to facilitate initiation and sustenance of spiral waves in idealized two-dimensional (2D) sheets of human atrial tissue, which is a likely mechanism for increased susceptibility to AF. However, both the intrinsic electrical heterogeneities and complex anatomy of the human atria have also been suggested to influence arrhythmia vulnerability and dynamics in overall response to K<sup>&#43;</sup> channel mutations (<a href="#B15">Colman et al., 2017</a>; <a href="#B74">Whittaker et al., 2017b</a>). Consequently, the first aim of the present study was to assess the arrhythmogenicity of the N588K-hERG mutation in anatomically-detailed models of the human atria with realistic structure and inclusion of regional differences in electrophysiology.</p>
<p class="mb0">The class Ia anti-arrhythmic drug quinidine is typically used as the frontline therapy for QT interval normalization in SQT1 (<a href="#B26">Gaita et al., 2004</a>; <a href="#B27">Giustetto, 2006</a>; <a href="#B34">Hu et al., 2017</a>), and disopyramide has been suggested as a possible alternative (<a href="#B20">Dumaine and Antzelevitch, 2006</a>; <a href="#B61">Schimpf et al., 2007</a>). Regarding management of atrial arrhythmias, the class Ic anti-arrhythmic drug propafenone has been reported to be effective at preventing recurrent episodes of (paroxysmal) AF mediated by the N588K mutation to hERG (<a href="#B33">Hong et al., 2005</a>; <a href="#B9">Bjerregaard et al., 2006</a>), maintaining 2 patients free of arrhythmia recurrence for &#x0003E;2 years (<a href="#B33">Hong et al., 2005</a>). In an experimental setting in which a hERG activator was used to approximate SQT1, quinidine (a blocker of <i>I</i><sub>Na</sub> and <i>I</i><sub>Kr</sub>) was effective at extending atrial AP duration and ERP and preventing AF (<a href="#B54">Nof et al., 2010</a>), more so than E-4031 (a selective <i>I</i><sub>Kr</sub> blocker) or lidocaine (an <i>I</i><sub>Na</sub> blocker) alone, suggesting that K<sup>&#43;</sup> and Na<sup>&#43;</sup> channel blocking effects combine synergistically for improved management of AF in SQT1. Similarly, in our previous study, a multi-scale computational modeling approach was used to investigate ventricular pharmacological effects of disopyramide and quinidine in SQT1 (<a href="#B73">Whittaker et al., 2017a</a>), where combined <i>I</i><sub>Na</sub> and <i>I</i><sub>Kr</sub> block by both compounds was shown to prolong ERP to a greater extent than <i>I</i><sub>Na</sub> or <i>I</i><sub>Kr</sub> block alone. Mechanisms by which Na<sup>&#43;</sup> and K<sup>&#43;</sup>-channel blocking agents may provide beneficial effects in the context of SQT1-mediated human atrial pro-arrhythmia remain unclear. A multi-scale cardiac modeling approach is being used increasingly for optimisation of therapy (<a href="#B77">Yuan et al., 2015</a>). Consequently, the second aim of the present study was to assess the efficacy of the class I drugs disopyramide, quinidine, and propafenone on rate and rhythm control of human atrial arrhythmias mediated by SQT1, from cell to 3D tissue levels, using drug binding models (including reduced potency of drugs against SQT1 mutant <i>I</i><sub>Kr</sub>) with multi-channel pharmacology.</p>
<a id="h3" name="h3"></a><h2>Methods</h2>
<h3 class="pt0">Modeling Human Atrial Electrophysiology</h3>
<p class="mb0">Human atrial electrophysiology was simulated using the Colman et al. model (<a href="#B14">Colman et al., 2013</a>), as updated recently (<a href="#B53">Ni et al., 2017</a>), and is hereinafter referred to as the CNZ (Colman-Ni-Zhang) model. The equations for <i>I</i><sub>Kr</sub> in the CNZ model were replaced with previously developed and validated Markov chain formulations of wild type (WT) and N588K mutant <i>I</i><sub>Kr</sub>/hERG (<a href="#B73">Whittaker et al., 2017a</a>). The maximal conductance of <i>I</i><sub>Kr</sub> was set to <i>g</i><sub>Kr</sub> = 0.0111375<math><mo>&#x000B7;</mo><msubsup><mrow><mrow><mo>[</mo><mrow><msup><mrow><mi>K</mi></mrow><mrow><mo>&#43;</mo></mrow></msup></mrow><mo>]</mo></mrow></mrow><mrow><mi>o</mi></mrow><mrow><mn>0</mn><mo>.</mo><mn>59</mn></mrow></msubsup></math>, where <math><msub><mrow><mrow><mo>[</mo><mrow><msup><mrow><mi>K</mi></mrow><mrow><mo>&#43;</mo></mrow></msup></mrow><mo>]</mo></mrow></mrow><mrow><mi>o</mi></mrow></msub></math> is the extracellular potassium concentration (<a href="#B2">Adeniran et al., 2011</a>), resulting in an action potential duration (APD) at 90% repolarisation (APD<sub>90</sub>) of 248.8 ms at 1 Hz in the baseline human atrial cell model, which is well within the experimentally-measured range of APDs in human atrial myocytes (<a href="#B10">Bosch et al., 1999</a>; <a href="#B36">Kim et al., 2002</a>; <a href="#B18">Dobrev and Ravens, 2003</a>; <a href="#B35">Katoh et al., 2005</a>; <a href="#B59">Redpath et al., 2006</a>; <a href="#B57">Pau et al., 2007</a>). A family of regional human atrial cell models was incorporated into the CNZ model, accounting for distinct differences in electrophysiology of the right and left atrium (RA and LA, respectively), right and left atrial appendages (RAA and LAA, respectively), crista terminalis (CT), pectinate muscles (PM), atrio-ventricular ring (AVR), atrial septum (AS), Bachmann&#x00027;s bundle (BB), and pulmonary veins (PV) (<a href="#B14">Colman et al., 2013</a>). Changes to maximal ionic conductances relative to the RA model implemented in order to create a family of regional cell models are given in Table <a href="#SM1">S1</a>. The homozygous (N588K) form of SQT1 was modeled as consisting of 100% mutant subunits, whereas the heterozygous (WT-N588K) form was assumed to consist of a 1:1 WT:mutant subunit ratio (<a href="#B73">Whittaker et al., 2017a</a>).</p>
<h3>Modeling Pharmacological Actions of Disopyramide and Quinidine</h3>
<p class="mb0">In our previous study (<a href="#B73">Whittaker et al., 2017a</a>), the actions of the class Ia anti-arrhythmic drugs disopyramide and quinidine on human ventricles were simulated in the setting of SQT1. State-dependent binding of disopyramide and quinidine to hERG channels was simulated through addition of drug-bound open and inactivated states to Markov chain formulations of <i>I</i><sub>Kr</sub>, and the guarded receptor model (<a href="#B66">Starmer et al., 1984</a>) was used to describe use-dependent block of fast sodium current, <i>I</i><sub>Na</sub>, by both agents. Furthermore, the blocking actions of disopyramide and quinidine on slow delayed rectifier potassium current, <i>I</i><sub>Ks</sub>, L-type calcium current, <i>I</i><sub>CaL</sub>, transient outward potassium current, <i>I</i><sub>to</sub>, inward rectifier potassium current, <i>I</i><sub>K1</sub> (quinidine only), and late sodium current, <i>I</i><sub>NaL</sub> (quinidine only), were modeled using a simple &#x0201C;pore block&#x0201D; approach. In the present study, the actions of disopyramide and quinidine on human atrial electrophysiology were represented using the same formulations and IC<sub>50</sub> (half maximal inhibitory concentration) values presented in <a href="#B73">Whittaker et al. (2017a)</a>. In addition, disopyramide and quinidine have both been reported to block the atrial-specific ultra-rapid delayed rectifier potassium current, <i>I</i><sub>Kur</sub>. For disopyramide, the IC<sub>50</sub> for block of <i>I</i><sub>Kur</sub> was taken to be 25.0 &#x003BC;M (<a href="#B6">Ar&#x000E9;chiga et al., 2008</a>), and for quinidine the IC<sub>50</sub> was taken to be 6.6 &#x003BC;M, as measured in human atrial myocytes (<a href="#B52">Nenov et al., 1998</a>). As the CNZ model does not include late sodium current, quinidine block of <i>I</i><sub>NaL</sub> was not included in simulations. Full details of disopyramide and quinidine models can be found in <a href="#B73">Whittaker et al. (2017a)</a>.</p>
<h3>Modeling Pharmacological Actions of Propafenone</h3>
<p class="mb0">Using the same approach as detailed for disopyramide and quinidine in <a href="#B73">Whittaker et al. (2017a)</a>, state-dependent models of drug block by propafenone were developed. Interactions between propafenone and <i>I</i><sub>Kr</sub>/hERG were developed based on experimental data obtained at 37&#x000B0;C (<a href="#B58">Paul et al., 2002</a>; <a href="#B47">McPate et al., 2008</a>), where estimation of parameters for drug-bound states of the Markov chain formulation of <i>I</i><sub>Kr</sub> was performed using the procedure outlined in <a href="#B50">Moreno et al. (2016)</a>. Binding and unbinding rates to activated and inactivated state channels were allowed to vary freely in order to minimize the difference between simulated and experimental dose-dependent steady state block (WT and N588K), mean fractional block of tail currents during a pulse protocol, and voltage-dependence of tail current block (<a href="#B58">Paul et al., 2002</a>; <a href="#B47">McPate et al., 2008</a>). The extended drug-free Markov chain model of <i>I</i><sub>Kr</sub>/hERG is shown in Figure <a href="#F1">1</a>, as well as the close concordance between simulated and experimental data regarding propafenone block of <i>I</i><sub>hERG</sub>. Parameters and state affinities are given in Table <a href="#SM1">S2</a>.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 1</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg" name="figure1" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg" alt="www.frontiersin.org" id="F1" loading="lazy">
  </picture>
</a>
<p><strong>Figure 1</strong>. Propafenone interactions with hERG channels. <strong>(Ai)</strong> Drug-free and <strong>(Aii)</strong> drug-bound (additional states shown in green) Markov chain models of <i>I</i><sub>Kr</sub>/hERG. Simulated (solid line) and experimental (points) mean fractional block by 0.5 &#x003BC;M propafenone (PROPAF) of <i>I</i><sub>hERG</sub> during pulse protocol (shown inset) <strong>(Bi)</strong>, and dose-response curve under WT (blue) and SQT1 mutant N588K (red) conditions <strong>(Bii)</strong>, where IC<sub>50</sub> values are 390 nM and 936 nM (2.4-fold increase), respectively. <strong>(Ci)</strong> Simulated and <strong>(Cii)</strong> experimental current traces in response to a 10,000 ms depolarising voltage step to 0 mV from a holding potential of &#x02212;80 mV <strong>(Di,Dii)</strong> under control conditions and with application of 0.5 &#x003BC;M PROPAF &#x02013; these data were used to validate and not to further train the model. Experimental data at 37&#x000B0;C are taken from <a style="color:grey;" href="#B58">Paul et al. (2002)</a> and <a style="color:grey;" href="#B47">McPate et al. (2008)</a>.</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mt15 w100pc float_left">Propafenone is a class Ic sodium channel blocking anti-arrhythmic drug (<a href="#B60">Roden, 2014</a>). Use-dependent block of sodium channels by propafenone was represented using the guarded receptor hypothesis (<a href="#B66">Starmer et al., 1984</a>), as described for disopyramide and quinidine. Propafenone is predominantly an open state sodium channel blocker with little to no resting state block (<a href="#B21">Edrich et al., 2005</a>; <a href="#B13">Burashnikov et al., 2012</a>), and was thus assumed to bind only to activated and inactivated states. Binding and unbinding parameters were constrained based on the dose-dependent, use-dependent, and steady state block of <i>I</i><sub>Na</sub> by propafenone (<a href="#B32">Harmer et al., 2008</a>), as shown in Figure <a href="#F2">2A</a>. Binding and unbinding parameters and state affinities are given in Table <a href="#SM1">S3</a>.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 2</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg" name="figure2" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg" alt="www.frontiersin.org" id="F2" loading="lazy">
  </picture>
</a>
<p><strong>Figure 2</strong>. Propafenone interactions with sodium channels. <strong>(Ai)</strong> Simulated (solid lines) and experimental (points) use-dependent block of sodium channels by propafenone (PROPAF) elicited using a series of 8 pulses from &#x02212;90 mV to 0 mV at 3 Hz for three different test concentrations. <strong>(Aii)</strong> Steady state block of sodium channels using pulses from &#x02212;90 mV to 0 mV at 3 Hz until a steady state was achieved. Experimental data are taken from <a style="color:grey;" href="#B32">Harmer et al. (2008)</a>, where the steady state block IC<sub>50</sub> value is given as 1.4 &#x003BC;M. <strong>(B)</strong> Simulated and <strong>(C)</strong> experimentally-measured PROPAF-induced reduction in maximum upstroke velocity (<math><msub><mrow><mover accent="true"><mrow><mi>V</mi></mrow><mo>&#x000B0;</mo></mover></mrow><mrow><mo class="qopname">max</mo></mrow></msub></math>) upon application of 0.3 and 1.5 &#x003BC;M PROPAF at a cycle length (CL) of (i) 500 ms and (ii) 300 ms. All <math><msub><mrow><mover accent="true"><mrow><mi>V</mi></mrow><mo>&#x000B0;</mo></mover></mrow><mrow><mo class="qopname">max</mo></mrow></msub></math> reductions are relative to the control (C) value at a CL of 500 ms. Experimental data, recorded from canine atrial myocytes, are taken from <a style="color:grey;" href="#B13">Burashnikov et al. (2012)</a>.</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb15 w100pc float_left mt15">Whilst propafenone most potently blocks <i>I</i><sub>Kr</sub> and <i>I</i><sub>Na</sub>, it is a multi-channel blocker, and thus exerts secondary effects on other ion channels, which were modeled using a simple pore block based on IC<sub>50</sub> values from the literature. Propafenone blocks <i>I</i><sub>CaL</sub> with an IC<sub>50</sub> of 1.5&#x02013;1.7 &#x003BC;M in mammalian cardiac myocytes (<a href="#B23">Fei et al., 1993</a>; <a href="#B30">Hancox and Mitcheson, 1997</a>). In human atrial myocytes, propafenone has been shown to block <i>I</i><sub>to</sub> with an IC<sub>50</sub> of 4.8 &#x003BC;M (<a href="#B29">Gross and Castle, 1998</a>; <a href="#B64">Seki et al., 1999</a>) and <i>I</i><sub>K1</sub> with an IC<sub>50</sub> of 16.8 &#x003BC;M (<a href="#B5">Amor&#x000F3;s et al., 2013</a>). Finally, <i>I</i><sub>Kur</sub> is blocked with an IC<sub>50</sub> of 4.4 &#x003BC;M (<a href="#B24">Franqueza et al., 1998</a>). The therapeutic range of propafenone has been estimated to be between 2 and 6 &#x003BC;M (<a href="#B58">Paul et al., 2002</a>). Taking into account plasma protein binding, estimates of the most likely unbound concentrations have been given as 0.15&#x02013;0.7 &#x003BC;M (<a href="#B65">Slawsky and Castle, 1994</a>), 0.2&#x02013;0.6 &#x003BC;M (<a href="#B19">Duan et al., 1993</a>), and 0.33&#x02013;1 &#x003BC;M (<a href="#B64">Seki et al., 1999</a>). In this study, the effects of three equally-spaced concentrations which fell within this range were studied&#x02212;0.2, 0.5, and 0.8 &#x003BC;M propafenone. It should be noted that these concentrations are not intended to be compared directly with those chosen for disopyramide and quinidine (1, 2, and 5 &#x003BC;M), which were taken from <a href="#B73">Whittaker et al. (2017a)</a> and are not equally-spaced. A comparison of IC<sub>50</sub> values used for disopyramide, quinidine, and propafenone is given in Table <a href="#SM1">S4</a>.</p>
<p class="mb0">In order to assess whether the combined actions of propafenone in the model induced reasonable rate- and concentration- dependent effects on the AP under control conditions, alterations in the maximum upstroke velocity (<math><msub><mrow><mover accent="true"><mrow><mi>V</mi></mrow><mo>&#x000B0;</mo></mover></mrow><mrow><mo class="qopname">max</mo></mrow></msub></math>) upon application of propafenone were compared with experimental data taken from canine atrial cells (<a href="#B13">Burashnikov et al., 2012</a>). Figure <a href="#F2">2B</a> shows changes in <math><msub><mrow><mover accent="true"><mrow><mi>V</mi></mrow><mo>&#x000B0;</mo></mover></mrow><mrow><mo class="qopname">max</mo></mrow></msub></math> upon application of 0.3 and 1.5 &#x003BC;M propafenone at cycle lengths of 500 and 300 ms, where close concordance can be seen between simulation and experiment (Figure <a href="#F2">2C</a>). Although experimental data were taken from canine atrial myocytes, the human atrial simulation data nonetheless recapitulated the considerable reduction in <math><msub><mrow><mover accent="true"><mrow><mi>V</mi></mrow><mo>&#x000B0;</mo></mover></mrow><mrow><mo class="qopname">max</mo></mrow></msub></math> at both concentrations and cycle lengths, which is primarily due to the sodium channel blocking actions of propafenone.</p>
<h3>Tissue Simulations</h3>
<p class="mb0">Propagation of excitation waves in tissue was described using the monodomain equation,</p>
<div class="equationImageholder"><math id="M1"><mtable class="eqnarray" columnalign="right center left"><mtr><mtd><mfrac><mrow><mi mathsize="10.5pt" mathcolor="black">&#x02202;</mi><mi mathsize="10.5pt" mathcolor="black">V</mi></mrow><mrow><mi mathsize="10.5pt" mathcolor="black">&#x02202;</mi><mi mathsize="10.5pt" mathcolor="black">t</mi></mrow></mfrac><mo mathsize="10.5pt" mathcolor="black">=</mo><mo mathsize="10.5pt" mathcolor="black">&#x02207;</mo><mrow><mo stretchy="false">(</mo><mrow><mstyle mathvariant="bold"><mstyle class="text" mathsize="10.5pt" mathcolor="black"><mtext>D</mtext></mstyle></mstyle><mo mathsize="10.5pt" mathcolor="black">&#x02207;</mo><mi mathsize="10.5pt" mathcolor="black">V</mi></mrow><mo stretchy="false">)</mo></mrow><mo mathsize="10.5pt" mathcolor="black">-</mo><mfrac><mrow><msub><mrow><mi mathsize="10.5pt" mathcolor="black">I</mi></mrow><mrow><mstyle class="text" mathsize="10.5pt" mathcolor="black"><mtext>ion</mtext></mstyle></mrow></msub></mrow><mrow><msub><mrow><mi mathsize="10.5pt" mathcolor="black">C</mi></mrow><mrow><mstyle class="text" mathsize="10.5pt" mathcolor="black"><mtext>m</mtext></mstyle></mrow></msub></mrow></mfrac><mo mathsize="10.5pt" mathcolor="black">,</mo></mtd><mtd><mstyle class="text" mathsize="10.5pt" mathcolor="black"><mtext>&#x000A0;&#x000A0;&#x000A0;&#x000A0;</mtext></mstyle><mrow><mo mathsize="10.5pt" mathcolor="black" stretchy='false'>(</mo><mn mathsize="10.5pt" mathcolor="black">1</mn><mo mathsize="10.5pt" mathcolor="black" stretchy='false'>)</mo></mrow></mtd></mtr></mtable></math><div class="clear"></div></div>
<p class="mb15">where <i>V</i> is the transmembrane voltage, <strong>D</strong> is the global conductivity tensor, <i>I</i><sub>ion</sub> is the total ionic current, and <i>C</i><sub>m</sub> is the membrane capacitance. Equation (1) was solved using a finite difference PDE solver based on the explicit forward Euler method and Strang splitting scheme. Effects of the N588K-hERG mutation on ERP, WL, conduction velocity (CV), and spiral wave dynamics were determined using 1D and 2D models of RA tissue, as described previously (<a href="#B74">Whittaker et al., 2017b</a>, <a href="#B72">2018</a>). Spiral waves were initiated in 2D models using an S1-S2 cross-shock protocol, and spiral wave core trajectories over a 5.0 s simulation period were traced by locating phase singularities (<a href="#B11">Bray and Wikswo, 2002</a>). The behavior of re-entrant excitations in an anatomically-realistic setting was determined using a 3D human atrial structured grid geometry based on the Visible Female dataset (<a href="#B63">Seemann et al., 2006</a>; <a href="#B14">Colman et al., 2013</a>; <a href="#B74">Whittaker et al., 2017b</a>) with rule-based fiber orientations (<a href="#B38">Krueger et al., 2011</a>). The transverse value of the diffusion coefficient, <i>D</i><sub>&#x022A5;</sub>, was set to 0.1 mm<sup>2</sup> ms<sup>&#x02212;1</sup>, where an anisotropy ratio (<i>D</i><sub>||</sub>:<i>D</i><sub>&#x022A5;</sub>) of 3:1 in directions longitudinal and transverse to fibers was applied in the atrial working myocardium, and a ratio of 9:1 along the fast conducting bundles of the BB, CT, and PM (<a href="#B14">Colman et al., 2013</a>; <a href="#B74">Whittaker et al., 2017b</a>), which gave global and specific regional activation times in close agreement with experimental measurements (<a href="#B42">Lemery et al., 2007</a>). The activation (ACT) time was defined as the time required for the membrane potential to reach &#x02212;20 mV at each point in the geometry (<a href="#B53">Ni et al., 2017</a>). Activation-recovery interval (ARI) was defined as the time interval between membrane potential depolarisation to &#x02212;20 mV and repolarisation to &#x02212;70 mV (adjusted to &#x02212;65 mV in the PV region due to higher resting membrane potential) (<a href="#B53">Ni et al., 2017</a>).</p>
<p class="mb0">Re-entry was initiated using the phase distribution method (<a href="#B8">Biktashev and Holden, 1998</a>; <a href="#B73">Whittaker et al., 2017a</a>), by initiating either a clockwise or anti-clockwise scroll wave (as seen from a RA posterior wall view). Where sustained re-entrant activity was initiated, a power spectrum was obtained through fast Fourier transform analysis of pseudo ECG (pECG) time series (recorded from within the RA cavity). The dominant frequency (DF) was computed in Matlab from the largest peak in the power spectrum density. For simulating the effects of disopyramide, quinidine, and propafenone on re-entrant excitation, state variables for each node within the 3D anatomical model were saved after 2.5 s of a 10.0 s episode of sustained re-entrant activity in drug-free conditions. These were then used as initial conditions for new 3D simulations of duration 7.5 s (giving 10.0 s activity overall) in which varying concentrations of anti-arrhythmic drugs (1, 2, or 5 &#x003BC;M disopyramide and quinidine; 0.2, 0.5, or 0.8 &#x003BC;M propafenone) were applied immediately. This gave 18 simulations in total; 3 doses for each of the 3 anti-arrhythmic drugs, with 2 scroll wave initial conditions (both clockwise and anti-clockwise).</p>
<a id="h4" name="h4"></a><h2>Results</h2>
<h3 class="pt0">Effects of SQT1 Mutant <i>I</i><sub>Kr</sub> on Human Atrial Action Potentials</h3>
<p class="mb0">Both SQT1 mutant conditions shortened the human atrial APD at a pacing rate of 1 Hz (Figure <a href="#F3">3Ai</a>), from 248.8 ms in the WT condition to 195.4 and 163.3 ms in heterozygous (WT-N588K) and homozygous (N588K) mutation conditions, respectively. This was due to loss of inactivation associated with the N588K-hERG mutation, which increased <i>I</i><sub>Kr</sub> early during the AP and served to accelerate the repolarisation process (Figure <a href="#F3">3Aii</a>). Action potential abbreviation reduced considerably the duration of the plateau phase, causing <i>I</i><sub>K1</sub> to contribute to terminal repolarisation earlier during the AP (Figure <a href="#F3">3Aiii</a>), and lesser activation and reduced contribution of <i>I</i><sub>Ks</sub> (Figure <a href="#F3">3Aiv</a>). The SQT1 mutation also decreased net <i>I</i><sub>CaL</sub> due to the abbreviated plateau phase (Figure <a href="#F3">3Av</a>), shortening the APD<sub>90</sub> under heterozygous and homozygous conditions (Figure <a href="#F3">3Avi</a>). In tissue, accelerated repolarisation under SQT1 conditions shortened the ERP and consequently the excitation WL. At the organ scale (in the 3D anatomical human atria model), both heterozygous and homozygous forms of the N588K-hERG mutation decreased global ARI (Figure <a href="#F3">3B</a>), whilst preserving the global dispersion of ARI. Furthermore, whereas &#x00394;ARI was decreased between CT/PM regions, it was increased between PV/LA and RA/LA regions under SQT1 conditions (Figure <a href="#F3">3C</a>). A summary of the effects of the N588K-hERG mutation on multi-scale human atrial AP biomarkers is given in Table <a href="#T1">1</a>.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 3</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg" name="figure3" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg" alt="www.frontiersin.org" id="F3" loading="lazy">
  </picture>
</a>
<p><strong>Figure 3</strong>. Effects of the N588K-hERG mutation at the single cell and whole human atria level. <strong>(Ai)</strong> Single cell action potential profiles under WT (blue), WT-N588K (green), and N588K (red) conditions at a pacing frequency of 1 Hz, with corresponding current traces for <strong>(Aii)</strong> <i>I</i><sub>Kr</sub>, <strong>(Aiii)</strong> <i>I</i><sub>K1</sub>, <strong>(Aiv)</strong> <i>I</i><sub>Ks</sub>, and <strong>(Av)</strong> <i>I</i><sub>CaL</sub>, and <strong>(Avi)</strong> a summary of the measured APD<sub>90</sub>. <strong>(B)</strong> Activation-recovery interval (ARI) maps under (i) WT, (ii) WT-N588K, and (iii) N588K conditions. <strong>(Ci)</strong> View looking into the cavities of the 3D anatomical human atria model, with the following regions highlighted: crista terminalis (CT), left atrium (LA), pectinate muscles (PM), pulmonary veins (PV), and right atrium (RA). <strong>(Cii)</strong> Measured dispersion of activation-recovery interval, &#x00394;ARI, between different atrial regions under WT and SQT1 mutation conditions.</p></div>
<div class="clear"></div>
<div class="DottedLine mb15"></div>
<div class="Imageheaders">TABLE 1</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg" name="Table1" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy">
  </picture>
</a>
<p><strong>Table 1</strong>. A summary of multi-scale simulation results.</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Scroll Wave Dynamics in 3D Anatomical Human Atria Geometry</h3>
<p class="mb0">A summary of 3D scroll wave simulations in the anatomical human atria model under WT and SQT1 mutation conditions (in a clockwise configuration from a RA posterior wall aspect) is given in Figure <a href="#F4">4</a>. In the WT condition, scroll waves followed 2 transient, fragmented circuits around the RA, before self-terminating at &#x0007E;0.7 s (Video <a href="#SM1">S1</a>), which precluded accurate measurement of the DF. In the WT-N588K condition, re-entrant wave activity sustained for the entire 10.0 s with a DF of 4.99 Hz, and was driven mostly by a macro re-entrant circuit around the right AVR, whilst also showing CT/isthmus driven activity in the RA (Video <a href="#SM1">S2</a>). Under homozygous N588K mutation conditions, scroll wave activity was also driven predominantly by a re-entrant circuit around the AVR, with occasional existence of multiple waves on the RA free wall (Video <a href="#SM1">S3</a>), and a DF of 5.59 Hz. A summary of simulations using anti-clockwise scroll wave initial conditions is shown in Figure <a href="#SM1">S1</a>, and an average of the DF from both simulations (where applicable) measured from the first 5.0 s of activity is given in Table <a href="#T1">1</a>.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 4</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg" name="figure4" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg" alt="www.frontiersin.org" id="F4" loading="lazy">
  </picture>
</a>
<p><strong>Figure 4</strong>. Scroll waves under WT and SQT1 mutation conditions in the 3D anatomical human atria model. (i) Evolution of scroll waves following initiation of re-entry in a clockwise configuration (from a RA posterior wall aspect) at times <i>t</i> = 100 ms, <i>t</i> = 1,000 ms, <i>t</i> = 5,000 ms, and <i>t</i> = 10,000 ms under <strong>(A)</strong> WT, <strong>(B)</strong> WT-N588K, and <strong>(C)</strong> N588K conditions, with (ii) corresponding pseudo ECGs taken from the first 5.0 s of re-entry simulations.</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Effects of Class I Drugs on Human Atrial Action Potentials</h3>
<p class="mb0">In order to assess the actions of class I anti-arrhythmic drugs on the human atria at the cellular level, the effects of applying various concentrations of disopyramide, quinidine, and propafenone were investigated on the single cell AP under heterozygous WT-N588K (hereinafter referred to simply as SQT1) conditions. Figure <a href="#F5">5</a> shows AP profiles under drug-free SQT1 conditions and upon application of different concentrations of each drug at a pacing frequency of 1 Hz, with corresponding fractional block of <i>I</i><sub>Kr</sub> and <i>I</i><sub>Na</sub>. Application of all concentrations of disopyramide and propafenone produced only modest prolongation of the APD, failing to restore it to that of the WT condition. Quinidine, on the other hand, was more effective at prolonging the APD due to extensive <i>I</i><sub>Kr</sub> block, with the highest concentration (5 &#x003BC;M) prolonging the APD beyond that of the WT level. In contrast, all three agents prolonged the ERP effectively, restoring it to (or exceeding) that of the WT level at the highest respective concentrations tested, due to additional ERP-prolonging effects of <i>I</i><sub>Na</sub> block.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 5</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg" name="figure5" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg" alt="www.frontiersin.org" id="F5" loading="lazy">
  </picture>
</a>
<p><strong>Figure 5</strong>. Effects of class I drugs on human atrial electrophysiology in SQT1. Effects of <strong>(A)</strong> disopyramide (DISO), <strong>(B)</strong> quinidine (QUIN), and <strong>(C)</strong> propafenone (PROPAF) on (i) single human atrial cell action potentials (APs) under wild type (WT) conditions (blue, dashed line), drug-free WT-N588K (SQT1) conditions (green, solid line), and SQT1 &#43; varying drug concentrations (purple, orange, and red solid lines). Corresponding fractional block of (ii) <i>I</i><sub>Kr</sub> and (iii) <i>I</i><sub>Na</sub>, and (iv) increase in APD<sub>90</sub> (red) and effective refractory period (ERP; blue). <strong>(D)</strong> Activation sequences in the 3D anatomical human atria model under (i) drug-free SQT1 (control &#x02013; C), (ii) SQT1 &#43; 2 &#x003BC;M DISO, (iii) SQT1 &#43; 2 &#x003BC;M QUIN, and (iv) SQT1 &#43; 0.5 &#x003BC;M PROPAF conditions, with corresponding <strong>(E)</strong> activation (ACT) time summarized as a barchart. All simulations performed at a basic cycle length of 1,000 ms.</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mt15 w100pc float_left">Conduction slowing due to sodium channel block by the three drugs caused an increase in activation time in the 3D anatomical human atria model (Figure <a href="#F5">5D</a>), which was most prominent for quinidine and least prominent for propafenone at the concentrations tested. A summary of the effects of pharmacological modulation across multiple scales is given in Table <a href="#T2">2</a>. In addition, in the 1D tissue model, the rate-dependent effects of disopyramide, quinidine, and propafenone on the ERP, CV, and WL are shown in Figure <a href="#SM1">S2</a>. Quinidine was shown to produce the most potent effects on CV and ERP at all pacing rates. Propafenone exerted the weakest effects on ERP at fast pacing rates, but had the greatest propensity to promote beat-to-beat alternans.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">TABLE 2</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg" name="Table2" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg" alt="www.frontiersin.org" id="T2" loading="lazy">
  </picture>
</a>
<p><strong>Table 2</strong>. A summary of multi-scale pharmacological simulation results.</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Pharmacological Effects of Class I Drugs on Re-entry Dynamics</h3>
<p class="mb0">In 2D simulations, under drug-free WT conditions the initiated spiral wave failed to re-enter the tissue (not shown). Under drug-free SQT1 conditions, the initiated spiral wave sustained for the 5.0 s duration of the simulation, eventually settling into a stationary, epicycloidal trajectory (Figure <a href="#F6">6Ai</a>). Application of 5 &#x003BC;M disopyramide was sufficient to terminate re-entry, as the re-entry wavelength was increased to such an extent that the spiral wave meandered out of the tissue (Figure <a href="#F6">6Aii</a>). On the other hand, both 1 and 2 &#x003BC;M disopyramide did not terminate re-entrant activity, but did increase the area over which spiral waves meandered (from 0.35 mm<sup>2</sup> ms<sup>&#x02212;1</sup> in the WT condition to 0.40 and 0.47 mm<sup>2</sup> ms<sup>&#x02212;1</sup>, respectively &#x00027;(Figure <a href="#F6">6B</a>). Similarly, 1 &#x003BC;M quinidine increased the area of meander to 0.44 mm<sup>2</sup> ms<sup>&#x02212;1</sup> without terminating re-entry, whereas 2 and 5 &#x003BC;M quinidine terminated re-entry without inducing wave break (Figure <a href="#F6">6C</a>). Application of 0.2 and 0.5 &#x003BC;M propafenone resulted in termination of re-entry by decreasing both the stationarity and stability of spiral waves (Figure <a href="#F6">6D</a>), whereas 0.8 &#x003BC;M propafenone did not terminate re-entry but did destabilize the re-entrant circuit and substantially increase the area of meander (to 0.75 mm<sup>2</sup> ms<sup>&#x02212;1</sup>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 6</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg" name="figure6" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg" alt="www.frontiersin.org" id="F6" loading="lazy">
  </picture>
</a>
<p><strong>Figure 6</strong>. Re-entry dynamics in homogeneous 2D sheets upon application of disopyramide, propafenone, and quinidine in SQT1 mutation conditions. <strong>(A)</strong> Representative snapshots of re-entrant spiral waves under (i) drug-free SQT1 and (ii) SQT1 &#43; 5 &#x003BC;M disopyramide (DISO) conditions at times, <i>t</i> = 250, 500, 750, and 1,000 ms following re-entry initiation, with spiral wave core trajectories superimposed onto membrane potentials in black. Spiral wave core trajectories over a 5,000 ms period under <strong>(Bi, Ci, Di)</strong> drug-free SQT1 conditions, and upon application of <strong>(Bii)</strong> 1 &#x003BC;M, <strong>(Biii)</strong> 2 &#x003BC;M, and <strong>(Biv)</strong> 5 &#x003BC;M DISO, <strong>(Cii)</strong> 1 &#x003BC;M, <strong>(Ciii)</strong> 2 &#x003BC;M, and <strong>(Civ)</strong> 5 &#x003BC;M quinidine (QUIN), and <strong>(Dii)</strong> 0.2 &#x003BC;M, <strong>(Diii)</strong> 0.5 &#x003BC;M, and <strong>(Div)</strong> 0.8 &#x003BC;M propafenone (PROPAF).</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mt15 w100pc float_left">In 3D simulations using clockwise scroll wave initial conditions, quinidine terminated re-entry at all concentrations, and disopyramide terminated re-entry at concentrations of 1 and 5 &#x003BC;M (arrhythmia termination by 5 &#x003BC;M disopyramide and 2 &#x003BC;M quinidine are shown in Videos <a href="#SM1">S4</a>, <a href="#SM1">S5</a>, respectively). At a concentration of 2 &#x003BC;M disopyramide, the DF was reduced from 4.79 to 3.99 Hz (measured from the final 5.0 s of activity). Propafenone, on the other hand, was comparatively ineffective at reducing the DF at the concentrations tested, but terminated re-entry at a concentration of 0.5 &#x003BC;M (Video <a href="#SM1">S6</a>). Representative examples of arrhythmia termination by disopyramide, propafenone, and quinidine are shown in Figure <a href="#F7">7</a>. Disopyramide and quinidine produced a dose-dependent decrease in the DF which was greater than for propafenone (Figure <a href="#F7">7C</a>). In an anti-clockwise scroll wave configuration, the efficacy of anti-arrhythmic drugs was less favorable, with pharmacological conversion of re-entrant waves occurring only for 0.5 &#x003BC;M propafenone and 5 &#x003BC;M quinidine. A quantitative summary of all 2D and 3D re-entry simulations is given in Table <a href="#SM1">S5</a>.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 7</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg" name="figure7" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg" alt="www.frontiersin.org" id="F7" loading="lazy">
  </picture>
</a>
<p><strong>Figure 7</strong>. Arrhythmia termination in 3D anatomical human atria by representative concentrations of disopyramide, propafenone, and quinidine under SQT1 mutation conditions. <strong>(A)</strong> Snapshots of re-entrant scroll waves in a clockwise configuration (viewed from RA posterior wall) at various time points after initiation of a scroll wave in the 3D anatomical human atrial model under (i) drug-free WT-N588K conditions, and upon application of (ii) 5 &#x003BC;M disopyramide (DISO), (iii) 0.5 &#x003BC;M propafenone (PROPAF), and (iv) 2 &#x003BC;M quinidine (QUIN) conditions, with <strong>(B)</strong> corresponding pseudo ECG recorded during the final 5.0 s. In pharmacological simulation drugs were applied at <i>t</i> = 2,500 ms. <strong>(C)</strong> Barcharts summarizing DF upon application of various concentrations of (i) DISO, (ii) PROPAF, and (iii) QUIN for clockwise and anti-clockwise initial conditions (ICs 1 and ICs 2, respectively). * denotes simulations in which DF was not calculated due to occurrence of re-entry termination.</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<a id="h5" name="h5"></a><h2>Discussion</h2>
<p class="mb0">In this study, pathophysiological effects of the SQT1-related N588K-hERG mutation on human atrial electrophysiology were assessed, investigating mechanisms of increased susceptibility to the development of atrial arrhythmias in multi-scale cellular and tissue models incorporating electrical and anatomical heterogeneities. Furthermore, the actions of the class I anti-arrhythmic drugs disopyramide, quinidine, and propafenone were assessed in the context of sustained atrial arrhythmic excitations mediated by the SQT1 N588K mutation using drug simulations including binding kinetics, altered potency of <i>I</i><sub>Kr</sub>/hERG block in SQT1, and multiple ion channel block. Both quinidine and disopyramide have demonstrated efficacy in QT interval prolongation in the setting of SQT1 (<a href="#B26">Gaita et al., 2004</a>; <a href="#B61">Schimpf et al., 2007</a>; <a href="#B49">Mizobuchi et al., 2008</a>; <a href="#B28">Giustetto et al., 2011</a>; <a href="#B34">Hu et al., 2017</a>), whereas propafenone has been used in 3 patients for management of episodes of paroxysmal AF mediated by SQT1, which prevented recurrence of arrhythmias but did not prolong the QT interval (<a href="#B33">Hong et al., 2005</a>; <a href="#B9">Bjerregaard et al., 2006</a>). This study provides clinically-relevant insights into pharmacology of SQT1 by evaluating and comparing the actions of all three drugs in the context of accelerated atrial repolarisation and arrhythmias mediated by SQT1, offering an important step toward <i>in silico</i> optimisation of pharmacological therapy in this context.</p>
<h3>Main Findings</h3>
<p class="mb0">The major findings presented in this study are as follows. (1) Heterozygous and homozygous forms of the SQT1-linked N588K-hERG mutation shortened significantly the APD of human atrial cells, whilst preserving global dispersion of ARI, and increasing &#x00394;ARI between certain regions of the human atria. (2) The dominant frequency and lifespan of re-entry in 3D arrhythmia simulations was increased by heterozygous and homozygous forms of the N588K mutation. (3) Disopyramide, quinidine, and propafenone all produced ERP prolongation in the setting of SQT1, the extent of which was greatest for quinidine. (4) In 2D simulations, disopyramide and quinidine terminated re-entry at high concentrations due to increased re-entry wavelength, whereas propafenone terminated re-entry in a non-dose-dependent manner, by inducing secondary waves. (5) In 3D simulations, the DF of re-entry was reduced in a dose-dependent manner for clinically-relevant doses of disopyramide and quinidine, and propafenone to a lesser extent. (6) All three anti-arrhythmic agents demonstrated some efficacy in pharmacological rhythm control, most frequently terminating re-entry in the order quinidine &#x0003E; propafenone = disopyramide. A summary of findings regarding pro-arrhythmic mechanisms of the N588K-hERG mutation in human atria and anti-arrhythmic actions of selected class I drugs is given in Figure <a href="#F8">8</a>.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 8</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg" name="figure8" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg" alt="www.frontiersin.org" id="F8" loading="lazy">
  </picture>
</a>
<p><strong>Figure 8</strong>. A schematic summary of pro-arrhythmic effects of the N588K-hERG mutation in human atria and anti-arrhythmic effects of class I drugs. At the ion channel level, the N588K mutation impairs hERG channel inactivation, increasing <i>I</i><sub>Kr</sub> which shortens the action potential duration (APD) at the cellular level, and increases its dispersion, &#x00394;APD, between certain regions of the human atria. In tissue, shortened APD corresponds to shortened effective refractory period (ERP) and excitation wavelength (WL), promoting sustenance of arrhythmias at the organ scale through higher dominant frequency (DF) and lifespan (LS) of re-entry. Class I drugs disopyramide (DISO), quinidine (QUIN), and propafenone (PROPAF) exert effects at the ion channel level by blocking <i>I</i><sub>Kr</sub> and <i>I</i><sub>Na</sub>, in addition to secondary actions. This prolongs APD and ERP, and reduces maximum upstroke velocity (MUV) and conduction velocity (CV) at the cellular and tissue levels, respectively. At the organ scale these pharmacological actions promote arrhythmia rate and rhythm control through reduced DF and LS of re-entry.</p></div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>SQT1 Mutant <i>I</i><sub>Kr</sub> Promotes Human Atrial Arrhythmogenesis</h3>
<p class="mb15">The fact that the N588K-hERG mutation is associated with both a short QT interval and reports of AF (<a href="#B33">Hong et al., 2005</a>) suggests that pathophysiological mechanisms leading to QT interval shortening in SQT1 also affect the atria and may promote AF. In an experimental model of SQT1, application of 20 &#x003BC;M of the <i>I</i><sub>Kr</sub> agonist PD-118057 shortened the APD in both CT and PM cell types of canine atrial tissue (<a href="#B54">Nof et al., 2010</a>), as well as increasing APD dispersion between them. In the present study, at the cellular level heterozygous and homozygous forms of the N588K-hERG mutation produced a shortening of the human right atrial APD of 53.4 and 85.5 ms, respectively&#x02013;values which are consistent with a previous simulation study (<a href="#B44">Loewe et al., 2014b</a>). At the tissue level, global &#x00394;ARI was unaffected by the WT-N588K mutation condition, and was slightly decreased by the homozygous form. The model predicted an increase in &#x00394;ARI between PV/LA and RA/LA regions for both heterozygous and homozygous forms of the N588K mutation (Figure <a href="#F3">3C</a>), but not between CT/PM regions. This may be due to the fact that the effects of the hERG activator PD-118057 and of the N588K mutation on <i>I</i><sub>Kr</sub>/hERG are different: the former increases <i>I</i><sub>Kr</sub>/hERG channel open probability without altering gating kinetics (<a href="#B79">Zhou et al., 2005</a>), whereas the latter alters kinetics through profound attenuation of inactivation (<a href="#B16">Cordeiro et al., 2005</a>; <a href="#B48">McPate et al., 2005</a>).</p>
<p class="mb15">Interestingly, there is clinical evidence of a LA-RA gradient in the DF in paroxysmal AF (<a href="#B40">Lazar et al., 2004</a>), which may be underlain by APD differences between the RA and LA in pathological conditions which promote AF (<a href="#B70">Voigt et al., 2010</a>). Furthermore, regional differences in APD between PV/LA regions have been identified previously as high frequency excitation or microreentrant sources underlying AF (<a href="#B45">Mandapati et al., 2000</a>; <a href="#B7">Arora et al., 2003</a>; <a href="#B39">Kumagai et al., 2004</a>)&#x02013;this suggests that localized increases in the spatial dispersion of repolarisation could be a mechanism by which atrial arrhythmogenesis is promoted in SQT1, as suggested in the previous experimental study (<a href="#B54">Nof et al., 2010</a>).</p>
<p class="mb0">In a previous simulation study (<a href="#B44">Loewe et al., 2014b</a>), the N588K-hERG mutation in a 1:1 mutant to WT ratio was shown to increase inducibility and lifespan of rotors in idealized 2D sheets of human atrial tissue, but did not permit sustained re-entry. By contrast, in the present study, the heterozygous WT-N588K (SQT1) condition permitted the sustenance of spiral waves in 2D simulations. This may be due to several differences in the modeling, one of which is that the CRN model used in that study (<a href="#B44">Loewe et al., 2014b</a>) produces an ERP restitution curve which is around 50 ms higher than available experimental data (<a href="#B75">Wilhelms et al., 2013</a>), making re-entry more difficult to sustain, whereas the CNZ model ERP restitution curve lies mostly within the experimental range (Figure <a href="#SM1">S3</a>). In this study, the presence of realistic structure and heterogeneous electrophysiology, in addition to the cellular electrophysiological substrate induced by the N588K-hERG mutation, also favored the sustenance of re-entrant scroll waves in the 3D anatomical human atria model (using both clockwise and anti-clockwise scroll wave initial conditions), and could both prolong or shorten the lifespan of re-entrant excitations under pharmacological modulation conditions when compared directly to observations in 2D homogeneous sheets. This highlights the value of including both approaches in probing the arrhythmia substrate associated with genetic mutations in human atria, as behavior in heterogeneous 3D anatomical models cannot necessarily be predicted from homogeneous 2D simulations, and vice versa. It should be noted nonetheless that electrical activity observed in 3D re-entry simulations in this study remained relatively organized and generally not driven by multiple wavelets. This lack of complex, chaotic behavior which is observed in persistent AF is consistent with reports of paroxysmal AF in some patients with the N588K-hERG mutation (<a href="#B33">Hong et al., 2005</a>) &#x02013; addition of electrical and intracellular gap junction remodeling or fibrosis in patients may be required to promote degeneration of paroxysmal AF into persistent AF.</p>
<h3>Class I Drugs May Represent Useful SQT1-Specific Pharmacotherapy for AF</h3>
<p class="mb15">Despite the prevalence of AF and decades of research, anti-arrhythmic therapies for AF continue to have limited efficacy and safety (<a href="#B76">Workman et al., 2011</a>). In this study, the class I anti-arrhythmic drugs disopyramide, quinidine, and propafenone were shown to be only moderately effective in the management of atrial arrhythmias mediated by the SQT1-linked N588K-hERG mutation, although it should be noted that the 7.5 s duration of 3D drug simulations is much shorter than clinical time scales. Pharmacological rhythm control occurred under application of both disopyramide and quinidine, but in an unpredictable, non-dose-dependent way, as observed in our previous <i>in silico</i> study (<a href="#B73">Whittaker et al., 2017a</a>). One mechanism of re-entry termination involving reduction of the excitable gap under application of 5 &#x003BC;M quinidine is shown in Figure <a href="#SM1">S4</a>.</p>
<p class="mb15">Both disopyramide and quinidine reduced consistently the DF of re-entry in a dose-dependent manner, although as in (<a href="#B73">Whittaker et al., 2017a</a>) quinidine was more effective than disopyramide at rate control in the setting of SQT1, likely due to its more potent block of <i>I</i><sub>Kr</sub> (<a href="#B47">McPate et al., 2008</a>) and <i>I</i><sub>Na</sub> (<a href="#B37">Koumi et al., 1992</a>). Propafenone was comparatively ineffective at controlling the rate of atrial arrhythmias under the WT-N588K mutation condition, although did demonstrate some efficacy in re-entry termination. Figure <a href="#SM1">S5</a> shows a mechanism of pharmacological rhythm control by 0.5 &#x003BC;M propafenone, in which secondary waves induced by propafenone extinguished all re-entrant pathways. This is consistent with the use of propafenone to manage paroxysmal AF in SQT1 patients (<a href="#B33">Hong et al., 2005</a>; <a href="#B9">Bjerregaard et al., 2006</a>), which maintained 3 patients free of arrhythmia recurrence during follow up. However, as propafenone has been reported to have no prolonging effect on the QT interval in the setting of SQT1 (<a href="#B33">Hong et al., 2005</a>)&#x02014; an effect which was demonstrated with variable success using two leading human ventricle models (ten <a href="#B68">Tusscher and Panfilov, 2006</a>; <a href="#B55">O&#x00027;Hara et al., 2011</a>) in Figure <a href="#SM1">S6</a>&#x02014;it is likely that quinidine and disopyramide will remain more suitable pharmacotherapies.</p>
<p class="mb0">In this study, cellular and tissue level simulations (in a 1D model) alone did not serve as good predictors of the overall effects of anti-arrhythmic drugs in the electrically-heterogeneous, 3D anatomical whole atria model, consistent with previous modeling studies (<a href="#B69">Varela et al., 2016</a>; <a href="#B74">Whittaker et al., 2017b</a>). For example, disopyramide was shown not to strongly affect the excitation WL in RA tissue (Table <a href="#T2">2</a>; Figure <a href="#SM1">S2</a>), and yet it decreased reliably the DF of re-entrant excitations under heterozygous N588K mutation conditions in 3D simulations. This is likely due to the fact that scroll waves were largely anatomically driven by a typical macro re-entrant atrial flutter/tachycardia circuit (<a href="#B41">Lee et al., 2012</a>) which was larger than the functional WL; effects of disopyramide on CV were thus more important. In contrast, propafenone produced only modest changes to the CV and was thus less effective at rate control in the model, but did terminate re-entry under conditions in which the re-entrant circuit was abolished by interaction with secondary waves (Figure <a href="#SM1">S5</a>).</p>
<h3>Insights Into the Efficacy of Class I Drugs in SQT1</h3>
<p class="mb0">Further support for quinidine as a useful pharmacotherapy for AF in the setting of SQT1 comes from the experimental use of the <i>I</i><sub>Kr</sub> agonist PD-118057 model (<a href="#B54">Nof et al., 2010</a>). That study suggested that the combined blocking actions on <i>I</i><sub>Kr</sub> and <i>I</i><sub>Na</sub> are what made quinidine effective at preventing sustained AF in canine right atrial tissue preparations, as neither <i>I</i><sub>Kr</sub> nor <i>I</i><sub>Na</sub> block alone (by E-4031 or lidocaine, respectively) was effective at terminating AF. Similarly, in our previous simulation study of ventricular pharmacotherapy for SQT1 we showed that combined block of <i>I</i><sub>Na</sub> and <i>I</i><sub>Kr</sub> by disopyramide and quinidine prolonged the ERP to a greater extent than block of <i>I</i><sub>Na</sub> or <i>I</i><sub>Kr</sub> alone (<a href="#B73">Whittaker et al., 2017a</a>). In this study, we sought to determine whether the greater ERP prolongation associated with the synergistic combination of <i>I</i><sub>Na</sub> and <i>I</i><sub>Kr</sub> block by class I drugs would also translate to greater efficacy in terminating re-entry in a 2D sheet of SQT1 mutant human atrial tissue. Figure <a href="#SM1">S7</a> shows that the actions of 5 &#x003BC;M of a hypothetical drug with disopyramide kinetics for <i>I</i><sub>Na</sub> and <i>I</i><sub>Kr</sub> block were able to terminate re-entry, whereas <i>I</i><sub>Na</sub> or <i>I</i><sub>Kr</sub> block alone did not, as combined block produced the greatest prolongation of the ERP. The spiral wave trajectories highlight the fact that <i>I</i><sub>Na</sub> block in particular destabilized the re-entrant circuit, which, when combined with <i>I</i><sub>Kr</sub> block, caused the spiral wave to meander out of the tissue boundaries (Video <a href="#SM1">S7</a>). The findings from <i>in silico</i> and <i>in vitro</i> experiments thus suggest that the combination of prolonged APD and refractoriness arising from K<sup>&#43;</sup> and Na<sup>&#43;</sup> channel inhibition is likely to be valuable in the setting of SQT1. Though selective blockers of <i>I</i><sub>Ks</sub> and <i>I</i><sub>K1</sub> are not yet clinically-available, this combination may also warrant investigation as a pharmacotherapeutic strategy for other forms of K<sup>&#43;</sup>-linked SQTS (SQT2 and SQT3).</p>
<a id="h6" name="h6"></a><h2>Limitations</h2>
<p class="mb15">There are a number of limitations of the simulations presented in this study. The 3D anatomical human atria model which was employed for simulations in this study incorporated rule-based fiber orientations (<a href="#B38">Krueger et al., 2011</a>), which may not capture sufficiently the complex cardiac microstructure of the human atria (<a href="#B67">Stephenson et al., 2017</a>) which could contribute to the arrhythmia substrate. Whilst several hERG mutations have now been identified in SQT1 (<a href="#B31">Hancox et al., 2018</a>), the present study focused only on the N588K-hERG mutation (which produces a more marked effect on hERG kinetics than some other mutations, <a href="#B31">Hancox et al., 2018</a>), so the results here may not apply to all forms of SQT1. However, recently the S631A-hERG mutation (previously engineered for hERG structure-function studies), which produces a similar extent of attenuation of inactivation to N588K-hERG (<a href="#B47">McPate et al., 2008</a>) has been reported in an SQT1 family (<a href="#B4">Akdis et al., 2018</a>), and thus the findings of this study are likely also to be relevant to that form of SQT1. An additional potential limitation arises from the fact that mechanical contraction was not considered, which has been reported previously to be impaired in the setting of SQT1 in single human atrial cell simulations (<a href="#B71">Whittaker et al., 2015</a>) as well as in organ-scale ventricle simulations (<a href="#B1">Adeniran et al., 2013</a>), and based on clinical measurements (<a href="#B25">Frea et al., 2015</a>).</p>
<p class="mb0">The models of disopyramide and quinidine used in this study were adopted from (<a href="#B73">Whittaker et al., 2017a</a>), in which the effects of anti-arrhythmic drugs were assessed in the setting of SQT1 in the human ventricles. However, both agents also exhibit modest anti-cholinergic effects in the atria (<a href="#B51">Nakajima et al., 1989</a>) which were not accounted for, due to the absence of a formulation for acetylcholine-activated potassium current, <i>I</i><sub>K, ACh</sub>, in the CNZ model. Similarly, the &#x003B2;-adrenergic receptor blocking effects of propafenone were not considered (<a href="#B46">McLeod et al., 1984</a>). Inclusion of these factors could give some insight into the response of the SQT1 phenotype to anti-arrhythmic drugs in the presence of autonomic modulation, and could give more favorable results in terms of arrhythmia prevention, especially for propafenone, which may be particularly effective against AF triggered by increased vagal tone. In addition, dynamic effects of agents due to the influence of circadian variations in drug concentration and heart rate on bioavailability were not investigated, which can give further insights into differing clinical efficacies of drugs (<a href="#B43">Loewe et al., 2014a</a>). In relation to this, a further, more general limitation is that translation of drug concentrations from experiments and computer simulations to meaningful clinical concentrations is potentially problematic. Finally, whilst the 1:1 mutant to WT ratio, which was intended to represent the heterozygous state of the proband, may represent an oversimplification of the real hERG channel population in SQT1, the approach adopted in this and our previous studies (<a href="#B2">Adeniran et al., 2011</a>, <a href="#B3">2017</a>; <a href="#B73">Whittaker et al., 2017a</a>) reproduced quantitatively QT interval shortening and T wave morphology in SQTS conditions which was concordant with clinical observations.</p>
<a id="h7" name="h7"></a><h2>Conclusions</h2>
<p class="mb0">The simulations performed in this study further substantiate a causative link between the SQTS-related N588K mutation and APD/ERP shortening in human atria, as well as increased spatial dispersion of repolarisation, which promotes development of AF. In 3D human atria simulations which included heterogeneous anatomy and electrophysiology, the N588K mutation was shown to increase the dominant frequency and lifespan of re-entrant excitation beyond that observed in WT conditions. Pharmacological simulations demonstrated that disopyramide and quinidine were more effective at rate control than propafenone in the setting of SQT1, and quinidine was most effective at rhythm control. Combined block of <i>I</i><sub>Na</sub> and <i>I</i><sub>Kr</sub> by a hypothetical drug was shown to be more beneficial in terms of re-entry termination in a 2D sheet of human atrial tissue than <i>I</i><sub>Kr</sub> or <i>I</i><sub>Na</sub> block alone in this context, suggesting useful targets for future pharmacotherapies. The multi-scale integrative cardiac modeling approach adopted in this study serves as a useful paradigm for optimisation of pharmacological therapy, allowing investigation of how genetic defects at the ion channel level influence organ scale propagation, arrhythmogenesis, and response to pharmacotherapies.</p>
<a id="h8" name="h8"></a><h2>Author Contributions</h2>
<p class="mb0">DW, JH, and HZ conceived the experiments and wrote the manuscript. DW developed and validated computer models and performed numerical experiments and analysis.</p>
<a id="h9" name="h9"></a><h2>Funding</h2>
<p class="mb0">DW was supported by the British Heart Foundation (FS/14/5/30533&#x02013;HZ and JH) and is now supported by a Wellcome Trust ISSF fellowship (204825/Z/16/Z). This work was also supported by grants from EPSRC (UK) (EP/J00958X/1; EP/I029826/1), MC-IRSES CORDIS3D (317766), NSFC (61179009), Shenzhen Science and Technology Innovation Committee (JCYJ20151029173639477; JSGG20160229125049615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
<a id="h10" name="h10"></a><h2>Conflict of Interest Statement</h2>
<p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<a id="h11" name="h11"></a><h2>Acknowledgments</h2>
<p class="mb0">JH gratefully acknowledges receipt of a University of Bristol research fellowship.</p>
<a id="h12" name="h12"></a><h2>Supplementary Material</h2>
<p class="mb0" id="SM1">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fphys.2018.01888/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphys.2018.01888/full#supplementary-material</a></p>
<a id="h13" name="h13"></a><h2>References</h2>
<div class="References">
<p class="ReferencesCopy1"><a name="B1" id="B1"></a> Adeniran, I., Hancox, J. C., and Zhang, H. (2013). <i>In silico</i> investigation of the short QT syndrome, using human ventricle models incorporating electromechanical coupling. <i>Front. Physiol.</i> 4:166. doi: 10.3389/fphys.2013.00166</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23847545" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fphys.2013.00166" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I.+Adeniran&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2013&#x00026;title=In+silico+investigation+of+the+short+QT+syndrome,+using+human+ventricle+models+incorporating+electromechanical+coupling&#x00026;journal=Front.+Physiol.&#x00026;volume=4&#x00026;pages=166" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B2" id="B2"></a> Adeniran, I., McPate, M. J., Witchel, H. J., Hancox, J. C., and Zhang, H. (2011). Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome. <i>PLoS Comput. Biol.</i> 7:e1002313. doi: 10.1371/journal.pcbi.1002313</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=22194679" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pcbi.1002313" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I.+Adeniran&#x00026;author=M.+J.+McPate&#x00026;author=H.+J.+Witchel&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2011&#x00026;title=Increased+vulnerability+of+human+ventricle+to+re-entrant+excitation+in+hERG-linked+variant+1+short+QT+syndrome&#x00026;journal=PLoS+Comput.+Biol.&#x00026;volume=7&#x00026;pages=e1002313" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B3" id="B3"></a> Adeniran, I., Whittaker, D. G., Harchi, A. E., Hancox, J. C., and Zhang, H. (2017). <i>In silico</i> investigation of a KCNQ1 mutation associated with short QT syndrome. <i>Sci. Rep.</i> 7:8469. doi: 10.1038/s41598-017-08367-2</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=28814790" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41598-017-08367-2" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I.+Adeniran&#x00026;author=D.+G.+Whittaker&#x00026;author=A.+E.+Harchi&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2017&#x00026;title=In+silico+investigation+of+a+KCNQ1+mutation+associated+with+short+QT+syndrome&#x00026;journal=Sci.+Rep.&#x00026;volume=7&#x00026;pages=8469" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B4" id="B4"></a> Akdis, D., Saguner, A. M., Medeiros-Domingo, A., Schaller, A., Balmer, C., Steffel, J., et al. (2018). Multiple clinical profiles of families with the short QT syndrome. <i>EP Eur.</i> 20, f113&#x02013;f121. doi: 10.1093/europace/eux186</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29016797" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/europace/eux186" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+Akdis&#x00026;author=A.+M.+Saguner&#x00026;author=A.+Medeiros-Domingo&#x00026;author=A.+Schaller&#x00026;author=C.+Balmer&#x00026;author=J.+Steffel+&#x00026;publication_year=2018&#x00026;title=Multiple+clinical+profiles+of+families+with+the+short+QT+syndrome&#x00026;journal=EP+Eur.&#x00026;volume=20&#x00026;pages=f113-f121" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B5" id="B5"></a> Amor&#x000F3;s, I., Dolz-Gait&#x000F3;n, P., G&#x000F3;mez, R., Matamoros, M., Barana, A., de la Fuente, M. G., et al. (2013). Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore. <i>Biochem. Pharmacol.</i> 86, 267&#x02013;278. doi: 10.1016/j.bcp.2013.04.023</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23648307" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bcp.2013.04.023" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I.+Amor&#x000F3;s&#x00026;author=P.+Dolz-Gait&#x000F3;n&#x00026;author=R.+G&#x000F3;mez&#x00026;author=M.+Matamoros&#x00026;author=A.+Barana&#x00026;author=M.+G.+de+la+Fuente+&#x00026;publication_year=2013&#x00026;title=Propafenone+blocks+human+cardiac+Kir2.x+channels+by+decreasing+the+negative+electrostatic+charge+in+the+cytoplasmic+pore&#x00026;journal=Biochem.+Pharmacol.&#x00026;volume=86&#x00026;pages=267-278" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B6" id="B6"></a> Ar&#x000E9;chiga, I. A., Barrio-Echavarria, G. F., Rodr&#x000ED;guez-Menchaca, A. A., Moreno-Galindo, E. G., Decher, N., Tristani-Firouzi, M., et al. (2008). Kv1.5 open channel block by the antiarrhythmic drug disopyramide: molecular determinants of block. <i>J. Pharmacol. Sci.</i> 108, 49&#x02013;55. doi: 10.1254/jphs.08084FP</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18818480" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1254/jphs.08084FP" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I.+A.+Ar&#x000E9;chiga&#x00026;author=G.+F.+Barrio-Echavarria&#x00026;author=A.+A.+Rodr&#x000ED;guez-Menchaca&#x00026;author=E.+G.+Moreno-Galindo&#x00026;author=N.+Decher&#x00026;author=M.+Tristani-Firouzi+&#x00026;publication_year=2008&#x00026;title=Kv1.5+open+channel+block+by+the+antiarrhythmic+drug+disopyramide%3A+molecular+determinants+of+block&#x00026;journal=J.+Pharmacol.+Sci.&#x00026;volume=108&#x00026;pages=49-55" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B7" id="B7"></a> Arora, R., Verheule, S., Scott, L., Navarrete, A., Katari, V., Wilson, E., et al. (2003). Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. <i>Circulation</i> 107, 1816&#x02013;1821. doi: 10.1161/01.CIR.0000058461.86339.7E</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12665495" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1161/01.CIR.0000058461.86339.7E" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Arora&#x00026;author=S.+Verheule&#x00026;author=L.+Scott&#x00026;author=A.+Navarrete&#x00026;author=V.+Katari&#x00026;author=E.+Wilson+&#x00026;publication_year=2003&#x00026;title=Arrhythmogenic+substrate+of+the+pulmonary+veins+assessed+by+high-resolution+optical+mapping&#x00026;journal=Circulation&#x00026;volume=107&#x00026;pages=1816-1821" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B8" id="B8"></a> Biktashev, V. N., and Holden, A. V. (1998). Reentrant waves and their elimination in a model of mammalian ventricular tissue. <i>Chaos. Interdiscip. J. Nonlinear Sci.</i> 8, 48&#x02013;56. doi: 10.1063/1.166307</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12779709" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1063/1.166307" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=V.+N.+Biktashev&#x00026;author=A.+V.+Holden+&#x00026;publication_year=1998&#x00026;title=Reentrant+waves+and+their+elimination+in+a+model+of+mammalian+ventricular+tissue&#x00026;journal=Chaos.+Interdiscip.+J.+Nonlinear+Sci.&#x00026;volume=8&#x00026;pages=48-56" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B9" id="B9"></a> Bjerregaard, P., Jahangir, A., and Gussak, I. (2006). Targeted therapy for short QT syndrome. <i>Expert Opin. Ther. Targets</i> 10, 393&#x02013;400. doi: 10.1517/14728222.10.3.393</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16706679" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1517/14728222.10.3.393" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P.+Bjerregaard&#x00026;author=A.+Jahangir&#x00026;author=I.+Gussak+&#x00026;publication_year=2006&#x00026;title=Targeted+therapy+for+short+QT+syndrome&#x00026;journal=Expert+Opin.+Ther.+Targets&#x00026;volume=10&#x00026;pages=393-400" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B10" id="B10"></a> Bosch, R. F., Zeng, X., Grammer, J. B., Popovic, K., Mewis, C., and K&#x000FC;hlkamp, V. (1999). Ionic mechanisms of electrical remodeling in human atrial fibrillation. <i>Cardiovasc. Res.</i> 44, 121&#x02013;131. doi: 10.1016/S0008-6363(99)00178-9</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=10615396" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/S0008-6363(99)00178-9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+F.+Bosch&#x00026;author=X.+Zeng&#x00026;author=J.+B.+Grammer&#x00026;author=K.+Popovic&#x00026;author=C.+Mewis&#x00026;author=V.+K&#x000FC;hlkamp+&#x00026;publication_year=1999&#x00026;title=Ionic+mechanisms+of+electrical+remodeling+in+human+atrial+fibrillation&#x00026;journal=Cardiovasc.+Res.&#x00026;volume=44&#x00026;pages=121-131" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B11" id="B11"></a> Bray, M.-A., and Wikswo, J. P. (2002). Use of topological charge to determine filament location and dynamics in a numerical model of scroll wave activity. <i>IEEE Trans. Biomed. Eng.</i> 49, 1086&#x02013;1093. doi: 10.1109/TBME.2002.803516</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12374332" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1109/TBME.2002.803516" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+-A.+Bray&#x00026;author=J.+P.+Wikswo+&#x00026;publication_year=2002&#x00026;title=Use+of+topological+charge+to+determine+filament+location+and+dynamics+in+a+numerical+model+of+scroll+wave+activity&#x00026;journal=IEEE+Trans.+Biomed.+Eng.&#x00026;volume=49&#x00026;pages=1086-1093" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B12" id="B12"></a> Brugada, R., Hong, K., Dumaine, R., Cordeiro, J., Gaita, F., Borggrefe, M., et al. (2004). Sudden death associated with Short-QT syndrome linked to mutations in HERG. <i>Circulation</i> 109, 30&#x02013;35. doi: 10.1161/01.CIR.0000109482.92774.3A</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=14676148" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1161/01.CIR.0000109482.92774.3A" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Brugada&#x00026;author=K.+Hong&#x00026;author=R.+Dumaine&#x00026;author=J.+Cordeiro&#x00026;author=F.+Gaita&#x00026;author=M.+Borggrefe+&#x00026;publication_year=2004&#x00026;title=Sudden+death+associated+with+Short-QT+syndrome+linked+to+mutations+in+HERG&#x00026;journal=Circulation&#x00026;volume=109&#x00026;pages=30-35" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B13" id="B13"></a> Burashnikov, A., Belardinelli, L., and Antzelevitch, C. (2012). Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone. <i>J. Pharmacol. Exp. Ther.</i> 340, 161&#x02013;168. doi: 10.1124/jpet.111.186395</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=22005044" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1124/jpet.111.186395" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Burashnikov&#x00026;author=L.+Belardinelli&#x00026;author=C.+Antzelevitch+&#x00026;publication_year=2012&#x00026;title=Atrial-selective+sodium+channel+block+strategy+to+suppress+atrial+fibrillation%3A+ranolazine+versus+propafenone&#x00026;journal=J.+Pharmacol.+Exp.+Ther.&#x00026;volume=340&#x00026;pages=161-168" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B14" id="B14"></a> Colman, M. A., Aslanidi, O. V., Kharche, S., Boyett, M. R., Garratt, C., Hancox, J. C., et al. (2013). Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria. <i>J. Physiol.</i> 591, 4249&#x02013;4272. doi: 10.1113/jphysiol.2013.254987</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23732649" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1113/jphysiol.2013.254987" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+A.+Colman&#x00026;author=O.+V.+Aslanidi&#x00026;author=S.+Kharche&#x00026;author=M.+R.+Boyett&#x00026;author=C.+Garratt&#x00026;author=J.+C.+Hancox+&#x00026;publication_year=2013&#x00026;title=Pro-arrhythmogenic+effects+of+atrial+fibrillation-induced+electrical+remodelling%3A+insights+from+the+three-dimensional+virtual+human+atria&#x00026;journal=J.+Physiol.&#x00026;volume=591&#x00026;pages=4249-4272" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B15" id="B15"></a> Colman, M. A., Ni, H., Liang, B., Schmitt, N., and Zhang, H. (2017). <i>In silico</i> assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesis. <i>PLOS. Comput. Biol.</i> 13:e1005587. doi: 10.1371/journal.pcbi.1005587</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=28622331" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pcbi.1005587" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+A.+Colman&#x00026;author=H.+Ni&#x00026;author=B.+Liang&#x00026;author=N.+Schmitt&#x00026;author=H.+Zhang+&#x00026;publication_year=2017&#x00026;title=In+silico+assessment+of+genetic+variation+in+KCNA5+reveals+multiple+mechanisms+of+human+atrial+arrhythmogenesis&#x00026;journal=PLOS.+Comput.+Biol.&#x00026;volume=13&#x00026;pages=e1005587" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B16" id="B16"></a> Cordeiro, J. M., Brugada, R., Wu, Y. S., Hong, K., and Dumaine, R. (2005). Modulation of IKr inactivation by mutation N588K in KCNH2: A link to arrhythmogenesis in short QT syndrome. <i>Cardiovasc. Res.</i> 67, 498&#x02013;509. doi: 10.1016/j.cardiores.2005.02.018</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.cardiores.2005.02.018" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+M.+Cordeiro&#x00026;author=R.+Brugada&#x00026;author=Y.+S.+Wu&#x00026;author=K.+Hong&#x00026;author=R.+Dumaine+&#x00026;publication_year=2005&#x00026;title=Modulation+of+IKr+inactivation+by+mutation+N588K+in+KCNH2%3A+A+link+to+arrhythmogenesis+in+short+QT+syndrome&#x00026;journal=Cardiovasc.+Res.&#x00026;volume=67&#x00026;pages=498-509" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B17" id="B17"></a> Courtemanche, M., Ramirez, R. J., and Nattel, S. (1998). Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. <i>Am. J. Physiol. Heart Circ. Physiol.</i> 275, H301&#x02013;H321.</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9688927" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Courtemanche&#x00026;author=R.+J.+Ramirez&#x00026;author=S.+Nattel+&#x00026;publication_year=1998&#x00026;title=Ionic+mechanisms+underlying+human+atrial+action+potential+properties%3A+insights+from+a+mathematical+model&#x00026;journal=Am.+J.+Physiol.+Heart+Circ.+Physiol.&#x00026;volume=275&#x00026;pages=H301-H321" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B18" id="B18"></a> Dobrev, D., and Ravens, U. (2003). Remodeling of cardiomyocyte ion channels in human atrial fibrillation. <i>Basic Res. Cardiol.</i> 98, 137&#x02013;148. doi: 10.1007/s00395-003-0409-8</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12883831" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00395-003-0409-8" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+Dobrev&#x00026;author=U.+Ravens+&#x00026;publication_year=2003&#x00026;title=Remodeling+of+cardiomyocyte+ion+channels+in+human+atrial+fibrillation&#x00026;journal=Basic+Res.+Cardiol.&#x00026;volume=98&#x00026;pages=137-148" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B19" id="B19"></a> Duan, D., Fermini, B., and Nattel, S. (1993). Potassium channel blocking properties of propafenone in rabbit atrial myocytes. <i>J. Pharmacol. Exp. Ther.</i> 264, 1113&#x02013;1123.</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=8450455" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+Duan&#x00026;author=B.+Fermini&#x00026;author=S.+Nattel+&#x00026;publication_year=1993&#x00026;title=Potassium+channel+blocking+properties+of+propafenone+in+rabbit+atrial+myocytes&#x00026;journal=J.+Pharmacol.+Exp.+Ther.&#x00026;volume=264&#x00026;pages=1113-1123" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B20" id="B20"></a> Dumaine, R., and Antzelevitch, C. (2006). Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome? <i>J. Mol. Cell. Cardiol.</i> 41, 421&#x02013;423. doi: 10.1016/j.yjmcc.2006.06.070</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16863649" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.yjmcc.2006.06.070" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Dumaine&#x00026;author=C.+Antzelevitch+&#x00026;publication_year=2006&#x00026;title=Disopyramide%3A+although+potentially+life-threatening+in+the+setting+of+long+QT,+could+it+be+life-saving+in+short+QT+syndrome%3F&#x00026;journal=J.+Mol.+Cell.+Cardiol.&#x00026;volume=41&#x00026;pages=421-423" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B21" id="B21"></a> Edrich, T., Wang, S.-Y., and Wang, G. K. (2005). State-dependent block of human cardiac hNav1.5 sodium channels by propafenone. <i>J. Membr. Biol.</i> 207, 35&#x02013;43. doi: 10.1007/s00232-005-0801-4</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16463141" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00232-005-0801-4" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=T.+Edrich&#x00026;author=S.+-Y.+Wang&#x00026;author=G.+K.+Wang+&#x00026;publication_year=2005&#x00026;title=State-dependent+block+of+human+cardiac+hNav1.5+sodium+channels+by+propafenone&#x00026;journal=J.+Membr.+Biol.&#x00026;volume=207&#x00026;pages=35-43" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B22" id="B22"></a> Enriquez, A., Antzelevitch, C., Bismah, V., and Baranchuk, A. (2016). Atrial fibrillation in inherited cardiac channelopathies: from mechanisms to management. <i>Heart Rhythm</i>. 13, 1878&#x02013;1884. doi: 10.1016/j.hrthm.2016.06.008</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27291509" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.hrthm.2016.06.008" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Enriquez&#x00026;author=C.+Antzelevitch&#x00026;author=V.+Bismah&#x00026;author=A.+Baranchuk+&#x00026;publication_year=2016&#x00026;title=Atrial+fibrillation+in+inherited+cardiac+channelopathies%3A+from+mechanisms+to+management&#x00026;journal=Heart+Rhythm&#x00026;volume=13&#x00026;pages=1878-1884" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B23" id="B23"></a> Fei, L., Gill, J. S., McKenna, W. J., and Camm, A. J. (1993). Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig. <i>Br. J. Pharmacol.</i> 109, 178&#x02013;182. doi: 10.1111/j.1476-5381.1993.tb13550.x</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=8388297" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/j.1476-5381.1993.tb13550.x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=L.+Fei&#x00026;author=J.+S.+Gill&#x00026;author=W.+J.+McKenna&#x00026;author=A.+J.+Camm+&#x00026;publication_year=1993&#x00026;title=Effects+of+propafenone+on+calcium+currents+in+single+ventricular+myocytes+of+guinea-pig&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=109&#x00026;pages=178-182" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B24" id="B24"></a> Franqueza, L., Valenzuela, C., Delp&#x000F3;n, E., Longobardo, M., Caballero, R., and Tamargo, J. (1998). Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels. <i>Br. J. Pharmacol.</i> 125, 969&#x02013;978. doi: 10.1038/sj.bjp.0702129</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9846634" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.bjp.0702129" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=L.+Franqueza&#x00026;author=C.+Valenzuela&#x00026;author=E.+Delp&#x000F3;n&#x00026;author=M.+Longobardo&#x00026;author=R.+Caballero&#x00026;author=J.+Tamargo+&#x00026;publication_year=1998&#x00026;title=Effects+of+propafenone+and+5-hydroxy-propafenone+on+hKv1.5+channels&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=125&#x00026;pages=969-978" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B25" id="B25"></a> Frea, S., Giustetto, C., Capriolo, M., Scrocco, C., Fornengo, C., Benedetto, S., et al. (2015). New echocardiographic insights in short QT syndrome: more than a channelopathy? <i>Heart Rhythm</i>. 12, 2096&#x02013;2105. doi: 10.1016/j.hrthm.2015.05.024</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26001507" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.hrthm.2015.05.024" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+Frea&#x00026;author=C.+Giustetto&#x00026;author=M.+Capriolo&#x00026;author=C.+Scrocco&#x00026;author=C.+Fornengo&#x00026;author=S.+Benedetto+&#x00026;publication_year=2015&#x00026;title=New+echocardiographic+insights+in+short+QT+syndrome%3A+more+than+a+channelopathy%3F&#x00026;journal=Heart+Rhythm&#x00026;volume=12&#x00026;pages=2096-2105" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B26" id="B26"></a> Gaita, F., Giustetto, C., Bianchi, F., Schimpf, R., Haissaguerre, M., Cal,&#x000F2;, L., et al. (2004). Short QT syndrome: pharmacological treatment. <i>J. Am. Coll. Cardiol.</i> 43, 1494&#x02013;1499. doi: 10.1016/j.jacc.2004.02.034</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15093889" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.jacc.2004.02.034" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=F.+Gaita&#x00026;author=C.+Giustetto&#x00026;author=F.+Bianchi&#x00026;author=R.+Schimpf&#x00026;author=M.+Haissaguerre&#x00026;author=L.+Cal,&#x000F2;+&#x00026;publication_year=2004&#x00026;title=Short+QT+syndrome%3A+pharmacological+treatment&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=43&#x00026;pages=1494-1499" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B27" id="B27"></a> Giustetto, C. (2006). &#x0201C;Quinidine to treat short QT syndrome: a real alternative to ICD?,&#x0201D; in <i>Cardiac Arrhythmias 2005</i>, ed. A. R. MD (Milan: Springer), 333&#x02013;335.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?author=C.+Giustetto+&#x00026;publication_year=2006&#x00026;title=&#x0201C;Quinidine+to+treat+short+QT+syndrome%3A+a+real+alternative+to+ICD%3F,&#x0201D;&#x00026;pages=333-335" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B28" id="B28"></a> Giustetto, C., Schimpf, R., Mazzanti, A., Scrocco, C., Maury, P., Anttonen, O., et al. (2011). Long-term follow-Up of patients with short QT syndrome. <i>J. Am. Coll. Cardiol.</i> 58, 587&#x02013;595. doi: 10.1016/j.jacc.2011.03.038</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21798421" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.jacc.2011.03.038" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+Giustetto&#x00026;author=R.+Schimpf&#x00026;author=A.+Mazzanti&#x00026;author=C.+Scrocco&#x00026;author=P.+Maury&#x00026;author=O.+Anttonen+&#x00026;publication_year=2011&#x00026;title=Long-term+follow-Up+of+patients+with+short+QT+syndrome&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=58&#x00026;pages=587-595" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B29" id="B29"></a> Gross, G. J., and Castle, N. A. (1998). Propafenone inhibition of human atrial myocyte repolarizing currents. <i>J. Mol. Cell. Cardiol.</i> 30, 783&#x02013;793. doi: 10.1006/jmcc.1998.0643</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9602427" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1006/jmcc.1998.0643" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=G.+J.+Gross&#x00026;author=N.+A.+Castle+&#x00026;publication_year=1998&#x00026;title=Propafenone+inhibition+of+human+atrial+myocyte+repolarizing+currents&#x00026;journal=J.+Mol.+Cell.+Cardiol.&#x00026;volume=30&#x00026;pages=783-793" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B30" id="B30"></a> Hancox, J. C., and Mitcheson, J. S. (1997). Inhibition of L-type calcium current by propafenone in single myocytes isolated from the rabbit atrioventricular node. <i>Br. J. Pharmacol.</i> 121, 7&#x02013;14. doi: 10.1038/sj.bjp.0701086</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9146880" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.bjp.0701086" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+C.+Hancox&#x00026;author=J.+S.+Mitcheson+&#x00026;publication_year=1997&#x00026;title=Inhibition+of+L-type+calcium+current+by+propafenone+in+single+myocytes+isolated+from+the+rabbit+atrioventricular+node&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=121&#x00026;pages=7-14" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B31" id="B31"></a> Hancox, J. C., Whittaker, D. G., Du, C., Stuart, A. G., and Zhang, H. (2018). Emerging therapeutic targets in the short QT syndrome. <i>Expert Opin. Ther. Targets</i> 22:439&#x02013;51. doi: 10.1080/14728222.2018.1470621</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29697308" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1080/14728222.2018.1470621" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+C.+Hancox&#x00026;author=D.+G.+Whittaker&#x00026;author=C.+Du&#x00026;author=A.+G.+Stuart&#x00026;author=H.+Zhang+&#x00026;publication_year=2018&#x00026;title=Emerging+therapeutic+targets+in+the+short+QT+syndrome&#x00026;journal=Expert+Opin.+Ther.+Targets&#x00026;volume=22&#x00026;pages=439-51" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B32" id="B32"></a> Harmer, A. R., Abi-Gerges, N., Easter, A., Woods, A., Lawrence, C. L., Small, B. G., et al. (2008). Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks<sup>TM</sup>. <i>J. Pharmacol. Toxicol. Methods</i> 57, 30&#x02013;41. doi: 10.1016/j.vascn.2007.09.002</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17980627" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.vascn.2007.09.002" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+R.+Harmer&#x00026;author=N.+Abi-Gerges&#x00026;author=A.+Easter&#x00026;author=A.+Woods&#x00026;author=C.+L.+Lawrence&#x00026;author=B.+G.+Small+&#x00026;publication_year=2008&#x00026;title=Optimisation+and+validation+of+a+medium-throughput+electrophysiology-based+hNav1.5+assay+using+IonWorksTM&#x00026;journal=J.+Pharmacol.+Toxicol.+Methods&#x00026;volume=57&#x00026;pages=30-41" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B33" id="B33"></a> Hong, K., Bjerregaard, P., Gussak, I., and Brugada, R. (2005). Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. <i>J. Cardiovasc. Electrophysiol.</i> 16, 394&#x02013;396. doi: 10.1046/j.1540-8167.2005.40621.x</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15828882" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1046/j.1540-8167.2005.40621.x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K.+Hong&#x00026;author=P.+Bjerregaard&#x00026;author=I.+Gussak&#x00026;author=R.+Brugada+&#x00026;publication_year=2005&#x00026;title=Short+QT+syndrome+and+atrial+fibrillation+caused+by+mutation+in+KCNH2&#x00026;journal=J.+Cardiovasc.+Electrophysiol.&#x00026;volume=16&#x00026;pages=394-396" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B34" id="B34"></a> Hu, D., Li, Y., Zhang, J., Pfeiffer, R., Gollob, M. H., Healey, J., et al. (2017). The phenotypic spectrum of a mutation hotspot responsible for the short QT syndrome. <i>JACC. Clin. Electrophysiol.</i> 3, 727&#x02013;43. doi: 10.1016/j.jacep.2016.11.013</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29759541" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.jacep.2016.11.013" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+Hu&#x00026;author=Y.+Li&#x00026;author=J.+Zhang&#x00026;author=R.+Pfeiffer&#x00026;author=M.+H.+Gollob&#x00026;author=J.+Healey+&#x00026;publication_year=2017&#x00026;title=The+phenotypic+spectrum+of+a+mutation+hotspot+responsible+for+the+short+QT+syndrome&#x00026;journal=JACC.+Clin.+Electrophysiol.&#x00026;volume=3&#x00026;pages=727-43" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B35" id="B35"></a> Katoh, H., Shinozaki, T., Baba, S., Satoh, S., Kagaya, Y., Watanabe, J., et al. (2005). Monophasic action potential duration at the crista terminalis in patients with sinus node disease. <i>Circ. J.</i> 69, 1361&#x02013;1367. doi: 10.1253/circj.69.1361</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16247212" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1253/circj.69.1361" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H.+Katoh&#x00026;author=T.+Shinozaki&#x00026;author=S.+Baba&#x00026;author=S.+Satoh&#x00026;author=Y.+Kagaya&#x00026;author=J.+Watanabe+&#x00026;publication_year=2005&#x00026;title=Monophasic+action+potential+duration+at+the+crista+terminalis+in+patients+with+sinus+node+disease&#x00026;journal=Circ.+J.&#x00026;volume=69&#x00026;pages=1361-1367" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B36" id="B36"></a> Kim, B.-S., Kim, Y.-H., Hwang, G.-S., Pak, H.-N., Lee, S. C., Shim, W. J., et al. (2002). Action potential duration restitution kinetics in human atrial fibrillation. <i>J. Am. Coll. Cardiol.</i> 39, 1329&#x02013;1336. doi: 10.1016/S0735-1097(02)01760-6</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=11955851" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/S0735-1097(02)01760-6" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=B.+-S.+Kim&#x00026;author=Y.+-H.+Kim&#x00026;author=G.+-S.+Hwang&#x00026;author=H.+-N.+Pak&#x00026;author=S.+C.+Lee&#x00026;author=W.+J.+Shim+&#x00026;publication_year=2002&#x00026;title=Action+potential+duration+restitution+kinetics+in+human+atrial+fibrillation&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=39&#x00026;pages=1329-1336" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B37" id="B37"></a> Koumi, S., Sato, R., Katori, R., Hisatome, I., Nagasawa, K., and Hayakawa, H. (1992). Sodium channel states control binding and unbinding behaviour of antiarrhythmic drugs in cardiac myocytes from the guinea pig. <i>Cardiovasc. Res.</i> 26, 1199&#x02013;1205. doi: 10.1093/cvr/26.12.1199</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=1337728" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/cvr/26.12.1199" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+Koumi&#x00026;author=R.+Sato&#x00026;author=R.+Katori&#x00026;author=I.+Hisatome&#x00026;author=K.+Nagasawa&#x00026;author=H.+Hayakawa+&#x00026;publication_year=1992&#x00026;title=Sodium+channel+states+control+binding+and+unbinding+behaviour+of+antiarrhythmic+drugs+in+cardiac+myocytes+from+the+guinea+pig&#x00026;journal=Cardiovasc.+Res.&#x00026;volume=26&#x00026;pages=1199-1205" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B38" id="B38"></a> Krueger, M. W., Schmidt, V., Tob&#x000F3;n, C., Weber, F. M., Lorenz, C., Keller, D. U. J., et al. (2011). &#x0201C;Modeling atrial fiber orientation in patient-specific geometries: a semi-automatic rule-based approach,&#x0201D; in <i>Functional Imaging and Modeling of the Heart Lecture Notes in Computer Science.</i> (Springer, Berlin, Heidelberg), 223&#x02013;232.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?author=M.+W.+Krueger&#x00026;author=V.+Schmidt&#x00026;author=C.+Tob&#x000F3;n&#x00026;author=F.+M.+Weber&#x00026;author=C.+Lorenz&#x00026;author=D.+U.+J.+Keller+&#x00026;publication_year=2011&#x00026;title=&#x0201C;Modeling+atrial+fiber+orientation+in+patient-specific+geometries%3A+a+semi-automatic+rule-based+approach,&#x0201D;&#x00026;pages=223-232" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B39" id="B39"></a> Kumagai, K., Ogawa, M., Noguchi, H., Yasuda, T., Nakashima, H., and Saku, K. (2004). Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. <i>J. Am. Coll. Cardiol.</i> 43, 2281&#x02013;2289. doi: 10.1016/j.jacc.2004.01.051</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15193694" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.jacc.2004.01.051" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K.+Kumagai&#x00026;author=M.+Ogawa&#x00026;author=H.+Noguchi&#x00026;author=T.+Yasuda&#x00026;author=H.+Nakashima&#x00026;author=K.+Saku+&#x00026;publication_year=2004&#x00026;title=Electrophysiologic+properties+of+pulmonary+veins+assessed+using+a+multielectrode+basket+catheter&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=43&#x00026;pages=2281-2289" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B40" id="B40"></a> Lazar, S., Dixit, S., Marchlinski, F. E., Callans, D. J., and Gerstenfeld, E. P. (2004). Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. <i>Circulation</i> 110, 3181&#x02013;3186. doi: 10.1161/01.CIR.0000147279.91094.5E</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1161/01.CIR.0000147279.91094.5E" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+Lazar&#x00026;author=S.+Dixit&#x00026;author=F.+E.+Marchlinski&#x00026;author=D.+J.+Callans&#x00026;author=E.+P.+Gerstenfeld+&#x00026;publication_year=2004&#x00026;title=Presence+of+left-to-right+atrial+frequency+gradient+in+paroxysmal+but+not+persistent+atrial+fibrillation+in+humans&#x00026;journal=Circulation&#x00026;volume=110&#x00026;pages=3181-3186" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B41" id="B41"></a> Lee, G., Sanders, P., and Kalman, J. M. (2012). Catheter ablation of atrial arrhythmias: state of the art. <i>Lancet</i> 380, 1509&#x02013;1519. doi: 10.1016/S0140-6736(12)61463-9</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23101718" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/S0140-6736(12)61463-9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=G.+Lee&#x00026;author=P.+Sanders&#x00026;author=J.+M.+Kalman+&#x00026;publication_year=2012&#x00026;title=Catheter+ablation+of+atrial+arrhythmias%3A+state+of+the+art&#x00026;journal=Lancet&#x00026;volume=380&#x00026;pages=1509-1519" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B42" id="B42"></a> Lemery, R., Birnie, D., Tang, A. S., Green, M., Gollob, M., Hendry, M., et al. (2007). Normal atrial activation and voltage during sinus rhythm in the human heart: an endocardial and epicardial mapping study in patients with a history of atrial fibrillation. <i>J. Cardiovasc. Electrophysiol.</i> 18, 402&#x02013;408. doi: 10.1111/j.1540-8167.2007.00762.x</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17394455" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/j.1540-8167.2007.00762.x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Lemery&#x00026;author=D.+Birnie&#x00026;author=A.+S.+Tang&#x00026;author=M.+Green&#x00026;author=M.+Gollob&#x00026;author=M.+Hendry+&#x00026;publication_year=2007&#x00026;title=Normal+atrial+activation+and+voltage+during+sinus+rhythm+in+the+human+heart%3A+an+endocardial+and+epicardial+mapping+study+in+patients+with+a+history+of+atrial+fibrillation&#x00026;journal=J.+Cardiovasc.+Electrophysiol.&#x00026;volume=18&#x00026;pages=402-408" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B43" id="B43"></a> Loewe, A., Lutz, Y., Wilhelms, M., Sinnecker, D., Barthel, P., Scholz, E. P., et al. (2014a). <i>In-silico</i> assessment of the dynamic effects of amiodarone and dronedarone on human atrial patho-electrophysiology. <i>Europace</i> 16, iv30&#x02013;iv38. doi: 10.1093/europace/euu230</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25362168" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/europace/euu230" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Loewe&#x00026;author=Y.+Lutz&#x00026;author=M.+Wilhelms&#x00026;author=D.+Sinnecker&#x00026;author=P.+Barthel&#x00026;author=E.+P.+Scholz+&#x00026;publication_year=2014a&#x00026;title=In-silico+assessment+of+the+dynamic+effects+of+amiodarone+and+dronedarone+on+human+atrial+patho-electrophysiology&#x00026;journal=Europace" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B44" id="B44"></a> Loewe, A., Wilhelms, M., Fischer, F., Scholz, E. P., D&#x000F6;ssel, O., and Seemann, G. (2014b). Arrhythmic potency of human ether-&#x000E0;-go-go-related gene mutations L532P and N588K in a computational model of human atrial myocytes. <i>Europace</i> 16, 435&#x02013;443. doi: 10.1093/europace/eut375</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24569898" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/europace/eut375" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Loewe&#x00026;author=M.+Wilhelms&#x00026;author=F.+Fischer&#x00026;author=E.+P.+Scholz&#x00026;author=O.+D&#x000F6;ssel&#x00026;author=G.+Seemann+&#x00026;publication_year=2014b&#x00026;title=Arrhythmic+potency+of+human+ether-&#x000E0;-go-go-related+gene+mutations+L532P+and+N588K+in+a+computational+model+of+human+atrial+myocytes&#x00026;journal=Europace&#x00026;volume=16&#x00026;pages=435-443" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B45" id="B45"></a> Mandapati, R., Skanes, A., Chen, J., Berenfeld, O., and Jalife, J. (2000). Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. <i>Circulation</i> 101, 194&#x02013;199. doi: 10.1161/01.CIR.101.2.194</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=10637208" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1161/01.CIR.101.2.194" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Mandapati&#x00026;author=A.+Skanes&#x00026;author=J.+Chen&#x00026;author=O.+Berenfeld&#x00026;author=J.+Jalife+&#x00026;publication_year=2000&#x00026;title=Stable+microreentrant+sources+as+a+mechanism+of+atrial+fibrillation+in+the+isolated+sheep+heart&#x00026;journal=Circulation&#x00026;volume=101&#x00026;pages=194-199" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B46" id="B46"></a> McLeod, A. A., Stiles, G. L., and Shand, D. G. (1984). Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies. <i>J. Pharmacol. Exp. Ther.</i> 228, 461&#x02013;466.</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=6141285" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+A.+McLeod&#x00026;author=G.+L.+Stiles&#x00026;author=D.+G.+Shand+&#x00026;publication_year=1984&#x00026;title=Demonstration+of+beta+adrenoceptor+blockade+by+propafenone+hydrochloride%3A+clinical+pharmacologic,+radioligand+binding+and+adenylate+cyclase+activation+studies&#x00026;journal=J.+Pharmacol.+Exp.+Ther.&#x00026;volume=228&#x00026;pages=461-466" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B47" id="B47"></a> McPate, M. J., Duncan, R. S., Hancox, J. C., and Witchel, H. J. (2008). Pharmacology of the short QT syndrome N588K-hERG K&#43; channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. <i>Br. J. Pharmacol.</i> 155, 957&#x02013;966. doi: 10.1038/bjp.2008.325</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18724381" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/bjp.2008.325" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+J.+McPate&#x00026;author=R.+S.+Duncan&#x00026;author=J.+C.+Hancox&#x00026;author=H.+J.+Witchel+&#x00026;publication_year=2008&#x00026;title=Pharmacology+of+the+short+QT+syndrome+N588K-hERG+K&#43;+channel+mutation%3A+differential+impact+on+selected+class+I+and+class+III+antiarrhythmic+drugs&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=155&#x00026;pages=957-966" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B48" id="B48"></a> McPate, M. J., Duncan, R. S., Milnes, J. T., Witchel, H. J., and Hancox, J. C. (2005). The N588K-HERG K<sup>&#43;</sup> channel mutation in the &#x02018;short QT syndrome&#x00027;: mechanism of gain-in-function determined at 37 &#x000B0;C. <i>Biochem. Biophys. Res. Commun.</i> 334, 441&#x02013;449. doi: 10.1016/j.bbrc.2005.06.112</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16011830" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bbrc.2005.06.112" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+J.+McPate&#x00026;author=R.+S.+Duncan&#x00026;author=J.+T.+Milnes&#x00026;author=H.+J.+Witchel&#x00026;author=J.+C.+Hancox+&#x00026;publication_year=2005&#x00026;title=The+N588K-HERG+K&#43;+channel+mutation+in+the+&#x02018;short+QT+syndrome&#x00027;%3A+mechanism+of+gain-in-function+determined+at+37+&#x000B0;C&#x00026;journal=Biochem.+Biophys.+Res.+Commun.&#x00026;volume=334&#x00026;pages=441-449" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B49" id="B49"></a> Mizobuchi, M., Enjoji, Y., Yamamoto, R., Ono, T., Funatsu, A., Kambayashi, D., et al. (2008). Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties. <i>Pacing Clin. Electrophysiol.</i> 31, 1229&#x02013;1232. doi: 10.1111/j.1540-8159.2008.01169.x</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18834480" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/j.1540-8159.2008.01169.x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Mizobuchi&#x00026;author=Y.+Enjoji&#x00026;author=R.+Yamamoto&#x00026;author=T.+Ono&#x00026;author=A.+Funatsu&#x00026;author=D.+Kambayashi+&#x00026;publication_year=2008&#x00026;title=Nifekalant+and+disopyramide+in+a+patient+with+short+QT+syndrome%3A+evaluation+of+pharmacological+effects+and+electrophysiological+properties&#x00026;journal=Pacing+Clin.+Electrophysiol.&#x00026;volume=31&#x00026;pages=1229-1232" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B50" id="B50"></a> Moreno, J. D., Lewis, T. J., and Clancy, C. E. (2016). Parameterization for <i>in-silico</i> modeling of ion channel interactions with drugs. <i>PLoS ONE</i> 11:e0150761. doi: 10.1371/journal.pone.0150761</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26963710" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0150761" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+D.+Moreno&#x00026;author=T.+J.+Lewis&#x00026;author=C.+E.+Clancy+&#x00026;publication_year=2016&#x00026;title=Parameterization+for+in-silico+modeling+of+ion+channel+interactions+with+drugs&#x00026;journal=PLoS+ONE&#x00026;volume=11&#x00026;pages=e0150761" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B51" id="B51"></a> Nakajima, T., Kurachi, Y., Ito, H., Takikawa, R., and Sugimoto, T. (1989). Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: mediation by different molecular mechanisms. <i>Circ. Res.</i> 64, 297&#x02013;303. doi: 10.1161/01.RES.64.2.297</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=2912601" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1161/01.RES.64.2.297" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=T.+Nakajima&#x00026;author=Y.+Kurachi&#x00026;author=H.+Ito&#x00026;author=R.+Takikawa&#x00026;author=T.+Sugimoto+&#x00026;publication_year=1989&#x00026;title=Anti-cholinergic+effects+of+quinidine,+disopyramide,+and+procainamide+in+isolated+atrial+myocytes%3A+mediation+by+different+molecular+mechanisms&#x00026;journal=Circ.+Res.&#x00026;volume=64&#x00026;pages=297-303" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B52" id="B52"></a> Nenov, N. I., Crumb, W. J., Pigott, J. D., Harrison, L. H., and Clarkson, C. W. (1998). Quinidine interactions with human atrial potassium channels. <i>Circ. Res.</i> 83, 1224&#x02013;1231. doi: 10.1161/01.RES.83.12.1224.</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9851939" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1161/01.RES.83.12.1224" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=N.+I.+Nenov&#x00026;author=W.+J.+Crumb&#x00026;author=J.+D.+Pigott&#x00026;author=L.+H.+Harrison&#x00026;author=C.+W.+Clarkson+&#x00026;publication_year=1998&#x00026;title=Quinidine+interactions+with+human+atrial+potassium+channels&#x00026;journal=Circ.+Res.&#x00026;volume=83&#x00026;pages=1224-1231" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B53" id="B53"></a> Ni, H., Whittaker, D. G., Wang, W., Giles, W. R., Narayan, S. M., and Zhang, H. (2017). Synergistic anti-arrhythmic effects in human atria with combined use of sodium blockers and acacetin. <i>Front. Physiol.</i> 8:946. doi: 10.3389/fphys.2017.00946</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29218016" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fphys.2017.00946" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H.+Ni&#x00026;author=D.+G.+Whittaker&#x00026;author=W.+Wang&#x00026;author=W.+R.+Giles&#x00026;author=S.+M.+Narayan&#x00026;author=H.+Zhang+&#x00026;publication_year=2017&#x00026;title=Synergistic+anti-arrhythmic+effects+in+human+atria+with+combined+use+of+sodium+blockers+and+acacetin&#x00026;journal=Front.+Physiol.&#x00026;volume=8&#x00026;pages=946" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B54" id="B54"></a> Nof, E., Burashnikov, A., and Antzelevitch, C. (2010). Cellular basis for atrial fibrillation in an experimental model of short QT1: Implications for a pharmacological approach to therapy. <i>Heart Rhythm</i> 7, 251&#x02013;257. doi: 10.1016/j.hrthm.2009.10.017</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20042373" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.hrthm.2009.10.017" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=E.+Nof&#x00026;author=A.+Burashnikov&#x00026;author=C.+Antzelevitch+&#x00026;publication_year=2010&#x00026;title=Cellular+basis+for+atrial+fibrillation+in+an+experimental+model+of+short+QT1%3A+Implications+for+a+pharmacological+approach+to+therapy&#x00026;journal=Heart+Rhythm&#x00026;volume=7&#x00026;pages=251-257" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B55" id="B55"></a> O&#x00027;Hara, T., Vir&#x000E1;g, L., Varr,&#x000F3;, A., and Rudy, Y. (2011). Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. <i>PLoS Comput. Biol.</i> 7:e1002061. doi: 10.1371/journal.pcbi.1002061</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21637795" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pcbi.1002061" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=T.+O&#x00027;Hara&#x00026;author=L.+Vir&#x000E1;g&#x00026;author=A.+Varr,&#x000F3;&#x00026;author=Y.+Rudy+&#x00026;publication_year=2011&#x00026;title=Simulation+of+the+undiseased+human+cardiac+ventricular+action+potential%3A+model+formulation+and+experimental+validation&#x00026;journal=PLoS+Comput.+Biol.&#x00026;volume=7&#x00026;pages=e1002061" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B56" id="B56"></a> Patel, C., and Antzelevitch, C. (2008). Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome. <i>Heart Rhythm</i> 5, 585&#x02013;590. doi: 10.1016/j.hrthm.2008.01.022</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18362027" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.hrthm.2008.01.022" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+Patel&#x00026;author=C.+Antzelevitch+&#x00026;publication_year=2008&#x00026;title=Cellular+basis+for+arrhythmogenesis+in+an+experimental+model+of+the+SQT1+form+of+the+short+QT+syndrome&#x00026;journal=Heart+Rhythm&#x00026;volume=5&#x00026;pages=585-590" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B57" id="B57"></a> Pau, D., Workman, A. J., Kane, K. A., and Rankin, A. C. (2007). Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. <i>J. Mol. Cell. Cardiol.</i> 42, 54&#x02013;62. doi: 10.1016/j.yjmcc.2006.08.007</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16989857" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.yjmcc.2006.08.007" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+Pau&#x00026;author=A.+J.+Workman&#x00026;author=K.+A.+Kane&#x00026;author=A.+C.+Rankin+&#x00026;publication_year=2007&#x00026;title=Electrophysiological+and+arrhythmogenic+effects+of+5-hydroxytryptamine+on+human+atrial+cells+are+reduced+in+atrial+fibrillation&#x00026;journal=J.+Mol.+Cell.+Cardiol.&#x00026;volume=42&#x00026;pages=54-62" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B58" id="B58"></a> Paul, A. A., Witchel, H. J., and Hancox, J. C. (2002). Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. <i>Br. J. Pharmacol.</i> 136, 717&#x02013;729. doi: 10.1038/sj.bjp.0704784</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12086981" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.bjp.0704784" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+A.+Paul&#x00026;author=H.+J.+Witchel&#x00026;author=J.+C.+Hancox+&#x00026;publication_year=2002&#x00026;title=Inhibition+of+the+current+of+heterologously+expressed+HERG+potassium+channels+by+flecainide+and+comparison+with+quinidine,+propafenone+and+lignocaine&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=136&#x00026;pages=717-729" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B59" id="B59"></a> Redpath, C. J., Rankin, A. C., Kane, K. A., and Workman, A. J. (2006). Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. <i>J. Mol. Cell. Cardiol.</i> 40, 717&#x02013;724. doi: 10.1016/j.yjmcc.2006.01.012</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16603181" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.yjmcc.2006.01.012" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+J.+Redpath&#x00026;author=A.+C.+Rankin&#x00026;author=K.+A.+Kane&#x00026;author=A.+J.+Workman+&#x00026;publication_year=2006&#x00026;title=Anti-adrenergic+effects+of+endothelin+on+human+atrial+action+potentials+are+potentially+anti-arrhythmic&#x00026;journal=J.+Mol.+Cell.+Cardiol.&#x00026;volume=40&#x00026;pages=717-724" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B60" id="B60"></a> Roden, D. M. (2014). Pharmacology and toxicology of Nav1.5-class 1 anti-arrhythmic drugs. <i>Card. Electrophysiol. Clin.</i> 6, 695&#x02013;704. doi: 10.1016/j.ccep.2014.07.003</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25395995" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ccep.2014.07.003" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+M.+Roden+&#x00026;publication_year=2014&#x00026;title=Pharmacology+and+toxicology+of+Nav1.5-class+1+anti-arrhythmic+drugs&#x00026;journal=Card.+Electrophysiol.+Clin.&#x00026;volume=6&#x00026;pages=695-704" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B61" id="B61"></a> Schimpf, R., Veltmann, C., Giustetto, C., Gaita, F., Borggrefe, M., and Wolpert, C. (2007). <i>In vivo</i> effects of mutant HERG K&#43; channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study. <i>J. Cardiovasc. Electrophysiol.</i> 18, 1157&#x02013;1160. doi: 10.1111/j.1540-8167.2007.00925.x</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17711440" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/j.1540-8167.2007.00925.x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Schimpf&#x00026;author=C.+Veltmann&#x00026;author=C.+Giustetto&#x00026;author=F.+Gaita&#x00026;author=M.+Borggrefe&#x00026;author=C.+Wolpert+&#x00026;publication_year=2007&#x00026;title=In+vivo+effects+of+mutant+HERG+K&#43;+channel+inhibition+by+disopyramide+in+patients+with+a+short+QT-1+syndrome%3A+a+pilot+study&#x00026;journal=J.+Cardiovasc.+Electrophysiol.&#x00026;volume=18&#x00026;pages=1157-1160" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B62" id="B62"></a> Schimpf, R., Wolpert, C., Gaita, F., Giustetto, C., and Borggrefe, M. (2005). Short QT syndrome. <i>Cardiovasc. Res.</i> 67, 357&#x02013;366. doi: 10.1016/j.cardiores.2005.03.026</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15890322" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cardiores.2005.03.026" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Schimpf&#x00026;author=C.+Wolpert&#x00026;author=F.+Gaita&#x00026;author=C.+Giustetto&#x00026;author=M.+Borggrefe+&#x00026;publication_year=2005&#x00026;title=Short+QT+syndrome&#x00026;journal=Cardiovasc.+Res.&#x00026;volume=67&#x00026;pages=357-366" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B63" id="B63"></a> Seemann, G., H&#x000F6;per, C., Sachse, F. B., D&#x000F6;ssel, O., Holden, A. V., and Zhang, H. (2006). Heterogeneous three-dimensional anatomical and electrophysiological model of human atria. <i>Philos. Trans. R. Soc. Lond. Math. Phys. Eng. Sci.</i> 364, 1465&#x02013;1481. doi: 10.1098/rsta.2006.1781</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16766355" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1098/rsta.2006.1781" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=G.+Seemann&#x00026;author=C.+H&#x000F6;per&#x00026;author=F.+B.+Sachse&#x00026;author=O.+D&#x000F6;ssel&#x00026;author=A.+V.+Holden&#x00026;author=H.+Zhang+&#x00026;publication_year=2006&#x00026;title=Heterogeneous+three-dimensional+anatomical+and+electrophysiological+model+of+human+atria&#x00026;journal=Philos.+Trans.+R.+Soc.+Lond.+Math.+Phys.+Eng.+Sci.&#x00026;volume=364&#x00026;pages=1465-1481" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B64" id="B64"></a> Seki, A., Hagiwara, N., and Kasanuki, H. (1999). Effects of propafenone on K currents in human atrial myocytes. <i>Br. J. Pharmacol.</i> 126, 1153&#x02013;1162. doi: 10.1038/sj.bjp.0702428</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=10205003" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.bjp.0702428" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Seki&#x00026;author=N.+Hagiwara&#x00026;author=H.+Kasanuki+&#x00026;publication_year=1999&#x00026;title=Effects+of+propafenone+on+K+currents+in+human+atrial+myocytes&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=126&#x00026;pages=1153-1162" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B65" id="B65"></a> Slawsky, M. T., and Castle, N. A. (1994). K&#43; channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. <i>J. Pharmacol. Exp. Ther.</i> 269, 66&#x02013;74.</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=8169853" target="_blank">PubMed Abstract</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+T.+Slawsky&#x00026;author=N.+A.+Castle+&#x00026;publication_year=1994&#x00026;title=K&#43;+channel+blocking+actions+of+flecainide+compared+with+those+of+propafenone+and+quinidine+in+adult+rat+ventricular+myocytes&#x00026;journal=J.+Pharmacol.+Exp.+Ther.&#x00026;volume=269&#x00026;pages=66-74" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B66" id="B66"></a> Starmer, C. F., Grant, A. O., and Strauss, H. C. (1984). Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. <i>Biophys. J.</i> 46, 15&#x02013;27. doi: 10.1016/S0006-3495(84)83994-6</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=6331543" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/S0006-3495(84)83994-6" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+F.+Starmer&#x00026;author=A.+O.+Grant&#x00026;author=H.+C.+Strauss+&#x00026;publication_year=1984&#x00026;title=Mechanisms+of+use-dependent+block+of+sodium+channels+in+excitable+membranes+by+local+anesthetics&#x00026;journal=Biophys.+J.&#x00026;volume=46&#x00026;pages=15-27" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B67" id="B67"></a> Stephenson, R. S., Atkinson, A., Kottas, P., Perde, F., Jafarzadeh, F., Bateman, M., et al. (2017). High resolution 3-Dimensional imaging of the human cardiac conduction system from microanatomy to mathematical modeling. <i>Sci. Rep.</i> 7:7188. doi: 10.1038/s41598-017-07694-8</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=28775383" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41598-017-07694-8" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+S.+Stephenson&#x00026;author=A.+Atkinson&#x00026;author=P.+Kottas&#x00026;author=F.+Perde&#x00026;author=F.+Jafarzadeh&#x00026;author=M.+Bateman+&#x00026;publication_year=2017&#x00026;title=High+resolution+3-Dimensional+imaging+of+the+human+cardiac+conduction+system+from+microanatomy+to+mathematical+modeling&#x00026;journal=Sci.+Rep.&#x00026;volume=7&#x00026;pages=7188" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B68" id="B68"></a> ten Tusscher, K. H., and Panfilov, A. V. (2006). Alternans and spiral breakup in a human ventricular tissue model. <i>Am. J. Physiol. - Heart Circ. Physiol.</i> 291, H1088&#x02013;H1100. doi: 10.1152/ajpheart.00109.2006</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16565318" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1152/ajpheart.00109.2006" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K.+H.+ten+Tusscher&#x00026;author=A.+V.+Panfilov+&#x00026;publication_year=2006&#x00026;title=Alternans+and+spiral+breakup+in+a+human+ventricular+tissue+model&#x00026;journal=Am.+J.+Physiol.+-+Heart+Circ.+Physiol.&#x00026;volume=291&#x00026;pages=H1088-H1100" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B69" id="B69"></a> Varela, M., Colman, M. A., Hancox, J. C., and Aslanidi, O. V. (2016). Atrial heterogeneity generates re-entrant substrate during atrial fibrillation and anti-arrhythmic drug action: mechanistic insights from canine atrial models. <i>PLOS. Comput. Biol.</i> 12:e1005245. doi: 10.1371/journal.pcbi.1005245.</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27984585" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pcbi.1005245" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Varela&#x00026;author=M.+A.+Colman&#x00026;author=J.+C.+Hancox&#x00026;author=O.+V.+Aslanidi+&#x00026;publication_year=2016&#x00026;title=Atrial+heterogeneity+generates+re-entrant+substrate+during+atrial+fibrillation+and+anti-arrhythmic+drug+action%3A+mechanistic+insights+from+canine+atrial+models&#x00026;journal=PLOS.+Comput.+Biol.&#x00026;volume=12&#x00026;pages=e1005245" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B70" id="B70"></a> Voigt, N., Trausch, A., Knaut, M., Matschke, K., Varr&#x000F3;, A., Wagoner, D. R. V., et al. (2010). Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillationclinical perspective. <i>Circ. Arrhythm. Electrophysiol.</i> 3, 472&#x02013;480. doi: 10.1161/CIRCEP.110.954636</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1161/CIRCEP.110.954636" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=N.+Voigt&#x00026;author=A.+Trausch&#x00026;author=M.+Knaut&#x00026;author=K.+Matschke&#x00026;author=A.+Varr&#x000F3;&#x00026;author=D.+R.+V.+Wagoner+&#x00026;publication_year=2010&#x00026;title=Left-to-right+atrial+inward+rectifier+potassium+current+gradients+in+patients+with+paroxysmal+versus+chronic+atrial+fibrillationclinical+perspective&#x00026;journal=Circ.+Arrhythm.+Electrophysiol.&#x00026;volume=3&#x00026;pages=472-480" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B71" id="B71"></a> Whittaker, D. G., Colman, M. A., Ni, H., Hancox, J. C., and Zhang, H. (2015). <i>In silico</i> investigation of short QT syndrome-linked potassium channel mutations on electro-mechanical function of human atrial cells. <i>Comput. Cardiol. Conference</i> 2015, 853&#x02013;856. doi: 10.1109/CIC.2015.7411045.</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1109/CIC.2015.7411045" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+G.+Whittaker&#x00026;author=M.+A.+Colman&#x00026;author=H.+Ni&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2015&#x00026;title=In+silico+investigation+of+short+QT+syndrome-linked+potassium+channel+mutations+on+electro-mechanical+function+of+human+atrial+cells&#x00026;journal=Comput.+Cardiol.+Conference&#x00026;volume=2015&#x00026;pages=853-856" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B72" id="B72"></a> Whittaker, D. G., Colman, M. A., Ni, H., Hancox, J. C., and Zhang, H. (2018). Human atrial arrhythmogenesis and sinus bradycardia in KCNQ1-linked short QT syndrome: insights from computational modelling. <i>Front. Physiol.</i> 9:1402. doi: 10.3389/fphys.2018.01402</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=30337886" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fphys.2018.01402" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+G.+Whittaker&#x00026;author=M.+A.+Colman&#x00026;author=H.+Ni&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2018&#x00026;title=Human+atrial+arrhythmogenesis+and+sinus+bradycardia+in+KCNQ1-linked+short+QT+syndrome%3A+insights+from+computational+modelling&#x00026;journal=Front.+Physiol.&#x00026;volume=9&#x00026;pages=1402" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B73" id="B73"></a> Whittaker, D. G., Ni, H., Benson, A. P., Hancox, J. C., and Zhang, H. (2017a). Computational analysis of the mode of action of disopyramide and quinidine on hERG-linked short QT syndrome in human ventricles. <i>Front. Physiol.</i> 8:759. doi: 10.3389/fphys.2017.00759</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29085299" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fphys.2017.00759" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+G.+Whittaker&#x00026;author=H.+Ni&#x00026;author=A.+P.+Benson&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2017a&#x00026;title=Computational+analysis+of+the+mode+of+action+of+disopyramide+and+quinidine+on+hERG-linked+short+QT+syndrome+in+human+ventricles&#x00026;journal=Front.+Physiol.&#x00026;volume=8&#x00026;pages=759" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B74" id="B74"></a> Whittaker, D. G., Ni, H., Harchi, A. E., Hancox, J. C., and Zhang, H. (2017b). Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: insights from virtual human atria. <i>PLOS. Comput. Biol.</i> 13:e1005593. doi: 10.1371/journal.pcbi.1005593</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=28609477" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pcbi.1005593" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+G.+Whittaker&#x00026;author=H.+Ni&#x00026;author=A.+E.+Harchi&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2017b&#x00026;title=Atrial+arrhythmogenicity+of+KCNJ2+mutations+in+short+QT+syndrome%3A+insights+from+virtual+human+atria&#x00026;journal=PLOS.+Comput.+Biol.&#x00026;volume=13&#x00026;pages=e1005593" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B75" id="B75"></a> Wilhelms, M., Hettmann, H., Maleckar, M. M., Koivum&#x000E4;ki, J. T., D&#x000F6;ssel, O., and Seemann, G. (2013). Benchmarking electrophysiological models of human atrial myocytes. <i>Front. Physiol.</i> 3:487. doi: 10.3389/fphys.2012.00487</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23316167" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fphys.2012.00487" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Wilhelms&#x00026;author=H.+Hettmann&#x00026;author=M.+M.+Maleckar&#x00026;author=J.+T.+Koivum&#x000E4;ki&#x00026;author=O.+D&#x000F6;ssel&#x00026;author=G.+Seemann+&#x00026;publication_year=2013&#x00026;title=Benchmarking+electrophysiological+models+of+human+atrial+myocytes&#x00026;journal=Front.+Physiol.&#x00026;volume=3&#x00026;pages=487" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B76" id="B76"></a> Workman, A. J., Smith, G. L., and Rankin, A. C. (2011). Mechanisms of termination and prevention of atrial fibrillation by drug therapy. <i>Pharmacol. Ther.</i> 131, 221&#x02013;241. doi: 10.1016/j.pharmthera.2011.02.002</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21334377" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.pharmthera.2011.02.002" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+J.+Workman&#x00026;author=G.+L.+Smith&#x00026;author=A.+C.+Rankin+&#x00026;publication_year=2011&#x00026;title=Mechanisms+of+termination+and+prevention+of+atrial+fibrillation+by+drug+therapy&#x00026;journal=Pharmacol.+Ther.&#x00026;volume=131&#x00026;pages=221-241" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B77" id="B77"></a> Yuan, Y., Bai, X., Luo, C., Wang, K., and Zhang, H. (2015). The virtual heart as a platform for screening drug cardiotoxicity. <i>Br. J. Pharmacol.</i> 172, 5531&#x02013;5547. doi: 10.1111/bph.12996</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25363597" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/bph.12996" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+Yuan&#x00026;author=X.+Bai&#x00026;author=C.+Luo&#x00026;author=K.+Wang&#x00026;author=H.+Zhang+&#x00026;publication_year=2015&#x00026;title=The+virtual+heart+as+a+platform+for+screening+drug+cardiotoxicity&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=172&#x00026;pages=5531-5547" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B78" id="B78"></a> Zhang, H., and Hancox, J. C. (2004). <i>In silico</i> study of action potential and QT interval shortening due to loss of inactivation of the cardiac rapid delayed rectifier potassium current. <i>Biochem. Biophys. Res. Commun.</i> 322, 693&#x02013;699. doi: 10.1016/j.bbrc.2004.07.176</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15325285" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bbrc.2004.07.176" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H.+Zhang&#x00026;author=J.+C.+Hancox+&#x00026;publication_year=2004&#x00026;title=In+silico+study+of+action+potential+and+QT+interval+shortening+due+to+loss+of+inactivation+of+the+cardiac+rapid+delayed+rectifier+potassium+current&#x00026;journal=Biochem.+Biophys.+Res.+Commun.&#x00026;volume=322&#x00026;pages=693-699" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="B79" id="B79"></a> Zhou, J., Augelli-Szafran, C. E., Bradley, J. A., Chen, X., Koci, B. J., Volberg, W. A., et al. (2005). Novel potent human ether-&#x000E0;-Go-Go-related gene (hERG) potassium channel enhancers and their <i>in vitro</i> antiarrhythmic activity. <i>Mol. Pharmacol.</i> 68, 876&#x02013;884. doi: 10.1124/mol.105.014035</p>
<p class="ReferencesCopy2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15976038" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1124/mol.105.014035" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Zhou&#x00026;author=C.+E.+Augelli-Szafran&#x00026;author=J.+A.+Bradley&#x00026;author=X.+Chen&#x00026;author=B.+J.+Koci&#x00026;author=W.+A.+Volberg+&#x00026;publication_year=2005&#x00026;title=Novel+potent+human+ether-&#x000E0;-Go-Go-related+gene+(hERG)+potassium+channel+enhancers+and+their+in+vitro+antiarrhythmic+activity&#x00026;journal=Mol.+Pharmacol.&#x00026;volume=68&#x00026;pages=876-884" target="_blank">Google Scholar</a></p></div>
</div>
<div class="thinLineM20"></div>
<div class="AbstractSummary">
<p><span>Keywords:</span> arrhythmia, short QT syndrome, atrial fibrillation, hERG, class I anti-arrhythmics, human atria, potassium channels</p>
<p><span>Citation:</span> Whittaker DG, Hancox JC and Zhang H (2019) <i>In silico</i> Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome. <i>Front. Physiol</i>. 9:1888. doi: 10.3389/fphys.2018.01888</p>
<p id="timestamps"><span>Received:</span> 01 August 2018; <span>Accepted:</span> 12 December 2018;<br> <span>Published:</span> 11 January 2019.</p>
<div><p>Edited by:</p> <a href="http://loop.frontiersin.org/people/24963/overview">Olaf Doessel</a>, Karlsruhe Institute of Technology (KIT), Germany</div>
<div><p>Reviewed by:</p> <a href="http://loop.frontiersin.org/people/27699/overview">Richard Gray</a>, United States Food and Drug Administration, United States<br> <a href="http://loop.frontiersin.org/people/63899/overview">Socrates Dokos</a>, University of New South Wales, Australia</div>
<p><span>Copyright</span> &#x000A9; 2019 Whittaker, Hancox and Zhang. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<p><span>*Correspondence:</span> Jules C. Hancox, <a id="encmail">anVsZXMuaGFuY294QGJyaXN0b2wuYWMudWs=</a><br> Henggui Zhang, <a id="encmail">aGVuZ2d1aS56aGFuZ0BtYW5jaGVzdGVyLmFjLnVr</a></p>
<div class="clear"></div></div>

</div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fphys.2018.01888" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">2,7K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1,4K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">13</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/417422#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fphys.2018.01888" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fphys.2018.01888" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/24963/overview" data-event="editorInfo-a-olafDoessel" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">O</span><span class="notranslate">D</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Olaf  Doessel</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Karlsruhe Institute of Technology (KIT), Germany</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/27699/overview" data-event="editorInfo-a-richardAGray" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">R</span><span class="notranslate">A</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Richard  A Gray</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">United States Food and Drug Administration, United States</div></div></a><a href="https://loop.frontiersin.org/people/63899/overview" data-event="editorInfo-a-socratesDokos" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">S</span><span class="notranslate">D</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Socrates  Dokos</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of New South Wales, Australia</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal">
<li><a href="#h1">Abstract</a></li>
<li><a href="#h2">Introduction</a></li>
<li><a href="#h3">Methods</a></li>
<li><a href="#h4">Results</a></li>
<li><a href="#h5">Discussion</a></li>
<li><a href="#h6">Limitations</a></li>
<li><a href="#h7">Conclusions</a></li>
<li><a href="#h8">Author Contributions</a></li>
<li><a href="#h9">Funding</a></li>
<li><a href="#h10">Conflict of Interest Statement</a></li>
<li><a href="#h11">Acknowledgments</a></li>
<li><a href="#h12">Supplementary Material</a></li>
<li><a href="#h13">References</a></li>
</ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fphys.2018.01888" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/physiology/articles/10.3389/fphys.2018.01888/full",["Reactive",16],{"main":17,"user":583,"article":584,"articleHub":836,"mainHeader":840},{"ibar":18,"footer":312,"newsletterComponent":-1,"snackbarItem":394,"toggleShowSnackbar":395,"contentfulJournal":396,"graphJournal":483,"settingsFeaturesSwitchers":487,"templateToggleBanner":488,"tenantConfig":548},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":243,"aboutJournal":244,"mainLinks":293,"journalLinks":300,"helpCenterLink":309},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=1&fieldid=65&specialtyid=0&entitytype=2&entityid=210",{"id":115,"name":116,"slug":117,"sections":118},210,"Frontiers in Physiology","physiology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211,215,219,223,227,231,235,239],{"id":120,"name":121,"slug":122},230,"Aquatic Physiology","aquatic-physiology",{"id":124,"name":125,"slug":126},157,"Autonomic Neuroscience","autonomic-neuroscience",{"id":128,"name":129,"slug":130},1328,"Avian Physiology","avian-physiology",{"id":132,"name":133,"slug":134},667,"Biophysics","biophysics",{"id":136,"name":137,"slug":138},211,"Cardiac Electrophysiology","cardiac-electrophysiology",{"id":140,"name":141,"slug":142},2468,"Cell Physiology","cell-physiology",{"id":144,"name":145,"slug":146},1393,"Chronobiology","chronobiology",{"id":148,"name":149,"slug":150},579,"Clinical and Translational Physiology","clinical-and-translational-physiology",{"id":152,"name":153,"slug":154},212,"Computational Physiology and Medicine","computational-physiology-and-medicine",{"id":156,"name":157,"slug":158},214,"Craniofacial Biology and Dental Research","craniofacial-biology-and-dental-research",{"id":160,"name":161,"slug":162},1346,"Developmental Physiology","developmental-physiology",{"id":164,"name":165,"slug":166},1331,"Environmental, Aviation and Space Physiology","environmental-aviation-and-space-physiology",{"id":168,"name":169,"slug":170},215,"Exercise Physiology","exercise-physiology",{"id":172,"name":173,"slug":174},216,"Gastrointestinal Sciences","gastrointestinal-sciences",{"id":176,"name":177,"slug":178},218,"Integrative Physiology","integrative-physiology",{"id":180,"name":181,"slug":182},229,"Invertebrate Physiology","invertebrate-physiology",{"id":184,"name":185,"slug":186},444,"Lipid and Fatty Acid Research","lipid-and-fatty-acid-research",{"id":188,"name":189,"slug":190},670,"Medical Physics and Imaging","medical-physics-and-imaging",{"id":192,"name":193,"slug":194},213,"Membrane Physiology and Membrane Biophysics","membrane-physiology-and-membrane-biophysics",{"id":196,"name":197,"slug":198},2071,"Metabolic Physiology","metabolic-physiology",{"id":200,"name":201,"slug":202},232,"Mitochondrial Research","mitochondrial-research",{"id":204,"name":205,"slug":206},1496,"Physio-logging","physio-logging",{"id":208,"name":209,"slug":210},1386,"Red Blood Cell Physiology","red-blood-cell-physiology",{"id":212,"name":213,"slug":214},219,"Redox Physiology","redox-physiology",{"id":216,"name":217,"slug":218},222,"Renal Physiology and Pathophysiology","renal-physiology-and-pathophysiology",{"id":220,"name":221,"slug":222},2527,"Reproductive and Mating Physiology","reproductive-and-mating-physiology",{"id":224,"name":225,"slug":226},224,"Respiratory Physiology and Pathophysiology","respiratory-physiology-and-pathophysiology",{"id":228,"name":229,"slug":230},2275,"Skeletal Physiology","skeletal-physiology",{"id":232,"name":233,"slug":234},2965,"Skin Physiology","skin-physiology",{"id":236,"name":237,"slug":238},221,"Striated Muscle Physiology","striated-muscle-physiology",{"id":240,"name":241,"slug":242},225,"Vascular Physiology","vascular-physiology","Sections",[245,269],{"title":246,"links":247},"Scope",[248,251,254,257,260,263,266],{"text":249,"url":250,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/physiology/about#about-editors",{"text":252,"url":253,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/physiology/about#about-scope",{"text":255,"url":256,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/physiology/about#about-facts",{"text":258,"url":259,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/physiology/about#about-submission",{"text":261,"url":262,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/physiology/about#about-open",{"text":264,"url":265,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/physiology/about#copyright-statement",{"text":267,"url":268,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/physiology/about#about-quality",{"title":270,"links":271},"For authors",[272,275,278,281,284,287,290],{"text":273,"url":274,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/physiology/for-authors/why-submit",{"text":276,"url":277,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/physiology/for-authors/article-types",{"text":279,"url":280,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/physiology/for-authors/author-guidelines",{"text":282,"url":283,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/physiology/for-authors/editor-guidelines",{"text":285,"url":286,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/physiology/for-authors/publishing-fees",{"text":288,"url":289,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/physiology/for-authors/submission-checklist",{"text":291,"url":292,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/physiology/for-authors/contact-editorial-office",[294,297],{"text":295,"url":296,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":298,"url":299,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[301,304,306],{"text":302,"url":303,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":305,"target":27,"ariaLabel":28},"research-topics",{"text":307,"url":308,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":310,"url":311,"target":77,"ariaLabel":310},"Help center","https://helpcenter.frontiersin.org",{"blocks":313,"socialLinks":367,"copyright":391,"termsAndConditionsUrl":392,"privacyPolicyUrl":393},[314,328,338,352],{"title":315,"links":316},"Guidelines",[317,319,322,325,327],{"text":279,"url":318,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":320,"url":321,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":323,"url":324,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":282,"url":326,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":329,"links":330},"Explore",[331,332,335,337],{"text":302,"url":299,"target":27,"ariaLabel":28},{"text":333,"url":334,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":336,"url":296,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":339,"links":340},"Outreach",[341,344,347,351],{"text":342,"url":92,"target":77,"ariaLabel":343},"Frontiers Forum ","Frontiers Forum website",{"text":345,"url":346,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":348,"url":349,"target":77,"ariaLabel":350},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":353,"links":354},"Connect",[355,356,360,363,366],{"text":310,"url":311,"target":77,"ariaLabel":310},{"text":357,"url":358,"target":77,"ariaLabel":359},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":361,"url":111,"target":27,"ariaLabel":362},"Contact us ","Subscribe to newsletter",{"text":364,"url":365,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[368,376,381,386],{"link":369,"type":372,"color":373,"icon":374,"size":375,"hiddenText":13},{"text":370,"url":371,"target":77,"ariaLabel":370},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":377,"type":372,"color":373,"icon":380,"size":375,"hiddenText":13},{"text":378,"url":379,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":382,"type":372,"color":373,"icon":385,"size":375,"hiddenText":13},{"text":383,"url":384,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":387,"type":372,"color":373,"icon":390,"size":375,"hiddenText":13},{"text":388,"url":389,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":397,"identifier":115,"name":116,"slug":117,"banner":398,"description":476,"mission":477,"palette":478,"impactFactor":479,"citeScore":480,"citations":481,"showTagline":28,"twitter":482},"Journal",[399],{"id":400,"src":401,"name":402,"tags":403,"type":435,"width":436,"height":437,"idHash":438,"archive":439,"brandId":440,"limited":439,"fileSize":441,"isPublic":442,"original":443,"copyright":19,"extension":444,"thumbnails":446,"dateCreated":454,"description":455,"orientation":456,"userCreated":457,"watermarked":439,"dateModified":454,"datePublished":458,"ecsArchiveFiles":459,"propertyOptions":460,"property_Channel":465,"property_Sub-Type":467,"property_Asset_Type":469,"activeOriginalFocusPoint":471,"property_Office_Department":474},"8661D86F-DC44-47C3-8EDF5AC7C3010522","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/webimage-175D1AF6-D0D7-457F-9F3319DF25C432BF.png","FPHYS_Main Visual_Red_Website",[404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,430,431,432,433,434],"medical","anatomical","healthy","athlete","muscular","chest","organs","education","health","system","anatomy","bones","person","shape","biology","male","shoulders","muscle","nature","face","science","torso","fitness","skeleton","man","illustration","skin","medicine","body","3d","human","image",5000,3750,"1748dd1e17cf8710",0,"22C10171-81B3-4DA6-99342F272A32E8BB",7157365,1,"https://brand.frontiersin.org/m/1748dd1e17cf8710/original/FPHYS_Main-Visual_Red_Website.jpg",[445],"jpg",{"mini":447,"thul":448,"webimage":401,"Guidelines":449,"WebsiteJpg_XL":450,"WebsiteWebP_L":451,"WebsiteWebP_M":452,"WebsiteWebP_XL":453},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/mini-C3B0E16A-BAEB-48B5-91EB5B674F1EF10C.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/thul-E9E052B8-3DB0-4F07-93D30E218A898731.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/Guidelines-FPHYS_Main Visual_Red_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/WebsiteJpg_XL-FPHYS_Main Visual_Red_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/WebsiteWebP_L-FPHYS_Main Visual_Red_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/WebsiteWebP_M-FPHYS_Main Visual_Red_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/WebsiteWebP_XL-FPHYS_Main Visual_Red_Website.webp","2022-06-27T10:00:47Z","Human anatomy showing face, head, shoulders and back muscular system, bone structure and vascular system.; Shutterstock ID 342678791; purchase_order: Main Visual; job: ; client: ; other:","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[461,462,463,464],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[466],"frontiersin_org",[468],"Main_Visual",[470],"Photography",{"x":472,"y":473},2500,1875,[475],"Publishing","The most cited physiology journal, promoting a multidisciplinary approach to the physiology of living systems - from the subcellular and molecular domains to the intact organism and its interaction with the environment.","\u003Cp>Frontiers in Physiology explores the physiology of living systems across all levels, from the molecular and subcellular to the intact organism and its interaction with the environment.\u003C/p>\n\n\u003Cp>Led by Field Chief Editor Prof John D Imig (University of Arkansas for Medical Sciences, USA) and indexed in Scopus, Web of Science (SCIE), PubMed Central (PMC), and DOAJ, the journal welcomes human and animal studies across all areas of physiology, including technologies for investigating physiological function. Topics of interest include, but are not limited to:\u003C/p>\n\u003Cul>\n  \u003Cli>avian, aquatic, and invertebrate physiology\u003C/li>\n  \u003Cli>biophysics, medical physics and imaging\u003C/li>\n  \u003Cli>cancer-related physiology and pathophysiology\u003C/li>\n  \u003Cli>cardiac electrophysiology\u003C/li>\n  \u003Cli>cell, membrane, metabolic, mitochondrial and redox physiology\u003C/li>\n  \u003Cli>chronobiology\u003C/li>\n  \u003Cli>computational physiology and medicine\u003C/li>\n  \u003Cli>craniofacial, tooth, skin, skeletal, and striated muscle physiology\u003C/li>\n  \u003Cli>developmental physiology\u003C/li>\n  \u003Cli>environmental, aviation, and space physiology\u003C/li>\n  \u003Cli>exercise physiology\u003C/li>\n  \u003Cli>gastrointestinal and physiology\u003C/li>\n  \u003Cli>integrative, clinical, and translational physiology\u003C/li>\n  \u003Cli>neurophysiology and autonomic neuroscience\u003C/li>\n  \u003Cli>physio-logging\u003C/li>\n  \u003Cli>reproductive and mating physiology\u003C/li>\n  \u003Cli>respiratory, vascular, renal and red blood cell physiology.\u003C/li>\n\u003C/ul>\n\n\u003Cp>Frontiers in Physiology particularly welcomes studies that support and advance the UNs Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being.\u003C/p>\n\n\u003Cp>Manuscripts that focus solely on clinical or medical research, including cancer studies, traditional medicine, and patient prognosis, are not suitable for publication in this journal. Additionally, research that is purely statistical or computational, such as regression analysis or network analysis, without a clear physiological context or application, is not within the scope of this journal.\u003C/p>\n\n\u003Cp>Frontiers in Physiology welcomes cancer-related research which focuses on the physiology and pathophysiology of the disease from cellular mechanisms to altered organ physiology. Should a manuscript purely focus on cancer etiology, cancer bioinformatics identifying novel biomarkers, cancer treatments, and cancer disease progression, it will not be considered in scope for the journal. Similarly, manuscripts on disease etiology, purely pathological processes, identification of novel biomarkers, and the progression, treatment, or management of disease  including clinical trials, and pilot studies  or purely bibliometric studies are not suitable for publication in this journal, and will be redirected to Frontiers in Medicine or Frontiers in Oncology as appropriate. Case reports will be considered in specified sections for publication in this journal. Please check section scope descriptions.\u003C/p>\n\n\u003Cp>Frontiers journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information. Manuscripts not adhering to these standards will not be considered.\u003Cp>\n\n\u003Cp>Frontiers in Physiology is committed to understanding how body components work together to maintain a healthy state by communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.\u003C/p>","red","4 .0","6.1","420871","@FrontPhysiol",{"id":115,"name":116,"slug":117,"abbreviation":484,"isOnline":13,"isOpenForSubmissions":13,"citeScore":485,"impactFactor":486},"fphys",7.3,3.4,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":395},{"isPublic":13,"allowCompanyUsers":395,"whiteListEmails":489,"enableAllJournals":13,"whiteListJournals":511},[490,491,492,493,494,495,496,497,498,495,499,500,501,502,503,504,505,506,507,508,509,510],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[512,513,514,515,516,517,442,518,519,520,521,522,523,524,525,526,527,528,529,530,531,532,533,534,535,536,537,538,539,540,541,542,543,544,545,546,547],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":442,"name":442,"availableJournalPages":549,"announcement":553},[303,308,305,550,551,552],"volumes","about","community-reviewers",{"__typename":554,"sys":555,"preHeader":42,"title":557,"description":558,"image":559,"link":581},"Announcement",{"id":556},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[560],{"archive":439,"brandId":440,"copyright":28,"dateCreated":561,"dateModified":562,"datePublished":563,"description":28,"extension":564,"fileSize":566,"height":567,"id":568,"isPublic":439,"limited":439,"name":569,"orientation":456,"original":28,"thumbnails":570,"type":435,"watermarked":439,"width":577,"videoPreviewURLs":578,"tags":579,"textMetaproperties":580,"src":571},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[565],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":571,"thul":572,"mini":573,"WebsiteWebP_L":574,"WebsiteWebP_M":575,"Guidelines":576},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":582,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":585,"isPreviewPage":395,"hasSupplementalData":395,"showCrossmarkWidget":13,"articleTemplate":722,"currentArticlePageMetaInfo":723,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":586,"doi":587,"title":588,"acceptanceDate":589,"receptionDate":590,"publicationDate":591,"lastModifiedDate":592,"isPublished":13,"abstract":593,"researchTopic":594,"articleType":600,"stage":603,"keywords":605,"authors":612,"editors":647,"reviewers":657,"journal":677,"section":684,"impactMetrics":686,"volume":690,"articleVolume":691,"relatedArticles":692,"isPublishedV2":395,"contents":693,"files":697},417422,"10.3389/fphys.2018.01888","In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome",["Date","2018-12-12T14:43:23.000Z"],["Date","2018-08-01T13:44:07.000Z"],["Date","2019-01-11T00:00:00.000Z"],["Date","2025-11-26T08:53:37.809Z"],"Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the human Ether--go-go-Related Gene (hERG), which encodes the  subunit of channels carrying rapid delayed rectifier potassium current, IKr. In addition to QT interval shortening and ventricular arrhythmias, SQT1 is associated with increased risk of atrial fibrillation (AF), which is often the only clinical presentation. However, the underlying basis of AF and its pharmacological treatment remain incompletely understood in the context of SQT1. \nIn this study, computational modelling was used to investigate mechanisms of human atrial arrhythmogenesis consequent to a SQT1 mutation, as well as pharmacotherapeutic effects of selected class I drugs  disopyramide, quinidine, and propafenone. A Markov chain formulation describing wild type (WT) and N588K-hERG mutant IKr was incorporated into a contemporary human atrial action potential (AP) model, which was integrated into one-dimensional (1D) tissue strands, idealised 2D sheets, and a 3D heterogeneous, anatomical human atria model. Multi-channel pharmacological effects of disopyramide, quinidine, and propafenone, including binding kinetics for IKr/hERG and sodium current, INa, were considered.\nHeterozygous and homozygous formulations of the N588K-hERG mutation shortened the AP duration (APD) by 53 and 86 ms, respectively, which abbreviated the effective refractory period (ERP) and excitation wavelength in tissue, increasing the lifespan and dominant frequency (DF) of scroll waves in the 3D anatomical human atria. At the concentrations tested in this study, quinidine most effectively prolonged the APD and ERP in the setting of SQT1, followed by disopyramide and propafenone. In 2D simulations, disopyramide and quinidine promoted re-entry termination by increasing the re-entry wavelength, whereas propafenone induced secondary waves which destabilised the re-entrant circuit. In 3D simulations, the DF of re-entry was reduced in a dose-dependent manner for disopyramide and quinidine, and propafenone to a lesser extent. All of the anti-arrhythmic agents promoted pharmacological conversion, most frequently terminating re-entry in the order quinidine > propafenone = disopyramide. \nOur findings provide further insight into mechanisms of SQT1-related AF and a rational basis for the pursuit of combined IKr and INa block based pharmacological strategies in the treatment of SQT1-linked AF. \n",{"id":595,"title":596,"articlesCount":597,"isMagazinePage":13,"slug":598,"isOpenForSubmission":395,"views":599},7807,"Cardiac Modeling: Aiming for Optimization of Therapy",16,"cardiac-modeling-aiming-for-optimization-of-therapy",95478,{"id":601,"name":602},24,"Original Research",{"id":604,"name":19},18,[606,607,608,609,610,611],"arrhythmia","short QT syndrome","Atrial Fibrillation","hERG, potassium channels","class I anti-arrhythmics","human atria",[613,624,633],{"id":614,"firstName":615,"middleName":19,"lastName":616,"givenNames":617,"isCorresponding":395,"isProfilePublic":13,"userId":614,"email":-1,"affiliations":618},462272,"Dominic G.","Whittaker","Dominic G. ",[619,622],{"organizationName":620,"countryName":621,"cityName":19,"stateName":19,"zipCode":19},"Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds","United Kingdom",{"organizationName":623,"countryName":621,"cityName":19,"stateName":19,"zipCode":19},"Biological Physics Group, School of Physics and Astronomy, The University of Manchester",{"id":625,"firstName":626,"middleName":19,"lastName":627,"givenNames":628,"isCorresponding":395,"isProfilePublic":13,"userId":625,"email":-1,"affiliations":629},91129,"Jules C.","Hancox","Jules C. ",[630,631],{"organizationName":623,"countryName":621,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":632,"countryName":621,"cityName":19,"stateName":19,"zipCode":19},"Cardiovascular Research Laboratories, Department of Physiology, Pharmacology and Neuroscience, School of Medical Sciences, University of Bristol",{"id":634,"firstName":635,"middleName":19,"lastName":636,"givenNames":637,"isCorresponding":395,"isProfilePublic":13,"userId":634,"email":-1,"affiliations":638},27383,"Henggui","Zhang","Henggui ",[639,640,643,645],{"organizationName":623,"countryName":621,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":641,"countryName":642,"cityName":19,"stateName":19,"zipCode":19},"School of Computer Science and Technology, Harbin Institute of Technology","China",{"organizationName":644,"countryName":642,"cityName":19,"stateName":19,"zipCode":19},"Space Institute of Southern China",{"organizationName":646,"countryName":642,"cityName":19,"stateName":19,"zipCode":19},"Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University",[648],{"id":649,"firstName":650,"middleName":19,"lastName":651,"givenNames":652,"isCorresponding":395,"isProfilePublic":13,"userId":649,"email":-1,"affiliations":653},24963,"Olaf","Doessel","Olaf ",[654],{"organizationName":655,"countryName":656,"cityName":19,"stateName":19,"zipCode":19},"Karlsruhe Institute of Technology (KIT)","Germany",[658,668],{"id":659,"firstName":660,"middleName":661,"lastName":662,"givenNames":663,"isCorresponding":395,"isProfilePublic":13,"userId":659,"email":-1,"affiliations":664},27699,"Richard","A","Gray","Richard  A",[665],{"organizationName":666,"countryName":667,"cityName":19,"stateName":19,"zipCode":19},"United States Food and Drug Administration","United States",{"id":669,"firstName":670,"middleName":19,"lastName":671,"givenNames":672,"isCorresponding":395,"isProfilePublic":13,"userId":669,"email":-1,"affiliations":673},63899,"Socrates","Dokos","Socrates ",[674],{"organizationName":675,"countryName":676,"cityName":19,"stateName":19,"zipCode":19},"University of New South Wales","Australia",{"id":115,"slug":117,"name":116,"shortName":678,"electronicISSN":679,"field":680,"specialtyId":28,"journalSectionPaths":682},"Front. Physiol.","1664-042X",{"id":681,"domainId":442},65,[683],{"section":684},{"id":152,"name":153,"slug":154,"specialtyId":685},238,{"views":687,"downloads":688,"citations":689},2668,1439,13,9,"Volume 9 - 2018",[],{"titleHtml":694,"fullTextHtml":695,"menuHtml":696},"\u003Ci>In silico\u003C/i> Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome","\u003Cdiv class=\"JournalAbstract\">\r\n\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\r\n\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\r\n\u003Ca href=\"https://loop.frontiersin.org/people/462272\" class=\"user-id-462272\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/462272/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"\r\nDominic G. Whittaker,\">Dominic G. Whittaker\u003C/a>\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/91129\" class=\"user-id-91129\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/91129/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Jules C. Hancox,*\">Jules C. Hancox\u003C/a>\u003Csup>2,3\u003C/sup>\u003Csup>*\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/27383\" class=\"user-id-27383\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/27383/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Henggui Zhang,,,*\">Henggui Zhang\u003C/a>\u003Csup>2,4,5,6\u003C/sup>\u003Csup>*\u003C/sup>\u003C/span>\u003C/div>\r\n\u003Cul class=\"notes\">\r\n\u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>Biological Physics Group, School of Physics and Astronomy, The University of Manchester, Manchester, United Kingdom\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>3\u003C/sup>\u003C/span>Cardiovascular Research Laboratories, Department of Physiology, Pharmacology and Neuroscience, School of Medical Sciences, University of Bristol, Bristol, United Kingdom\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>4\u003C/sup>\u003C/span>School of Computer Science and Technology, Harbin Institute of Technology, Harbin, China\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>5\u003C/sup>\u003C/span>Space Institute of Southern China, Shenzhen, China\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>6\u003C/sup>\u003C/span>Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China\u003C/li>\r\n\u003C/ul>\r\n\u003Cp>Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the \u003Ci>human Ether-&#x000E0;-go-go-Related Gene\u003C/i> (\u003Ci>hERG\u003C/i>), which encodes the &#x003B1; subunit of channels carrying rapid delayed rectifier potassium current, \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>. In addition to QT interval shortening and ventricular arrhythmias, SQT1 is associated with increased risk of atrial fibrillation (AF), which is often the only clinical presentation. However, the underlying basis of AF and its pharmacological treatment remain incompletely understood in the context of SQT1. In this study, computational modeling was used to investigate mechanisms of human atrial arrhythmogenesis consequent to a SQT1 mutation, as well as pharmacotherapeutic effects of selected class I drugs&#x02013;disopyramide, quinidine, and propafenone. A Markov chain formulation describing wild type (WT) and N588K-hERG mutant \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> was incorporated into a contemporary human atrial action potential (AP) model, which was integrated into one-dimensional (1D) tissue strands, idealized 2D sheets, and a 3D heterogeneous, anatomical human atria model. Multi-channel pharmacological effects of disopyramide, quinidine, and propafenone, including binding kinetics for \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>/hERG and sodium current, \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub>, were considered. Heterozygous and homozygous formulations of the N588K-hERG mutation shortened the AP duration (APD) by 53 and 86 ms, respectively, which abbreviated the effective refractory period (ERP) and excitation wavelength in tissue, increasing the lifespan and dominant frequency (DF) of scroll waves in the 3D anatomical human atria. At the concentrations tested in this study, quinidine most effectively prolonged the APD and ERP in the setting of SQT1, followed by disopyramide and propafenone. In 2D simulations, disopyramide and quinidine promoted re-entry termination by increasing the re-entry wavelength, whereas propafenone induced secondary waves which destabilized the re-entrant circuit. In 3D simulations, the DF of re-entry was reduced in a dose-dependent manner for disopyramide and quinidine, and propafenone to a lesser extent. All of the anti-arrhythmic agents promoted pharmacological conversion, most frequently terminating re-entry in the order quinidine &#x0003E; propafenone = disopyramide. Our findings provide further insight into mechanisms of SQT1-related AF and a rational basis for the pursuit of combined \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> block based pharmacological strategies in the treatment of SQT1-linked AF.\u003C/p>\r\n\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\r\n\u003Cdiv class=\"JournalFullText\">\r\n\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>Introduction\u003C/h2>\r\n\u003Cp class=\"mb15\">The short QT syndrome (SQTS) is characterized primarily by a short QT interval on the ECG, which corresponds to abbreviated ventricular repolarisation. However, symptomatic atrial fibrillation (AF) has also been reported as a common first clinical presentation of the SQTS (\u003Ca href=\"#B62\">Schimpf et al., 2005\u003C/a>), suggesting that pathophysiological mechanisms leading to shortening of the QT interval also affect the atria, which can increase susceptibility to AF. The N588K mutation to the \u003Ci>human Ether-&#x000E0;-go-go-Related gene (hERG)\u003C/i>, which encodes the &#x003B1; subunit of channels carrying rapid delayed rectifier potassium current, \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>, underlies a form of SQTS variant 1 (SQT1) (\u003Ca href=\"#B12\">Brugada et al., 2004\u003C/a>), and has been associated with a high incidence of AF in affected probands&#x02014;as high as 50% (\u003Ca href=\"#B34\">Hu et al., 2017\u003C/a>). Whilst ventricular arrhythmia substrates in SQT1 have received much attention (\u003Ca href=\"#B78\">Zhang and Hancox, 2004\u003C/a>; \u003Ca href=\"#B56\">Patel and Antzelevitch, 2008\u003C/a>; \u003Ca href=\"#B2\">Adeniran et al., 2011\u003C/a>), there have been comparatively fewer studies investigating mechanisms by which SQT1 mutations promote AF, which can be an important biomarker of the SQTS. Furthermore, effective management of AF remains a challenge, and is incompletely understood in the context of SQT1 (\u003Ca href=\"#B22\">Enriquez et al., 2016\u003C/a>; \u003Ca href=\"#B31\">Hancox et al., 2018\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb15\">A previous simulation study (\u003Ca href=\"#B44\">Loewe et al., 2014b\u003C/a>) used the Courtemanche-Ramirez-Nattel (CRN) mathematical model of the human atrial action potential (AP) (\u003Ca href=\"#B17\">Courtemanche et al., 1998\u003C/a>) to demonstrate shortening of the atrial effective refractory period (ERP) and tissue excitation wavelength (WL) consequent to the N588K-hERG mutation. This was shown to facilitate initiation and sustenance of spiral waves in idealized two-dimensional (2D) sheets of human atrial tissue, which is a likely mechanism for increased susceptibility to AF. However, both the intrinsic electrical heterogeneities and complex anatomy of the human atria have also been suggested to influence arrhythmia vulnerability and dynamics in overall response to K\u003Csup>&#43;\u003C/sup> channel mutations (\u003Ca href=\"#B15\">Colman et al., 2017\u003C/a>; \u003Ca href=\"#B74\">Whittaker et al., 2017b\u003C/a>). Consequently, the first aim of the present study was to assess the arrhythmogenicity of the N588K-hERG mutation in anatomically-detailed models of the human atria with realistic structure and inclusion of regional differences in electrophysiology.\u003C/p>\r\n\u003Cp class=\"mb0\">The class Ia anti-arrhythmic drug quinidine is typically used as the frontline therapy for QT interval normalization in SQT1 (\u003Ca href=\"#B26\">Gaita et al., 2004\u003C/a>; \u003Ca href=\"#B27\">Giustetto, 2006\u003C/a>; \u003Ca href=\"#B34\">Hu et al., 2017\u003C/a>), and disopyramide has been suggested as a possible alternative (\u003Ca href=\"#B20\">Dumaine and Antzelevitch, 2006\u003C/a>; \u003Ca href=\"#B61\">Schimpf et al., 2007\u003C/a>). Regarding management of atrial arrhythmias, the class Ic anti-arrhythmic drug propafenone has been reported to be effective at preventing recurrent episodes of (paroxysmal) AF mediated by the N588K mutation to hERG (\u003Ca href=\"#B33\">Hong et al., 2005\u003C/a>; \u003Ca href=\"#B9\">Bjerregaard et al., 2006\u003C/a>), maintaining 2 patients free of arrhythmia recurrence for &#x0003E;2 years (\u003Ca href=\"#B33\">Hong et al., 2005\u003C/a>). In an experimental setting in which a hERG activator was used to approximate SQT1, quinidine (a blocker of \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>) was effective at extending atrial AP duration and ERP and preventing AF (\u003Ca href=\"#B54\">Nof et al., 2010\u003C/a>), more so than E-4031 (a selective \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> blocker) or lidocaine (an \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> blocker) alone, suggesting that K\u003Csup>&#43;\u003C/sup> and Na\u003Csup>&#43;\u003C/sup> channel blocking effects combine synergistically for improved management of AF in SQT1. Similarly, in our previous study, a multi-scale computational modeling approach was used to investigate ventricular pharmacological effects of disopyramide and quinidine in SQT1 (\u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>), where combined \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> block by both compounds was shown to prolong ERP to a greater extent than \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> or \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> block alone. Mechanisms by which Na\u003Csup>&#43;\u003C/sup> and K\u003Csup>&#43;\u003C/sup>-channel blocking agents may provide beneficial effects in the context of SQT1-mediated human atrial pro-arrhythmia remain unclear. A multi-scale cardiac modeling approach is being used increasingly for optimisation of therapy (\u003Ca href=\"#B77\">Yuan et al., 2015\u003C/a>). Consequently, the second aim of the present study was to assess the efficacy of the class I drugs disopyramide, quinidine, and propafenone on rate and rhythm control of human atrial arrhythmias mediated by SQT1, from cell to 3D tissue levels, using drug binding models (including reduced potency of drugs against SQT1 mutant \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>) with multi-channel pharmacology.\u003C/p>\r\n\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>Methods\u003C/h2>\r\n\u003Ch3 class=\"pt0\">Modeling Human Atrial Electrophysiology\u003C/h3>\r\n\u003Cp class=\"mb0\">Human atrial electrophysiology was simulated using the Colman et al. model (\u003Ca href=\"#B14\">Colman et al., 2013\u003C/a>), as updated recently (\u003Ca href=\"#B53\">Ni et al., 2017\u003C/a>), and is hereinafter referred to as the CNZ (Colman-Ni-Zhang) model. The equations for \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> in the CNZ model were replaced with previously developed and validated Markov chain formulations of wild type (WT) and N588K mutant \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>/hERG (\u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>). The maximal conductance of \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> was set to \u003Ci>g\u003C/i>\u003Csub>Kr\u003C/sub> = 0.0111375\u003Cmath>\u003Cmo>&#x000B7;\u003C/mo>\u003Cmsubsup>\u003Cmrow>\u003Cmrow>\u003Cmo>[\u003C/mo>\u003Cmrow>\u003Cmsup>\u003Cmrow>\u003Cmi>K\u003C/mi>\u003C/mrow>\u003Cmrow>\u003Cmo>&#43;\u003C/mo>\u003C/mrow>\u003C/msup>\u003C/mrow>\u003Cmo>]\u003C/mo>\u003C/mrow>\u003C/mrow>\u003Cmrow>\u003Cmi>o\u003C/mi>\u003C/mrow>\u003Cmrow>\u003Cmn>0\u003C/mn>\u003Cmo>.\u003C/mo>\u003Cmn>59\u003C/mn>\u003C/mrow>\u003C/msubsup>\u003C/math>, where \u003Cmath>\u003Cmsub>\u003Cmrow>\u003Cmrow>\u003Cmo>[\u003C/mo>\u003Cmrow>\u003Cmsup>\u003Cmrow>\u003Cmi>K\u003C/mi>\u003C/mrow>\u003Cmrow>\u003Cmo>&#43;\u003C/mo>\u003C/mrow>\u003C/msup>\u003C/mrow>\u003Cmo>]\u003C/mo>\u003C/mrow>\u003C/mrow>\u003Cmrow>\u003Cmi>o\u003C/mi>\u003C/mrow>\u003C/msub>\u003C/math> is the extracellular potassium concentration (\u003Ca href=\"#B2\">Adeniran et al., 2011\u003C/a>), resulting in an action potential duration (APD) at 90% repolarisation (APD\u003Csub>90\u003C/sub>) of 248.8 ms at 1 Hz in the baseline human atrial cell model, which is well within the experimentally-measured range of APDs in human atrial myocytes (\u003Ca href=\"#B10\">Bosch et al., 1999\u003C/a>; \u003Ca href=\"#B36\">Kim et al., 2002\u003C/a>; \u003Ca href=\"#B18\">Dobrev and Ravens, 2003\u003C/a>; \u003Ca href=\"#B35\">Katoh et al., 2005\u003C/a>; \u003Ca href=\"#B59\">Redpath et al., 2006\u003C/a>; \u003Ca href=\"#B57\">Pau et al., 2007\u003C/a>). A family of regional human atrial cell models was incorporated into the CNZ model, accounting for distinct differences in electrophysiology of the right and left atrium (RA and LA, respectively), right and left atrial appendages (RAA and LAA, respectively), crista terminalis (CT), pectinate muscles (PM), atrio-ventricular ring (AVR), atrial septum (AS), Bachmann&#x00027;s bundle (BB), and pulmonary veins (PV) (\u003Ca href=\"#B14\">Colman et al., 2013\u003C/a>). Changes to maximal ionic conductances relative to the RA model implemented in order to create a family of regional cell models are given in Table \u003Ca href=\"#SM1\">S1\u003C/a>. The homozygous (N588K) form of SQT1 was modeled as consisting of 100% mutant subunits, whereas the heterozygous (WT-N588K) form was assumed to consist of a 1:1 WT:mutant subunit ratio (\u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>).\u003C/p>\r\n\u003Ch3>Modeling Pharmacological Actions of Disopyramide and Quinidine\u003C/h3>\r\n\u003Cp class=\"mb0\">In our previous study (\u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>), the actions of the class Ia anti-arrhythmic drugs disopyramide and quinidine on human ventricles were simulated in the setting of SQT1. State-dependent binding of disopyramide and quinidine to hERG channels was simulated through addition of drug-bound open and inactivated states to Markov chain formulations of \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>, and the guarded receptor model (\u003Ca href=\"#B66\">Starmer et al., 1984\u003C/a>) was used to describe use-dependent block of fast sodium current, \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub>, by both agents. Furthermore, the blocking actions of disopyramide and quinidine on slow delayed rectifier potassium current, \u003Ci>I\u003C/i>\u003Csub>Ks\u003C/sub>, L-type calcium current, \u003Ci>I\u003C/i>\u003Csub>CaL\u003C/sub>, transient outward potassium current, \u003Ci>I\u003C/i>\u003Csub>to\u003C/sub>, inward rectifier potassium current, \u003Ci>I\u003C/i>\u003Csub>K1\u003C/sub> (quinidine only), and late sodium current, \u003Ci>I\u003C/i>\u003Csub>NaL\u003C/sub> (quinidine only), were modeled using a simple &#x0201C;pore block&#x0201D; approach. In the present study, the actions of disopyramide and quinidine on human atrial electrophysiology were represented using the same formulations and IC\u003Csub>50\u003C/sub> (half maximal inhibitory concentration) values presented in \u003Ca href=\"#B73\">Whittaker et al. (2017a)\u003C/a>. In addition, disopyramide and quinidine have both been reported to block the atrial-specific ultra-rapid delayed rectifier potassium current, \u003Ci>I\u003C/i>\u003Csub>Kur\u003C/sub>. For disopyramide, the IC\u003Csub>50\u003C/sub> for block of \u003Ci>I\u003C/i>\u003Csub>Kur\u003C/sub> was taken to be 25.0 &#x003BC;M (\u003Ca href=\"#B6\">Ar&#x000E9;chiga et al., 2008\u003C/a>), and for quinidine the IC\u003Csub>50\u003C/sub> was taken to be 6.6 &#x003BC;M, as measured in human atrial myocytes (\u003Ca href=\"#B52\">Nenov et al., 1998\u003C/a>). As the CNZ model does not include late sodium current, quinidine block of \u003Ci>I\u003C/i>\u003Csub>NaL\u003C/sub> was not included in simulations. Full details of disopyramide and quinidine models can be found in \u003Ca href=\"#B73\">Whittaker et al. (2017a)\u003C/a>.\u003C/p>\r\n\u003Ch3>Modeling Pharmacological Actions of Propafenone\u003C/h3>\r\n\u003Cp class=\"mb0\">Using the same approach as detailed for disopyramide and quinidine in \u003Ca href=\"#B73\">Whittaker et al. (2017a)\u003C/a>, state-dependent models of drug block by propafenone were developed. Interactions between propafenone and \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>/hERG were developed based on experimental data obtained at 37&#x000B0;C (\u003Ca href=\"#B58\">Paul et al., 2002\u003C/a>; \u003Ca href=\"#B47\">McPate et al., 2008\u003C/a>), where estimation of parameters for drug-bound states of the Markov chain formulation of \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> was performed using the procedure outlined in \u003Ca href=\"#B50\">Moreno et al. (2016)\u003C/a>. Binding and unbinding rates to activated and inactivated state channels were allowed to vary freely in order to minimize the difference between simulated and experimental dose-dependent steady state block (WT and N588K), mean fractional block of tail currents during a pulse protocol, and voltage-dependence of tail current block (\u003Ca href=\"#B58\">Paul et al., 2002\u003C/a>; \u003Ca href=\"#B47\">McPate et al., 2008\u003C/a>). The extended drug-free Markov chain model of \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>/hERG is shown in Figure \u003Ca href=\"#F1\">1\u003C/a>, as well as the close concordance between simulated and experimental data regarding propafenone block of \u003Ci>I\u003C/i>\u003Csub>hERG\u003C/sub>. Parameters and state affinities are given in Table \u003Ca href=\"#SM1\">S2\u003C/a>.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 1\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg\" name=\"figure1\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg\" alt=\"www.frontiersin.org\" id=\"F1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 1\u003C/strong>. Propafenone interactions with hERG channels. \u003Cstrong>(Ai)\u003C/strong> Drug-free and \u003Cstrong>(Aii)\u003C/strong> drug-bound (additional states shown in green) Markov chain models of \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>/hERG. Simulated (solid line) and experimental (points) mean fractional block by 0.5 &#x003BC;M propafenone (PROPAF) of \u003Ci>I\u003C/i>\u003Csub>hERG\u003C/sub> during pulse protocol (shown inset) \u003Cstrong>(Bi)\u003C/strong>, and dose-response curve under WT (blue) and SQT1 mutant N588K (red) conditions \u003Cstrong>(Bii)\u003C/strong>, where IC\u003Csub>50\u003C/sub> values are 390 nM and 936 nM (2.4-fold increase), respectively. \u003Cstrong>(Ci)\u003C/strong> Simulated and \u003Cstrong>(Cii)\u003C/strong> experimental current traces in response to a 10,000 ms depolarising voltage step to 0 mV from a holding potential of &#x02212;80 mV \u003Cstrong>(Di,Dii)\u003C/strong> under control conditions and with application of 0.5 &#x003BC;M PROPAF &#x02013; these data were used to validate and not to further train the model. Experimental data at 37&#x000B0;C are taken from \u003Ca style=\"color:grey;\" href=\"#B58\">Paul et al. (2002)\u003C/a> and \u003Ca style=\"color:grey;\" href=\"#B47\">McPate et al. (2008)\u003C/a>.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mt15 w100pc float_left\">Propafenone is a class Ic sodium channel blocking anti-arrhythmic drug (\u003Ca href=\"#B60\">Roden, 2014\u003C/a>). Use-dependent block of sodium channels by propafenone was represented using the guarded receptor hypothesis (\u003Ca href=\"#B66\">Starmer et al., 1984\u003C/a>), as described for disopyramide and quinidine. Propafenone is predominantly an open state sodium channel blocker with little to no resting state block (\u003Ca href=\"#B21\">Edrich et al., 2005\u003C/a>; \u003Ca href=\"#B13\">Burashnikov et al., 2012\u003C/a>), and was thus assumed to bind only to activated and inactivated states. Binding and unbinding parameters were constrained based on the dose-dependent, use-dependent, and steady state block of \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> by propafenone (\u003Ca href=\"#B32\">Harmer et al., 2008\u003C/a>), as shown in Figure \u003Ca href=\"#F2\">2A\u003C/a>. Binding and unbinding parameters and state affinities are given in Table \u003Ca href=\"#SM1\">S3\u003C/a>.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 2\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg\" name=\"figure2\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g002.jpg\" alt=\"www.frontiersin.org\" id=\"F2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 2\u003C/strong>. Propafenone interactions with sodium channels. \u003Cstrong>(Ai)\u003C/strong> Simulated (solid lines) and experimental (points) use-dependent block of sodium channels by propafenone (PROPAF) elicited using a series of 8 pulses from &#x02212;90 mV to 0 mV at 3 Hz for three different test concentrations. \u003Cstrong>(Aii)\u003C/strong> Steady state block of sodium channels using pulses from &#x02212;90 mV to 0 mV at 3 Hz until a steady state was achieved. Experimental data are taken from \u003Ca style=\"color:grey;\" href=\"#B32\">Harmer et al. (2008)\u003C/a>, where the steady state block IC\u003Csub>50\u003C/sub> value is given as 1.4 &#x003BC;M. \u003Cstrong>(B)\u003C/strong> Simulated and \u003Cstrong>(C)\u003C/strong> experimentally-measured PROPAF-induced reduction in maximum upstroke velocity (\u003Cmath>\u003Cmsub>\u003Cmrow>\u003Cmover accent=\"true\">\u003Cmrow>\u003Cmi>V\u003C/mi>\u003C/mrow>\u003Cmo>&#x000B0;\u003C/mo>\u003C/mover>\u003C/mrow>\u003Cmrow>\u003Cmo class=\"qopname\">max\u003C/mo>\u003C/mrow>\u003C/msub>\u003C/math>) upon application of 0.3 and 1.5 &#x003BC;M PROPAF at a cycle length (CL) of (i) 500 ms and (ii) 300 ms. All \u003Cmath>\u003Cmsub>\u003Cmrow>\u003Cmover accent=\"true\">\u003Cmrow>\u003Cmi>V\u003C/mi>\u003C/mrow>\u003Cmo>&#x000B0;\u003C/mo>\u003C/mover>\u003C/mrow>\u003Cmrow>\u003Cmo class=\"qopname\">max\u003C/mo>\u003C/mrow>\u003C/msub>\u003C/math> reductions are relative to the control (C) value at a CL of 500 ms. Experimental data, recorded from canine atrial myocytes, are taken from \u003Ca style=\"color:grey;\" href=\"#B13\">Burashnikov et al. (2012)\u003C/a>.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mb15 w100pc float_left mt15\">Whilst propafenone most potently blocks \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub>, it is a multi-channel blocker, and thus exerts secondary effects on other ion channels, which were modeled using a simple pore block based on IC\u003Csub>50\u003C/sub> values from the literature. Propafenone blocks \u003Ci>I\u003C/i>\u003Csub>CaL\u003C/sub> with an IC\u003Csub>50\u003C/sub> of 1.5&#x02013;1.7 &#x003BC;M in mammalian cardiac myocytes (\u003Ca href=\"#B23\">Fei et al., 1993\u003C/a>; \u003Ca href=\"#B30\">Hancox and Mitcheson, 1997\u003C/a>). In human atrial myocytes, propafenone has been shown to block \u003Ci>I\u003C/i>\u003Csub>to\u003C/sub> with an IC\u003Csub>50\u003C/sub> of 4.8 &#x003BC;M (\u003Ca href=\"#B29\">Gross and Castle, 1998\u003C/a>; \u003Ca href=\"#B64\">Seki et al., 1999\u003C/a>) and \u003Ci>I\u003C/i>\u003Csub>K1\u003C/sub> with an IC\u003Csub>50\u003C/sub> of 16.8 &#x003BC;M (\u003Ca href=\"#B5\">Amor&#x000F3;s et al., 2013\u003C/a>). Finally, \u003Ci>I\u003C/i>\u003Csub>Kur\u003C/sub> is blocked with an IC\u003Csub>50\u003C/sub> of 4.4 &#x003BC;M (\u003Ca href=\"#B24\">Franqueza et al., 1998\u003C/a>). The therapeutic range of propafenone has been estimated to be between 2 and 6 &#x003BC;M (\u003Ca href=\"#B58\">Paul et al., 2002\u003C/a>). Taking into account plasma protein binding, estimates of the most likely unbound concentrations have been given as 0.15&#x02013;0.7 &#x003BC;M (\u003Ca href=\"#B65\">Slawsky and Castle, 1994\u003C/a>), 0.2&#x02013;0.6 &#x003BC;M (\u003Ca href=\"#B19\">Duan et al., 1993\u003C/a>), and 0.33&#x02013;1 &#x003BC;M (\u003Ca href=\"#B64\">Seki et al., 1999\u003C/a>). In this study, the effects of three equally-spaced concentrations which fell within this range were studied&#x02212;0.2, 0.5, and 0.8 &#x003BC;M propafenone. It should be noted that these concentrations are not intended to be compared directly with those chosen for disopyramide and quinidine (1, 2, and 5 &#x003BC;M), which were taken from \u003Ca href=\"#B73\">Whittaker et al. (2017a)\u003C/a> and are not equally-spaced. A comparison of IC\u003Csub>50\u003C/sub> values used for disopyramide, quinidine, and propafenone is given in Table \u003Ca href=\"#SM1\">S4\u003C/a>.\u003C/p>\r\n\u003Cp class=\"mb0\">In order to assess whether the combined actions of propafenone in the model induced reasonable rate- and concentration- dependent effects on the AP under control conditions, alterations in the maximum upstroke velocity (\u003Cmath>\u003Cmsub>\u003Cmrow>\u003Cmover accent=\"true\">\u003Cmrow>\u003Cmi>V\u003C/mi>\u003C/mrow>\u003Cmo>&#x000B0;\u003C/mo>\u003C/mover>\u003C/mrow>\u003Cmrow>\u003Cmo class=\"qopname\">max\u003C/mo>\u003C/mrow>\u003C/msub>\u003C/math>) upon application of propafenone were compared with experimental data taken from canine atrial cells (\u003Ca href=\"#B13\">Burashnikov et al., 2012\u003C/a>). Figure \u003Ca href=\"#F2\">2B\u003C/a> shows changes in \u003Cmath>\u003Cmsub>\u003Cmrow>\u003Cmover accent=\"true\">\u003Cmrow>\u003Cmi>V\u003C/mi>\u003C/mrow>\u003Cmo>&#x000B0;\u003C/mo>\u003C/mover>\u003C/mrow>\u003Cmrow>\u003Cmo class=\"qopname\">max\u003C/mo>\u003C/mrow>\u003C/msub>\u003C/math> upon application of 0.3 and 1.5 &#x003BC;M propafenone at cycle lengths of 500 and 300 ms, where close concordance can be seen between simulation and experiment (Figure \u003Ca href=\"#F2\">2C\u003C/a>). Although experimental data were taken from canine atrial myocytes, the human atrial simulation data nonetheless recapitulated the considerable reduction in \u003Cmath>\u003Cmsub>\u003Cmrow>\u003Cmover accent=\"true\">\u003Cmrow>\u003Cmi>V\u003C/mi>\u003C/mrow>\u003Cmo>&#x000B0;\u003C/mo>\u003C/mover>\u003C/mrow>\u003Cmrow>\u003Cmo class=\"qopname\">max\u003C/mo>\u003C/mrow>\u003C/msub>\u003C/math> at both concentrations and cycle lengths, which is primarily due to the sodium channel blocking actions of propafenone.\u003C/p>\r\n\u003Ch3>Tissue Simulations\u003C/h3>\r\n\u003Cp class=\"mb0\">Propagation of excitation waves in tissue was described using the monodomain equation,\u003C/p>\r\n\u003Cdiv class=\"equationImageholder\">\u003Cmath id=\"M1\">\u003Cmtable class=\"eqnarray\" columnalign=\"right center left\">\u003Cmtr>\u003Cmtd>\u003Cmfrac>\u003Cmrow>\u003Cmi mathsize=\"10.5pt\" mathcolor=\"black\">&#x02202;\u003C/mi>\u003Cmi mathsize=\"10.5pt\" mathcolor=\"black\">V\u003C/mi>\u003C/mrow>\u003Cmrow>\u003Cmi mathsize=\"10.5pt\" mathcolor=\"black\">&#x02202;\u003C/mi>\u003Cmi mathsize=\"10.5pt\" mathcolor=\"black\">t\u003C/mi>\u003C/mrow>\u003C/mfrac>\u003Cmo mathsize=\"10.5pt\" mathcolor=\"black\">=\u003C/mo>\u003Cmo mathsize=\"10.5pt\" mathcolor=\"black\">&#x02207;\u003C/mo>\u003Cmrow>\u003Cmo stretchy=\"false\">(\u003C/mo>\u003Cmrow>\u003Cmstyle mathvariant=\"bold\">\u003Cmstyle class=\"text\" mathsize=\"10.5pt\" mathcolor=\"black\">\u003Cmtext>D\u003C/mtext>\u003C/mstyle>\u003C/mstyle>\u003Cmo mathsize=\"10.5pt\" mathcolor=\"black\">&#x02207;\u003C/mo>\u003Cmi mathsize=\"10.5pt\" mathcolor=\"black\">V\u003C/mi>\u003C/mrow>\u003Cmo stretchy=\"false\">)\u003C/mo>\u003C/mrow>\u003Cmo mathsize=\"10.5pt\" mathcolor=\"black\">-\u003C/mo>\u003Cmfrac>\u003Cmrow>\u003Cmsub>\u003Cmrow>\u003Cmi mathsize=\"10.5pt\" mathcolor=\"black\">I\u003C/mi>\u003C/mrow>\u003Cmrow>\u003Cmstyle class=\"text\" mathsize=\"10.5pt\" mathcolor=\"black\">\u003Cmtext>ion\u003C/mtext>\u003C/mstyle>\u003C/mrow>\u003C/msub>\u003C/mrow>\u003Cmrow>\u003Cmsub>\u003Cmrow>\u003Cmi mathsize=\"10.5pt\" mathcolor=\"black\">C\u003C/mi>\u003C/mrow>\u003Cmrow>\u003Cmstyle class=\"text\" mathsize=\"10.5pt\" mathcolor=\"black\">\u003Cmtext>m\u003C/mtext>\u003C/mstyle>\u003C/mrow>\u003C/msub>\u003C/mrow>\u003C/mfrac>\u003Cmo mathsize=\"10.5pt\" mathcolor=\"black\">,\u003C/mo>\u003C/mtd>\u003Cmtd>\u003Cmstyle class=\"text\" mathsize=\"10.5pt\" mathcolor=\"black\">\u003Cmtext>&#x000A0;&#x000A0;&#x000A0;&#x000A0;\u003C/mtext>\u003C/mstyle>\u003Cmrow>\u003Cmo mathsize=\"10.5pt\" mathcolor=\"black\" stretchy='false'>(\u003C/mo>\u003Cmn mathsize=\"10.5pt\" mathcolor=\"black\">1\u003C/mn>\u003Cmo mathsize=\"10.5pt\" mathcolor=\"black\" stretchy='false'>)\u003C/mo>\u003C/mrow>\u003C/mtd>\u003C/mtr>\u003C/mtable>\u003C/math>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\r\n\u003Cp class=\"mb15\">where \u003Ci>V\u003C/i> is the transmembrane voltage, \u003Cstrong>D\u003C/strong> is the global conductivity tensor, \u003Ci>I\u003C/i>\u003Csub>ion\u003C/sub> is the total ionic current, and \u003Ci>C\u003C/i>\u003Csub>m\u003C/sub> is the membrane capacitance. Equation (1) was solved using a finite difference PDE solver based on the explicit forward Euler method and Strang splitting scheme. Effects of the N588K-hERG mutation on ERP, WL, conduction velocity (CV), and spiral wave dynamics were determined using 1D and 2D models of RA tissue, as described previously (\u003Ca href=\"#B74\">Whittaker et al., 2017b\u003C/a>, \u003Ca href=\"#B72\">2018\u003C/a>). Spiral waves were initiated in 2D models using an S1-S2 cross-shock protocol, and spiral wave core trajectories over a 5.0 s simulation period were traced by locating phase singularities (\u003Ca href=\"#B11\">Bray and Wikswo, 2002\u003C/a>). The behavior of re-entrant excitations in an anatomically-realistic setting was determined using a 3D human atrial structured grid geometry based on the Visible Female dataset (\u003Ca href=\"#B63\">Seemann et al., 2006\u003C/a>; \u003Ca href=\"#B14\">Colman et al., 2013\u003C/a>; \u003Ca href=\"#B74\">Whittaker et al., 2017b\u003C/a>) with rule-based fiber orientations (\u003Ca href=\"#B38\">Krueger et al., 2011\u003C/a>). The transverse value of the diffusion coefficient, \u003Ci>D\u003C/i>\u003Csub>&#x022A5;\u003C/sub>, was set to 0.1 mm\u003Csup>2\u003C/sup> ms\u003Csup>&#x02212;1\u003C/sup>, where an anisotropy ratio (\u003Ci>D\u003C/i>\u003Csub>||\u003C/sub>:\u003Ci>D\u003C/i>\u003Csub>&#x022A5;\u003C/sub>) of 3:1 in directions longitudinal and transverse to fibers was applied in the atrial working myocardium, and a ratio of 9:1 along the fast conducting bundles of the BB, CT, and PM (\u003Ca href=\"#B14\">Colman et al., 2013\u003C/a>; \u003Ca href=\"#B74\">Whittaker et al., 2017b\u003C/a>), which gave global and specific regional activation times in close agreement with experimental measurements (\u003Ca href=\"#B42\">Lemery et al., 2007\u003C/a>). The activation (ACT) time was defined as the time required for the membrane potential to reach &#x02212;20 mV at each point in the geometry (\u003Ca href=\"#B53\">Ni et al., 2017\u003C/a>). Activation-recovery interval (ARI) was defined as the time interval between membrane potential depolarisation to &#x02212;20 mV and repolarisation to &#x02212;70 mV (adjusted to &#x02212;65 mV in the PV region due to higher resting membrane potential) (\u003Ca href=\"#B53\">Ni et al., 2017\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">Re-entry was initiated using the phase distribution method (\u003Ca href=\"#B8\">Biktashev and Holden, 1998\u003C/a>; \u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>), by initiating either a clockwise or anti-clockwise scroll wave (as seen from a RA posterior wall view). Where sustained re-entrant activity was initiated, a power spectrum was obtained through fast Fourier transform analysis of pseudo ECG (pECG) time series (recorded from within the RA cavity). The dominant frequency (DF) was computed in Matlab from the largest peak in the power spectrum density. For simulating the effects of disopyramide, quinidine, and propafenone on re-entrant excitation, state variables for each node within the 3D anatomical model were saved after 2.5 s of a 10.0 s episode of sustained re-entrant activity in drug-free conditions. These were then used as initial conditions for new 3D simulations of duration 7.5 s (giving 10.0 s activity overall) in which varying concentrations of anti-arrhythmic drugs (1, 2, or 5 &#x003BC;M disopyramide and quinidine; 0.2, 0.5, or 0.8 &#x003BC;M propafenone) were applied immediately. This gave 18 simulations in total; 3 doses for each of the 3 anti-arrhythmic drugs, with 2 scroll wave initial conditions (both clockwise and anti-clockwise).\u003C/p>\r\n\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>Results\u003C/h2>\r\n\u003Ch3 class=\"pt0\">Effects of SQT1 Mutant \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> on Human Atrial Action Potentials\u003C/h3>\r\n\u003Cp class=\"mb0\">Both SQT1 mutant conditions shortened the human atrial APD at a pacing rate of 1 Hz (Figure \u003Ca href=\"#F3\">3Ai\u003C/a>), from 248.8 ms in the WT condition to 195.4 and 163.3 ms in heterozygous (WT-N588K) and homozygous (N588K) mutation conditions, respectively. This was due to loss of inactivation associated with the N588K-hERG mutation, which increased \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> early during the AP and served to accelerate the repolarisation process (Figure \u003Ca href=\"#F3\">3Aii\u003C/a>). Action potential abbreviation reduced considerably the duration of the plateau phase, causing \u003Ci>I\u003C/i>\u003Csub>K1\u003C/sub> to contribute to terminal repolarisation earlier during the AP (Figure \u003Ca href=\"#F3\">3Aiii\u003C/a>), and lesser activation and reduced contribution of \u003Ci>I\u003C/i>\u003Csub>Ks\u003C/sub> (Figure \u003Ca href=\"#F3\">3Aiv\u003C/a>). The SQT1 mutation also decreased net \u003Ci>I\u003C/i>\u003Csub>CaL\u003C/sub> due to the abbreviated plateau phase (Figure \u003Ca href=\"#F3\">3Av\u003C/a>), shortening the APD\u003Csub>90\u003C/sub> under heterozygous and homozygous conditions (Figure \u003Ca href=\"#F3\">3Avi\u003C/a>). In tissue, accelerated repolarisation under SQT1 conditions shortened the ERP and consequently the excitation WL. At the organ scale (in the 3D anatomical human atria model), both heterozygous and homozygous forms of the N588K-hERG mutation decreased global ARI (Figure \u003Ca href=\"#F3\">3B\u003C/a>), whilst preserving the global dispersion of ARI. Furthermore, whereas &#x00394;ARI was decreased between CT/PM regions, it was increased between PV/LA and RA/LA regions under SQT1 conditions (Figure \u003Ca href=\"#F3\">3C\u003C/a>). A summary of the effects of the N588K-hERG mutation on multi-scale human atrial AP biomarkers is given in Table \u003Ca href=\"#T1\">1\u003C/a>.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 3\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg\" name=\"figure3\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g003.jpg\" alt=\"www.frontiersin.org\" id=\"F3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 3\u003C/strong>. Effects of the N588K-hERG mutation at the single cell and whole human atria level. \u003Cstrong>(Ai)\u003C/strong> Single cell action potential profiles under WT (blue), WT-N588K (green), and N588K (red) conditions at a pacing frequency of 1 Hz, with corresponding current traces for \u003Cstrong>(Aii)\u003C/strong> \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>, \u003Cstrong>(Aiii)\u003C/strong> \u003Ci>I\u003C/i>\u003Csub>K1\u003C/sub>, \u003Cstrong>(Aiv)\u003C/strong> \u003Ci>I\u003C/i>\u003Csub>Ks\u003C/sub>, and \u003Cstrong>(Av)\u003C/strong> \u003Ci>I\u003C/i>\u003Csub>CaL\u003C/sub>, and \u003Cstrong>(Avi)\u003C/strong> a summary of the measured APD\u003Csub>90\u003C/sub>. \u003Cstrong>(B)\u003C/strong> Activation-recovery interval (ARI) maps under (i) WT, (ii) WT-N588K, and (iii) N588K conditions. \u003Cstrong>(Ci)\u003C/strong> View looking into the cavities of the 3D anatomical human atria model, with the following regions highlighted: crista terminalis (CT), left atrium (LA), pectinate muscles (PM), pulmonary veins (PV), and right atrium (RA). \u003Cstrong>(Cii)\u003C/strong> Measured dispersion of activation-recovery interval, &#x00394;ARI, between different atrial regions under WT and SQT1 mutation conditions.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine mb15\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">TABLE 1\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg\" name=\"Table1\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Table 1\u003C/strong>. A summary of multi-scale simulation results.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>Scroll Wave Dynamics in 3D Anatomical Human Atria Geometry\u003C/h3>\r\n\u003Cp class=\"mb0\">A summary of 3D scroll wave simulations in the anatomical human atria model under WT and SQT1 mutation conditions (in a clockwise configuration from a RA posterior wall aspect) is given in Figure \u003Ca href=\"#F4\">4\u003C/a>. In the WT condition, scroll waves followed 2 transient, fragmented circuits around the RA, before self-terminating at &#x0007E;0.7 s (Video \u003Ca href=\"#SM1\">S1\u003C/a>), which precluded accurate measurement of the DF. In the WT-N588K condition, re-entrant wave activity sustained for the entire 10.0 s with a DF of 4.99 Hz, and was driven mostly by a macro re-entrant circuit around the right AVR, whilst also showing CT/isthmus driven activity in the RA (Video \u003Ca href=\"#SM1\">S2\u003C/a>). Under homozygous N588K mutation conditions, scroll wave activity was also driven predominantly by a re-entrant circuit around the AVR, with occasional existence of multiple waves on the RA free wall (Video \u003Ca href=\"#SM1\">S3\u003C/a>), and a DF of 5.59 Hz. A summary of simulations using anti-clockwise scroll wave initial conditions is shown in Figure \u003Ca href=\"#SM1\">S1\u003C/a>, and an average of the DF from both simulations (where applicable) measured from the first 5.0 s of activity is given in Table \u003Ca href=\"#T1\">1\u003C/a>.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 4\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg\" name=\"figure4\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g004.jpg\" alt=\"www.frontiersin.org\" id=\"F4\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 4\u003C/strong>. Scroll waves under WT and SQT1 mutation conditions in the 3D anatomical human atria model. (i) Evolution of scroll waves following initiation of re-entry in a clockwise configuration (from a RA posterior wall aspect) at times \u003Ci>t\u003C/i> = 100 ms, \u003Ci>t\u003C/i> = 1,000 ms, \u003Ci>t\u003C/i> = 5,000 ms, and \u003Ci>t\u003C/i> = 10,000 ms under \u003Cstrong>(A)\u003C/strong> WT, \u003Cstrong>(B)\u003C/strong> WT-N588K, and \u003Cstrong>(C)\u003C/strong> N588K conditions, with (ii) corresponding pseudo ECGs taken from the first 5.0 s of re-entry simulations.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>Effects of Class I Drugs on Human Atrial Action Potentials\u003C/h3>\r\n\u003Cp class=\"mb0\">In order to assess the actions of class I anti-arrhythmic drugs on the human atria at the cellular level, the effects of applying various concentrations of disopyramide, quinidine, and propafenone were investigated on the single cell AP under heterozygous WT-N588K (hereinafter referred to simply as SQT1) conditions. Figure \u003Ca href=\"#F5\">5\u003C/a> shows AP profiles under drug-free SQT1 conditions and upon application of different concentrations of each drug at a pacing frequency of 1 Hz, with corresponding fractional block of \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub>. Application of all concentrations of disopyramide and propafenone produced only modest prolongation of the APD, failing to restore it to that of the WT condition. Quinidine, on the other hand, was more effective at prolonging the APD due to extensive \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> block, with the highest concentration (5 &#x003BC;M) prolonging the APD beyond that of the WT level. In contrast, all three agents prolonged the ERP effectively, restoring it to (or exceeding) that of the WT level at the highest respective concentrations tested, due to additional ERP-prolonging effects of \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> block.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 5\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg\" name=\"figure5\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g005.jpg\" alt=\"www.frontiersin.org\" id=\"F5\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 5\u003C/strong>. Effects of class I drugs on human atrial electrophysiology in SQT1. Effects of \u003Cstrong>(A)\u003C/strong> disopyramide (DISO), \u003Cstrong>(B)\u003C/strong> quinidine (QUIN), and \u003Cstrong>(C)\u003C/strong> propafenone (PROPAF) on (i) single human atrial cell action potentials (APs) under wild type (WT) conditions (blue, dashed line), drug-free WT-N588K (SQT1) conditions (green, solid line), and SQT1 &#43; varying drug concentrations (purple, orange, and red solid lines). Corresponding fractional block of (ii) \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> and (iii) \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub>, and (iv) increase in APD\u003Csub>90\u003C/sub> (red) and effective refractory period (ERP; blue). \u003Cstrong>(D)\u003C/strong> Activation sequences in the 3D anatomical human atria model under (i) drug-free SQT1 (control &#x02013; C), (ii) SQT1 &#43; 2 &#x003BC;M DISO, (iii) SQT1 &#43; 2 &#x003BC;M QUIN, and (iv) SQT1 &#43; 0.5 &#x003BC;M PROPAF conditions, with corresponding \u003Cstrong>(E)\u003C/strong> activation (ACT) time summarized as a barchart. All simulations performed at a basic cycle length of 1,000 ms.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mt15 w100pc float_left\">Conduction slowing due to sodium channel block by the three drugs caused an increase in activation time in the 3D anatomical human atria model (Figure \u003Ca href=\"#F5\">5D\u003C/a>), which was most prominent for quinidine and least prominent for propafenone at the concentrations tested. A summary of the effects of pharmacological modulation across multiple scales is given in Table \u003Ca href=\"#T2\">2\u003C/a>. In addition, in the 1D tissue model, the rate-dependent effects of disopyramide, quinidine, and propafenone on the ERP, CV, and WL are shown in Figure \u003Ca href=\"#SM1\">S2\u003C/a>. Quinidine was shown to produce the most potent effects on CV and ERP at all pacing rates. Propafenone exerted the weakest effects on ERP at fast pacing rates, but had the greatest propensity to promote beat-to-beat alternans.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">TABLE 2\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg\" name=\"Table2\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-t002.jpg\" alt=\"www.frontiersin.org\" id=\"T2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Table 2\u003C/strong>. A summary of multi-scale pharmacological simulation results.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>Pharmacological Effects of Class I Drugs on Re-entry Dynamics\u003C/h3>\r\n\u003Cp class=\"mb0\">In 2D simulations, under drug-free WT conditions the initiated spiral wave failed to re-enter the tissue (not shown). Under drug-free SQT1 conditions, the initiated spiral wave sustained for the 5.0 s duration of the simulation, eventually settling into a stationary, epicycloidal trajectory (Figure \u003Ca href=\"#F6\">6Ai\u003C/a>). Application of 5 &#x003BC;M disopyramide was sufficient to terminate re-entry, as the re-entry wavelength was increased to such an extent that the spiral wave meandered out of the tissue (Figure \u003Ca href=\"#F6\">6Aii\u003C/a>). On the other hand, both 1 and 2 &#x003BC;M disopyramide did not terminate re-entrant activity, but did increase the area over which spiral waves meandered (from 0.35 mm\u003Csup>2\u003C/sup> ms\u003Csup>&#x02212;1\u003C/sup> in the WT condition to 0.40 and 0.47 mm\u003Csup>2\u003C/sup> ms\u003Csup>&#x02212;1\u003C/sup>, respectively &#x00027;(Figure \u003Ca href=\"#F6\">6B\u003C/a>). Similarly, 1 &#x003BC;M quinidine increased the area of meander to 0.44 mm\u003Csup>2\u003C/sup> ms\u003Csup>&#x02212;1\u003C/sup> without terminating re-entry, whereas 2 and 5 &#x003BC;M quinidine terminated re-entry without inducing wave break (Figure \u003Ca href=\"#F6\">6C\u003C/a>). Application of 0.2 and 0.5 &#x003BC;M propafenone resulted in termination of re-entry by decreasing both the stationarity and stability of spiral waves (Figure \u003Ca href=\"#F6\">6D\u003C/a>), whereas 0.8 &#x003BC;M propafenone did not terminate re-entry but did destabilize the re-entrant circuit and substantially increase the area of meander (to 0.75 mm\u003Csup>2\u003C/sup> ms\u003Csup>&#x02212;1\u003C/sup>).\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 6\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg\" name=\"figure6\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g006.jpg\" alt=\"www.frontiersin.org\" id=\"F6\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 6\u003C/strong>. Re-entry dynamics in homogeneous 2D sheets upon application of disopyramide, propafenone, and quinidine in SQT1 mutation conditions. \u003Cstrong>(A)\u003C/strong> Representative snapshots of re-entrant spiral waves under (i) drug-free SQT1 and (ii) SQT1 &#43; 5 &#x003BC;M disopyramide (DISO) conditions at times, \u003Ci>t\u003C/i> = 250, 500, 750, and 1,000 ms following re-entry initiation, with spiral wave core trajectories superimposed onto membrane potentials in black. Spiral wave core trajectories over a 5,000 ms period under \u003Cstrong>(Bi, Ci, Di)\u003C/strong> drug-free SQT1 conditions, and upon application of \u003Cstrong>(Bii)\u003C/strong> 1 &#x003BC;M, \u003Cstrong>(Biii)\u003C/strong> 2 &#x003BC;M, and \u003Cstrong>(Biv)\u003C/strong> 5 &#x003BC;M DISO, \u003Cstrong>(Cii)\u003C/strong> 1 &#x003BC;M, \u003Cstrong>(Ciii)\u003C/strong> 2 &#x003BC;M, and \u003Cstrong>(Civ)\u003C/strong> 5 &#x003BC;M quinidine (QUIN), and \u003Cstrong>(Dii)\u003C/strong> 0.2 &#x003BC;M, \u003Cstrong>(Diii)\u003C/strong> 0.5 &#x003BC;M, and \u003Cstrong>(Div)\u003C/strong> 0.8 &#x003BC;M propafenone (PROPAF).\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mt15 w100pc float_left\">In 3D simulations using clockwise scroll wave initial conditions, quinidine terminated re-entry at all concentrations, and disopyramide terminated re-entry at concentrations of 1 and 5 &#x003BC;M (arrhythmia termination by 5 &#x003BC;M disopyramide and 2 &#x003BC;M quinidine are shown in Videos \u003Ca href=\"#SM1\">S4\u003C/a>, \u003Ca href=\"#SM1\">S5\u003C/a>, respectively). At a concentration of 2 &#x003BC;M disopyramide, the DF was reduced from 4.79 to 3.99 Hz (measured from the final 5.0 s of activity). Propafenone, on the other hand, was comparatively ineffective at reducing the DF at the concentrations tested, but terminated re-entry at a concentration of 0.5 &#x003BC;M (Video \u003Ca href=\"#SM1\">S6\u003C/a>). Representative examples of arrhythmia termination by disopyramide, propafenone, and quinidine are shown in Figure \u003Ca href=\"#F7\">7\u003C/a>. Disopyramide and quinidine produced a dose-dependent decrease in the DF which was greater than for propafenone (Figure \u003Ca href=\"#F7\">7C\u003C/a>). In an anti-clockwise scroll wave configuration, the efficacy of anti-arrhythmic drugs was less favorable, with pharmacological conversion of re-entrant waves occurring only for 0.5 &#x003BC;M propafenone and 5 &#x003BC;M quinidine. A quantitative summary of all 2D and 3D re-entry simulations is given in Table \u003Ca href=\"#SM1\">S5\u003C/a>.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 7\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg\" name=\"figure7\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g007.jpg\" alt=\"www.frontiersin.org\" id=\"F7\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 7\u003C/strong>. Arrhythmia termination in 3D anatomical human atria by representative concentrations of disopyramide, propafenone, and quinidine under SQT1 mutation conditions. \u003Cstrong>(A)\u003C/strong> Snapshots of re-entrant scroll waves in a clockwise configuration (viewed from RA posterior wall) at various time points after initiation of a scroll wave in the 3D anatomical human atrial model under (i) drug-free WT-N588K conditions, and upon application of (ii) 5 &#x003BC;M disopyramide (DISO), (iii) 0.5 &#x003BC;M propafenone (PROPAF), and (iv) 2 &#x003BC;M quinidine (QUIN) conditions, with \u003Cstrong>(B)\u003C/strong> corresponding pseudo ECG recorded during the final 5.0 s. In pharmacological simulation drugs were applied at \u003Ci>t\u003C/i> = 2,500 ms. \u003Cstrong>(C)\u003C/strong> Barcharts summarizing DF upon application of various concentrations of (i) DISO, (ii) PROPAF, and (iii) QUIN for clockwise and anti-clockwise initial conditions (ICs 1 and ICs 2, respectively). * denotes simulations in which DF was not calculated due to occurrence of re-entry termination.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>Discussion\u003C/h2>\r\n\u003Cp class=\"mb0\">In this study, pathophysiological effects of the SQT1-related N588K-hERG mutation on human atrial electrophysiology were assessed, investigating mechanisms of increased susceptibility to the development of atrial arrhythmias in multi-scale cellular and tissue models incorporating electrical and anatomical heterogeneities. Furthermore, the actions of the class I anti-arrhythmic drugs disopyramide, quinidine, and propafenone were assessed in the context of sustained atrial arrhythmic excitations mediated by the SQT1 N588K mutation using drug simulations including binding kinetics, altered potency of \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>/hERG block in SQT1, and multiple ion channel block. Both quinidine and disopyramide have demonstrated efficacy in QT interval prolongation in the setting of SQT1 (\u003Ca href=\"#B26\">Gaita et al., 2004\u003C/a>; \u003Ca href=\"#B61\">Schimpf et al., 2007\u003C/a>; \u003Ca href=\"#B49\">Mizobuchi et al., 2008\u003C/a>; \u003Ca href=\"#B28\">Giustetto et al., 2011\u003C/a>; \u003Ca href=\"#B34\">Hu et al., 2017\u003C/a>), whereas propafenone has been used in 3 patients for management of episodes of paroxysmal AF mediated by SQT1, which prevented recurrence of arrhythmias but did not prolong the QT interval (\u003Ca href=\"#B33\">Hong et al., 2005\u003C/a>; \u003Ca href=\"#B9\">Bjerregaard et al., 2006\u003C/a>). This study provides clinically-relevant insights into pharmacology of SQT1 by evaluating and comparing the actions of all three drugs in the context of accelerated atrial repolarisation and arrhythmias mediated by SQT1, offering an important step toward \u003Ci>in silico\u003C/i> optimisation of pharmacological therapy in this context.\u003C/p>\r\n\u003Ch3>Main Findings\u003C/h3>\r\n\u003Cp class=\"mb0\">The major findings presented in this study are as follows. (1) Heterozygous and homozygous forms of the SQT1-linked N588K-hERG mutation shortened significantly the APD of human atrial cells, whilst preserving global dispersion of ARI, and increasing &#x00394;ARI between certain regions of the human atria. (2) The dominant frequency and lifespan of re-entry in 3D arrhythmia simulations was increased by heterozygous and homozygous forms of the N588K mutation. (3) Disopyramide, quinidine, and propafenone all produced ERP prolongation in the setting of SQT1, the extent of which was greatest for quinidine. (4) In 2D simulations, disopyramide and quinidine terminated re-entry at high concentrations due to increased re-entry wavelength, whereas propafenone terminated re-entry in a non-dose-dependent manner, by inducing secondary waves. (5) In 3D simulations, the DF of re-entry was reduced in a dose-dependent manner for clinically-relevant doses of disopyramide and quinidine, and propafenone to a lesser extent. (6) All three anti-arrhythmic agents demonstrated some efficacy in pharmacological rhythm control, most frequently terminating re-entry in the order quinidine &#x0003E; propafenone = disopyramide. A summary of findings regarding pro-arrhythmic mechanisms of the N588K-hERG mutation in human atria and anti-arrhythmic actions of selected class I drugs is given in Figure \u003Ca href=\"#F8\">8\u003C/a>.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 8\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg\" name=\"figure8\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g008.jpg\" alt=\"www.frontiersin.org\" id=\"F8\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 8\u003C/strong>. A schematic summary of pro-arrhythmic effects of the N588K-hERG mutation in human atria and anti-arrhythmic effects of class I drugs. At the ion channel level, the N588K mutation impairs hERG channel inactivation, increasing \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> which shortens the action potential duration (APD) at the cellular level, and increases its dispersion, &#x00394;APD, between certain regions of the human atria. In tissue, shortened APD corresponds to shortened effective refractory period (ERP) and excitation wavelength (WL), promoting sustenance of arrhythmias at the organ scale through higher dominant frequency (DF) and lifespan (LS) of re-entry. Class I drugs disopyramide (DISO), quinidine (QUIN), and propafenone (PROPAF) exert effects at the ion channel level by blocking \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub>, in addition to secondary actions. This prolongs APD and ERP, and reduces maximum upstroke velocity (MUV) and conduction velocity (CV) at the cellular and tissue levels, respectively. At the organ scale these pharmacological actions promote arrhythmia rate and rhythm control through reduced DF and LS of re-entry.\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>SQT1 Mutant \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> Promotes Human Atrial Arrhythmogenesis\u003C/h3>\r\n\u003Cp class=\"mb15\">The fact that the N588K-hERG mutation is associated with both a short QT interval and reports of AF (\u003Ca href=\"#B33\">Hong et al., 2005\u003C/a>) suggests that pathophysiological mechanisms leading to QT interval shortening in SQT1 also affect the atria and may promote AF. In an experimental model of SQT1, application of 20 &#x003BC;M of the \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> agonist PD-118057 shortened the APD in both CT and PM cell types of canine atrial tissue (\u003Ca href=\"#B54\">Nof et al., 2010\u003C/a>), as well as increasing APD dispersion between them. In the present study, at the cellular level heterozygous and homozygous forms of the N588K-hERG mutation produced a shortening of the human right atrial APD of 53.4 and 85.5 ms, respectively&#x02013;values which are consistent with a previous simulation study (\u003Ca href=\"#B44\">Loewe et al., 2014b\u003C/a>). At the tissue level, global &#x00394;ARI was unaffected by the WT-N588K mutation condition, and was slightly decreased by the homozygous form. The model predicted an increase in &#x00394;ARI between PV/LA and RA/LA regions for both heterozygous and homozygous forms of the N588K mutation (Figure \u003Ca href=\"#F3\">3C\u003C/a>), but not between CT/PM regions. This may be due to the fact that the effects of the hERG activator PD-118057 and of the N588K mutation on \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>/hERG are different: the former increases \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub>/hERG channel open probability without altering gating kinetics (\u003Ca href=\"#B79\">Zhou et al., 2005\u003C/a>), whereas the latter alters kinetics through profound attenuation of inactivation (\u003Ca href=\"#B16\">Cordeiro et al., 2005\u003C/a>; \u003Ca href=\"#B48\">McPate et al., 2005\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb15\">Interestingly, there is clinical evidence of a LA-RA gradient in the DF in paroxysmal AF (\u003Ca href=\"#B40\">Lazar et al., 2004\u003C/a>), which may be underlain by APD differences between the RA and LA in pathological conditions which promote AF (\u003Ca href=\"#B70\">Voigt et al., 2010\u003C/a>). Furthermore, regional differences in APD between PV/LA regions have been identified previously as high frequency excitation or microreentrant sources underlying AF (\u003Ca href=\"#B45\">Mandapati et al., 2000\u003C/a>; \u003Ca href=\"#B7\">Arora et al., 2003\u003C/a>; \u003Ca href=\"#B39\">Kumagai et al., 2004\u003C/a>)&#x02013;this suggests that localized increases in the spatial dispersion of repolarisation could be a mechanism by which atrial arrhythmogenesis is promoted in SQT1, as suggested in the previous experimental study (\u003Ca href=\"#B54\">Nof et al., 2010\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">In a previous simulation study (\u003Ca href=\"#B44\">Loewe et al., 2014b\u003C/a>), the N588K-hERG mutation in a 1:1 mutant to WT ratio was shown to increase inducibility and lifespan of rotors in idealized 2D sheets of human atrial tissue, but did not permit sustained re-entry. By contrast, in the present study, the heterozygous WT-N588K (SQT1) condition permitted the sustenance of spiral waves in 2D simulations. This may be due to several differences in the modeling, one of which is that the CRN model used in that study (\u003Ca href=\"#B44\">Loewe et al., 2014b\u003C/a>) produces an ERP restitution curve which is around 50 ms higher than available experimental data (\u003Ca href=\"#B75\">Wilhelms et al., 2013\u003C/a>), making re-entry more difficult to sustain, whereas the CNZ model ERP restitution curve lies mostly within the experimental range (Figure \u003Ca href=\"#SM1\">S3\u003C/a>). In this study, the presence of realistic structure and heterogeneous electrophysiology, in addition to the cellular electrophysiological substrate induced by the N588K-hERG mutation, also favored the sustenance of re-entrant scroll waves in the 3D anatomical human atria model (using both clockwise and anti-clockwise scroll wave initial conditions), and could both prolong or shorten the lifespan of re-entrant excitations under pharmacological modulation conditions when compared directly to observations in 2D homogeneous sheets. This highlights the value of including both approaches in probing the arrhythmia substrate associated with genetic mutations in human atria, as behavior in heterogeneous 3D anatomical models cannot necessarily be predicted from homogeneous 2D simulations, and vice versa. It should be noted nonetheless that electrical activity observed in 3D re-entry simulations in this study remained relatively organized and generally not driven by multiple wavelets. This lack of complex, chaotic behavior which is observed in persistent AF is consistent with reports of paroxysmal AF in some patients with the N588K-hERG mutation (\u003Ca href=\"#B33\">Hong et al., 2005\u003C/a>) &#x02013; addition of electrical and intracellular gap junction remodeling or fibrosis in patients may be required to promote degeneration of paroxysmal AF into persistent AF.\u003C/p>\r\n\u003Ch3>Class I Drugs May Represent Useful SQT1-Specific Pharmacotherapy for AF\u003C/h3>\r\n\u003Cp class=\"mb15\">Despite the prevalence of AF and decades of research, anti-arrhythmic therapies for AF continue to have limited efficacy and safety (\u003Ca href=\"#B76\">Workman et al., 2011\u003C/a>). In this study, the class I anti-arrhythmic drugs disopyramide, quinidine, and propafenone were shown to be only moderately effective in the management of atrial arrhythmias mediated by the SQT1-linked N588K-hERG mutation, although it should be noted that the 7.5 s duration of 3D drug simulations is much shorter than clinical time scales. Pharmacological rhythm control occurred under application of both disopyramide and quinidine, but in an unpredictable, non-dose-dependent way, as observed in our previous \u003Ci>in silico\u003C/i> study (\u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>). One mechanism of re-entry termination involving reduction of the excitable gap under application of 5 &#x003BC;M quinidine is shown in Figure \u003Ca href=\"#SM1\">S4\u003C/a>.\u003C/p>\r\n\u003Cp class=\"mb15\">Both disopyramide and quinidine reduced consistently the DF of re-entry in a dose-dependent manner, although as in (\u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>) quinidine was more effective than disopyramide at rate control in the setting of SQT1, likely due to its more potent block of \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> (\u003Ca href=\"#B47\">McPate et al., 2008\u003C/a>) and \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> (\u003Ca href=\"#B37\">Koumi et al., 1992\u003C/a>). Propafenone was comparatively ineffective at controlling the rate of atrial arrhythmias under the WT-N588K mutation condition, although did demonstrate some efficacy in re-entry termination. Figure \u003Ca href=\"#SM1\">S5\u003C/a> shows a mechanism of pharmacological rhythm control by 0.5 &#x003BC;M propafenone, in which secondary waves induced by propafenone extinguished all re-entrant pathways. This is consistent with the use of propafenone to manage paroxysmal AF in SQT1 patients (\u003Ca href=\"#B33\">Hong et al., 2005\u003C/a>; \u003Ca href=\"#B9\">Bjerregaard et al., 2006\u003C/a>), which maintained 3 patients free of arrhythmia recurrence during follow up. However, as propafenone has been reported to have no prolonging effect on the QT interval in the setting of SQT1 (\u003Ca href=\"#B33\">Hong et al., 2005\u003C/a>)&#x02014; an effect which was demonstrated with variable success using two leading human ventricle models (ten \u003Ca href=\"#B68\">Tusscher and Panfilov, 2006\u003C/a>; \u003Ca href=\"#B55\">O&#x00027;Hara et al., 2011\u003C/a>) in Figure \u003Ca href=\"#SM1\">S6\u003C/a>&#x02014;it is likely that quinidine and disopyramide will remain more suitable pharmacotherapies.\u003C/p>\r\n\u003Cp class=\"mb0\">In this study, cellular and tissue level simulations (in a 1D model) alone did not serve as good predictors of the overall effects of anti-arrhythmic drugs in the electrically-heterogeneous, 3D anatomical whole atria model, consistent with previous modeling studies (\u003Ca href=\"#B69\">Varela et al., 2016\u003C/a>; \u003Ca href=\"#B74\">Whittaker et al., 2017b\u003C/a>). For example, disopyramide was shown not to strongly affect the excitation WL in RA tissue (Table \u003Ca href=\"#T2\">2\u003C/a>; Figure \u003Ca href=\"#SM1\">S2\u003C/a>), and yet it decreased reliably the DF of re-entrant excitations under heterozygous N588K mutation conditions in 3D simulations. This is likely due to the fact that scroll waves were largely anatomically driven by a typical macro re-entrant atrial flutter/tachycardia circuit (\u003Ca href=\"#B41\">Lee et al., 2012\u003C/a>) which was larger than the functional WL; effects of disopyramide on CV were thus more important. In contrast, propafenone produced only modest changes to the CV and was thus less effective at rate control in the model, but did terminate re-entry under conditions in which the re-entrant circuit was abolished by interaction with secondary waves (Figure \u003Ca href=\"#SM1\">S5\u003C/a>).\u003C/p>\r\n\u003Ch3>Insights Into the Efficacy of Class I Drugs in SQT1\u003C/h3>\r\n\u003Cp class=\"mb0\">Further support for quinidine as a useful pharmacotherapy for AF in the setting of SQT1 comes from the experimental use of the \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> agonist PD-118057 model (\u003Ca href=\"#B54\">Nof et al., 2010\u003C/a>). That study suggested that the combined blocking actions on \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> are what made quinidine effective at preventing sustained AF in canine right atrial tissue preparations, as neither \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> nor \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> block alone (by E-4031 or lidocaine, respectively) was effective at terminating AF. Similarly, in our previous simulation study of ventricular pharmacotherapy for SQT1 we showed that combined block of \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> by disopyramide and quinidine prolonged the ERP to a greater extent than block of \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> or \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> alone (\u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>). In this study, we sought to determine whether the greater ERP prolongation associated with the synergistic combination of \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> block by class I drugs would also translate to greater efficacy in terminating re-entry in a 2D sheet of SQT1 mutant human atrial tissue. Figure \u003Ca href=\"#SM1\">S7\u003C/a> shows that the actions of 5 &#x003BC;M of a hypothetical drug with disopyramide kinetics for \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> block were able to terminate re-entry, whereas \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> or \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> block alone did not, as combined block produced the greatest prolongation of the ERP. The spiral wave trajectories highlight the fact that \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> block in particular destabilized the re-entrant circuit, which, when combined with \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> block, caused the spiral wave to meander out of the tissue boundaries (Video \u003Ca href=\"#SM1\">S7\u003C/a>). The findings from \u003Ci>in silico\u003C/i> and \u003Ci>in vitro\u003C/i> experiments thus suggest that the combination of prolonged APD and refractoriness arising from K\u003Csup>&#43;\u003C/sup> and Na\u003Csup>&#43;\u003C/sup> channel inhibition is likely to be valuable in the setting of SQT1. Though selective blockers of \u003Ci>I\u003C/i>\u003Csub>Ks\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>K1\u003C/sub> are not yet clinically-available, this combination may also warrant investigation as a pharmacotherapeutic strategy for other forms of K\u003Csup>&#43;\u003C/sup>-linked SQTS (SQT2 and SQT3).\u003C/p>\r\n\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>Limitations\u003C/h2>\r\n\u003Cp class=\"mb15\">There are a number of limitations of the simulations presented in this study. The 3D anatomical human atria model which was employed for simulations in this study incorporated rule-based fiber orientations (\u003Ca href=\"#B38\">Krueger et al., 2011\u003C/a>), which may not capture sufficiently the complex cardiac microstructure of the human atria (\u003Ca href=\"#B67\">Stephenson et al., 2017\u003C/a>) which could contribute to the arrhythmia substrate. Whilst several hERG mutations have now been identified in SQT1 (\u003Ca href=\"#B31\">Hancox et al., 2018\u003C/a>), the present study focused only on the N588K-hERG mutation (which produces a more marked effect on hERG kinetics than some other mutations, \u003Ca href=\"#B31\">Hancox et al., 2018\u003C/a>), so the results here may not apply to all forms of SQT1. However, recently the S631A-hERG mutation (previously engineered for hERG structure-function studies), which produces a similar extent of attenuation of inactivation to N588K-hERG (\u003Ca href=\"#B47\">McPate et al., 2008\u003C/a>) has been reported in an SQT1 family (\u003Ca href=\"#B4\">Akdis et al., 2018\u003C/a>), and thus the findings of this study are likely also to be relevant to that form of SQT1. An additional potential limitation arises from the fact that mechanical contraction was not considered, which has been reported previously to be impaired in the setting of SQT1 in single human atrial cell simulations (\u003Ca href=\"#B71\">Whittaker et al., 2015\u003C/a>) as well as in organ-scale ventricle simulations (\u003Ca href=\"#B1\">Adeniran et al., 2013\u003C/a>), and based on clinical measurements (\u003Ca href=\"#B25\">Frea et al., 2015\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">The models of disopyramide and quinidine used in this study were adopted from (\u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>), in which the effects of anti-arrhythmic drugs were assessed in the setting of SQT1 in the human ventricles. However, both agents also exhibit modest anti-cholinergic effects in the atria (\u003Ca href=\"#B51\">Nakajima et al., 1989\u003C/a>) which were not accounted for, due to the absence of a formulation for acetylcholine-activated potassium current, \u003Ci>I\u003C/i>\u003Csub>K, ACh\u003C/sub>, in the CNZ model. Similarly, the &#x003B2;-adrenergic receptor blocking effects of propafenone were not considered (\u003Ca href=\"#B46\">McLeod et al., 1984\u003C/a>). Inclusion of these factors could give some insight into the response of the SQT1 phenotype to anti-arrhythmic drugs in the presence of autonomic modulation, and could give more favorable results in terms of arrhythmia prevention, especially for propafenone, which may be particularly effective against AF triggered by increased vagal tone. In addition, dynamic effects of agents due to the influence of circadian variations in drug concentration and heart rate on bioavailability were not investigated, which can give further insights into differing clinical efficacies of drugs (\u003Ca href=\"#B43\">Loewe et al., 2014a\u003C/a>). In relation to this, a further, more general limitation is that translation of drug concentrations from experiments and computer simulations to meaningful clinical concentrations is potentially problematic. Finally, whilst the 1:1 mutant to WT ratio, which was intended to represent the heterozygous state of the proband, may represent an oversimplification of the real hERG channel population in SQT1, the approach adopted in this and our previous studies (\u003Ca href=\"#B2\">Adeniran et al., 2011\u003C/a>, \u003Ca href=\"#B3\">2017\u003C/a>; \u003Ca href=\"#B73\">Whittaker et al., 2017a\u003C/a>) reproduced quantitatively QT interval shortening and T wave morphology in SQTS conditions which was concordant with clinical observations.\u003C/p>\r\n\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>Conclusions\u003C/h2>\r\n\u003Cp class=\"mb0\">The simulations performed in this study further substantiate a causative link between the SQTS-related N588K mutation and APD/ERP shortening in human atria, as well as increased spatial dispersion of repolarisation, which promotes development of AF. In 3D human atria simulations which included heterogeneous anatomy and electrophysiology, the N588K mutation was shown to increase the dominant frequency and lifespan of re-entrant excitation beyond that observed in WT conditions. Pharmacological simulations demonstrated that disopyramide and quinidine were more effective at rate control than propafenone in the setting of SQT1, and quinidine was most effective at rhythm control. Combined block of \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> and \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> by a hypothetical drug was shown to be more beneficial in terms of re-entry termination in a 2D sheet of human atrial tissue than \u003Ci>I\u003C/i>\u003Csub>Kr\u003C/sub> or \u003Ci>I\u003C/i>\u003Csub>Na\u003C/sub> block alone in this context, suggesting useful targets for future pharmacotherapies. The multi-scale integrative cardiac modeling approach adopted in this study serves as a useful paradigm for optimisation of pharmacological therapy, allowing investigation of how genetic defects at the ion channel level influence organ scale propagation, arrhythmogenesis, and response to pharmacotherapies.\u003C/p>\r\n\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>Author Contributions\u003C/h2>\r\n\u003Cp class=\"mb0\">DW, JH, and HZ conceived the experiments and wrote the manuscript. DW developed and validated computer models and performed numerical experiments and analysis.\u003C/p>\r\n\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Funding\u003C/h2>\r\n\u003Cp class=\"mb0\">DW was supported by the British Heart Foundation (FS/14/5/30533&#x02013;HZ and JH) and is now supported by a Wellcome Trust ISSF fellowship (204825/Z/16/Z). This work was also supported by grants from EPSRC (UK) (EP/J00958X/1; EP/I029826/1), MC-IRSES CORDIS3D (317766), NSFC (61179009), Shenzhen Science and Technology Innovation Committee (JCYJ20151029173639477; JSGG20160229125049615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\u003C/p>\r\n\u003Ca id=\"h10\" name=\"h10\">\u003C/a>\u003Ch2>Conflict of Interest Statement\u003C/h2>\r\n\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\r\n\u003Ca id=\"h11\" name=\"h11\">\u003C/a>\u003Ch2>Acknowledgments\u003C/h2>\r\n\u003Cp class=\"mb0\">JH gratefully acknowledges receipt of a University of Bristol research fellowship.\u003C/p>\r\n\u003Ca id=\"h12\" name=\"h12\">\u003C/a>\u003Ch2>Supplementary Material\u003C/h2>\r\n\u003Cp class=\"mb0\" id=\"SM1\">The Supplementary Material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fphys.2018.01888/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fphys.2018.01888/full#supplementary-material\u003C/a>\u003C/p>\r\n\u003Ca id=\"h13\" name=\"h13\">\u003C/a>\u003Ch2>References\u003C/h2>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a> Adeniran, I., Hancox, J. C., and Zhang, H. (2013). \u003Ci>In silico\u003C/i> investigation of the short QT syndrome, using human ventricle models incorporating electromechanical coupling. \u003Ci>Front. Physiol.\u003C/i> 4:166. doi: 10.3389/fphys.2013.00166\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23847545\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fphys.2013.00166\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I.+Adeniran&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2013&#x00026;title=In+silico+investigation+of+the+short+QT+syndrome,+using+human+ventricle+models+incorporating+electromechanical+coupling&#x00026;journal=Front.+Physiol.&#x00026;volume=4&#x00026;pages=166\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a> Adeniran, I., McPate, M. J., Witchel, H. J., Hancox, J. C., and Zhang, H. (2011). Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome. \u003Ci>PLoS Comput. Biol.\u003C/i> 7:e1002313. doi: 10.1371/journal.pcbi.1002313\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=22194679\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pcbi.1002313\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I.+Adeniran&#x00026;author=M.+J.+McPate&#x00026;author=H.+J.+Witchel&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2011&#x00026;title=Increased+vulnerability+of+human+ventricle+to+re-entrant+excitation+in+hERG-linked+variant+1+short+QT+syndrome&#x00026;journal=PLoS+Comput.+Biol.&#x00026;volume=7&#x00026;pages=e1002313\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a> Adeniran, I., Whittaker, D. G., Harchi, A. E., Hancox, J. C., and Zhang, H. (2017). \u003Ci>In silico\u003C/i> investigation of a KCNQ1 mutation associated with short QT syndrome. \u003Ci>Sci. Rep.\u003C/i> 7:8469. doi: 10.1038/s41598-017-08367-2\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=28814790\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41598-017-08367-2\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I.+Adeniran&#x00026;author=D.+G.+Whittaker&#x00026;author=A.+E.+Harchi&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2017&#x00026;title=In+silico+investigation+of+a+KCNQ1+mutation+associated+with+short+QT+syndrome&#x00026;journal=Sci.+Rep.&#x00026;volume=7&#x00026;pages=8469\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a> Akdis, D., Saguner, A. M., Medeiros-Domingo, A., Schaller, A., Balmer, C., Steffel, J., et al. (2018). Multiple clinical profiles of families with the short QT syndrome. \u003Ci>EP Eur.\u003C/i> 20, f113&#x02013;f121. doi: 10.1093/europace/eux186\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29016797\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/europace/eux186\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+Akdis&#x00026;author=A.+M.+Saguner&#x00026;author=A.+Medeiros-Domingo&#x00026;author=A.+Schaller&#x00026;author=C.+Balmer&#x00026;author=J.+Steffel+&#x00026;publication_year=2018&#x00026;title=Multiple+clinical+profiles+of+families+with+the+short+QT+syndrome&#x00026;journal=EP+Eur.&#x00026;volume=20&#x00026;pages=f113-f121\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a> Amor&#x000F3;s, I., Dolz-Gait&#x000F3;n, P., G&#x000F3;mez, R., Matamoros, M., Barana, A., de la Fuente, M. G., et al. (2013). Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore. \u003Ci>Biochem. Pharmacol.\u003C/i> 86, 267&#x02013;278. doi: 10.1016/j.bcp.2013.04.023\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23648307\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.bcp.2013.04.023\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I.+Amor&#x000F3;s&#x00026;author=P.+Dolz-Gait&#x000F3;n&#x00026;author=R.+G&#x000F3;mez&#x00026;author=M.+Matamoros&#x00026;author=A.+Barana&#x00026;author=M.+G.+de+la+Fuente+&#x00026;publication_year=2013&#x00026;title=Propafenone+blocks+human+cardiac+Kir2.x+channels+by+decreasing+the+negative+electrostatic+charge+in+the+cytoplasmic+pore&#x00026;journal=Biochem.+Pharmacol.&#x00026;volume=86&#x00026;pages=267-278\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a> Ar&#x000E9;chiga, I. A., Barrio-Echavarria, G. F., Rodr&#x000ED;guez-Menchaca, A. A., Moreno-Galindo, E. G., Decher, N., Tristani-Firouzi, M., et al. (2008). Kv1.5 open channel block by the antiarrhythmic drug disopyramide: molecular determinants of block. \u003Ci>J. Pharmacol. Sci.\u003C/i> 108, 49&#x02013;55. doi: 10.1254/jphs.08084FP\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18818480\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1254/jphs.08084FP\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I.+A.+Ar&#x000E9;chiga&#x00026;author=G.+F.+Barrio-Echavarria&#x00026;author=A.+A.+Rodr&#x000ED;guez-Menchaca&#x00026;author=E.+G.+Moreno-Galindo&#x00026;author=N.+Decher&#x00026;author=M.+Tristani-Firouzi+&#x00026;publication_year=2008&#x00026;title=Kv1.5+open+channel+block+by+the+antiarrhythmic+drug+disopyramide%3A+molecular+determinants+of+block&#x00026;journal=J.+Pharmacol.+Sci.&#x00026;volume=108&#x00026;pages=49-55\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a> Arora, R., Verheule, S., Scott, L., Navarrete, A., Katari, V., Wilson, E., et al. (2003). Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. \u003Ci>Circulation\u003C/i> 107, 1816&#x02013;1821. doi: 10.1161/01.CIR.0000058461.86339.7E\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12665495\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1161/01.CIR.0000058461.86339.7E\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Arora&#x00026;author=S.+Verheule&#x00026;author=L.+Scott&#x00026;author=A.+Navarrete&#x00026;author=V.+Katari&#x00026;author=E.+Wilson+&#x00026;publication_year=2003&#x00026;title=Arrhythmogenic+substrate+of+the+pulmonary+veins+assessed+by+high-resolution+optical+mapping&#x00026;journal=Circulation&#x00026;volume=107&#x00026;pages=1816-1821\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a> Biktashev, V. N., and Holden, A. V. (1998). Reentrant waves and their elimination in a model of mammalian ventricular tissue. \u003Ci>Chaos. Interdiscip. J. Nonlinear Sci.\u003C/i> 8, 48&#x02013;56. doi: 10.1063/1.166307\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12779709\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1063/1.166307\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=V.+N.+Biktashev&#x00026;author=A.+V.+Holden+&#x00026;publication_year=1998&#x00026;title=Reentrant+waves+and+their+elimination+in+a+model+of+mammalian+ventricular+tissue&#x00026;journal=Chaos.+Interdiscip.+J.+Nonlinear+Sci.&#x00026;volume=8&#x00026;pages=48-56\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a> Bjerregaard, P., Jahangir, A., and Gussak, I. (2006). Targeted therapy for short QT syndrome. \u003Ci>Expert Opin. Ther. Targets\u003C/i> 10, 393&#x02013;400. doi: 10.1517/14728222.10.3.393\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16706679\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1517/14728222.10.3.393\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P.+Bjerregaard&#x00026;author=A.+Jahangir&#x00026;author=I.+Gussak+&#x00026;publication_year=2006&#x00026;title=Targeted+therapy+for+short+QT+syndrome&#x00026;journal=Expert+Opin.+Ther.+Targets&#x00026;volume=10&#x00026;pages=393-400\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a> Bosch, R. F., Zeng, X., Grammer, J. B., Popovic, K., Mewis, C., and K&#x000FC;hlkamp, V. (1999). Ionic mechanisms of electrical remodeling in human atrial fibrillation. \u003Ci>Cardiovasc. Res.\u003C/i> 44, 121&#x02013;131. doi: 10.1016/S0008-6363(99)00178-9\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=10615396\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/S0008-6363(99)00178-9\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+F.+Bosch&#x00026;author=X.+Zeng&#x00026;author=J.+B.+Grammer&#x00026;author=K.+Popovic&#x00026;author=C.+Mewis&#x00026;author=V.+K&#x000FC;hlkamp+&#x00026;publication_year=1999&#x00026;title=Ionic+mechanisms+of+electrical+remodeling+in+human+atrial+fibrillation&#x00026;journal=Cardiovasc.+Res.&#x00026;volume=44&#x00026;pages=121-131\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a> Bray, M.-A., and Wikswo, J. P. (2002). Use of topological charge to determine filament location and dynamics in a numerical model of scroll wave activity. \u003Ci>IEEE Trans. Biomed. Eng.\u003C/i> 49, 1086&#x02013;1093. doi: 10.1109/TBME.2002.803516\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12374332\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1109/TBME.2002.803516\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+-A.+Bray&#x00026;author=J.+P.+Wikswo+&#x00026;publication_year=2002&#x00026;title=Use+of+topological+charge+to+determine+filament+location+and+dynamics+in+a+numerical+model+of+scroll+wave+activity&#x00026;journal=IEEE+Trans.+Biomed.+Eng.&#x00026;volume=49&#x00026;pages=1086-1093\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a> Brugada, R., Hong, K., Dumaine, R., Cordeiro, J., Gaita, F., Borggrefe, M., et al. (2004). Sudden death associated with Short-QT syndrome linked to mutations in HERG. \u003Ci>Circulation\u003C/i> 109, 30&#x02013;35. doi: 10.1161/01.CIR.0000109482.92774.3A\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=14676148\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1161/01.CIR.0000109482.92774.3A\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Brugada&#x00026;author=K.+Hong&#x00026;author=R.+Dumaine&#x00026;author=J.+Cordeiro&#x00026;author=F.+Gaita&#x00026;author=M.+Borggrefe+&#x00026;publication_year=2004&#x00026;title=Sudden+death+associated+with+Short-QT+syndrome+linked+to+mutations+in+HERG&#x00026;journal=Circulation&#x00026;volume=109&#x00026;pages=30-35\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a> Burashnikov, A., Belardinelli, L., and Antzelevitch, C. (2012). Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone. \u003Ci>J. Pharmacol. Exp. Ther.\u003C/i> 340, 161&#x02013;168. doi: 10.1124/jpet.111.186395\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=22005044\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1124/jpet.111.186395\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Burashnikov&#x00026;author=L.+Belardinelli&#x00026;author=C.+Antzelevitch+&#x00026;publication_year=2012&#x00026;title=Atrial-selective+sodium+channel+block+strategy+to+suppress+atrial+fibrillation%3A+ranolazine+versus+propafenone&#x00026;journal=J.+Pharmacol.+Exp.+Ther.&#x00026;volume=340&#x00026;pages=161-168\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a> Colman, M. A., Aslanidi, O. V., Kharche, S., Boyett, M. R., Garratt, C., Hancox, J. C., et al. (2013). Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria. \u003Ci>J. Physiol.\u003C/i> 591, 4249&#x02013;4272. doi: 10.1113/jphysiol.2013.254987\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23732649\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1113/jphysiol.2013.254987\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+A.+Colman&#x00026;author=O.+V.+Aslanidi&#x00026;author=S.+Kharche&#x00026;author=M.+R.+Boyett&#x00026;author=C.+Garratt&#x00026;author=J.+C.+Hancox+&#x00026;publication_year=2013&#x00026;title=Pro-arrhythmogenic+effects+of+atrial+fibrillation-induced+electrical+remodelling%3A+insights+from+the+three-dimensional+virtual+human+atria&#x00026;journal=J.+Physiol.&#x00026;volume=591&#x00026;pages=4249-4272\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a> Colman, M. A., Ni, H., Liang, B., Schmitt, N., and Zhang, H. (2017). \u003Ci>In silico\u003C/i> assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesis. \u003Ci>PLOS. Comput. Biol.\u003C/i> 13:e1005587. doi: 10.1371/journal.pcbi.1005587\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=28622331\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pcbi.1005587\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+A.+Colman&#x00026;author=H.+Ni&#x00026;author=B.+Liang&#x00026;author=N.+Schmitt&#x00026;author=H.+Zhang+&#x00026;publication_year=2017&#x00026;title=In+silico+assessment+of+genetic+variation+in+KCNA5+reveals+multiple+mechanisms+of+human+atrial+arrhythmogenesis&#x00026;journal=PLOS.+Comput.+Biol.&#x00026;volume=13&#x00026;pages=e1005587\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a> Cordeiro, J. M., Brugada, R., Wu, Y. S., Hong, K., and Dumaine, R. (2005). Modulation of IKr inactivation by mutation N588K in KCNH2: A link to arrhythmogenesis in short QT syndrome. \u003Ci>Cardiovasc. Res.\u003C/i> 67, 498&#x02013;509. doi: 10.1016/j.cardiores.2005.02.018\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.cardiores.2005.02.018\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+M.+Cordeiro&#x00026;author=R.+Brugada&#x00026;author=Y.+S.+Wu&#x00026;author=K.+Hong&#x00026;author=R.+Dumaine+&#x00026;publication_year=2005&#x00026;title=Modulation+of+IKr+inactivation+by+mutation+N588K+in+KCNH2%3A+A+link+to+arrhythmogenesis+in+short+QT+syndrome&#x00026;journal=Cardiovasc.+Res.&#x00026;volume=67&#x00026;pages=498-509\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a> Courtemanche, M., Ramirez, R. J., and Nattel, S. (1998). Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. \u003Ci>Am. J. Physiol. Heart Circ. Physiol.\u003C/i> 275, H301&#x02013;H321.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9688927\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Courtemanche&#x00026;author=R.+J.+Ramirez&#x00026;author=S.+Nattel+&#x00026;publication_year=1998&#x00026;title=Ionic+mechanisms+underlying+human+atrial+action+potential+properties%3A+insights+from+a+mathematical+model&#x00026;journal=Am.+J.+Physiol.+Heart+Circ.+Physiol.&#x00026;volume=275&#x00026;pages=H301-H321\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a> Dobrev, D., and Ravens, U. (2003). Remodeling of cardiomyocyte ion channels in human atrial fibrillation. \u003Ci>Basic Res. Cardiol.\u003C/i> 98, 137&#x02013;148. doi: 10.1007/s00395-003-0409-8\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12883831\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00395-003-0409-8\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+Dobrev&#x00026;author=U.+Ravens+&#x00026;publication_year=2003&#x00026;title=Remodeling+of+cardiomyocyte+ion+channels+in+human+atrial+fibrillation&#x00026;journal=Basic+Res.+Cardiol.&#x00026;volume=98&#x00026;pages=137-148\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a> Duan, D., Fermini, B., and Nattel, S. (1993). Potassium channel blocking properties of propafenone in rabbit atrial myocytes. \u003Ci>J. Pharmacol. Exp. Ther.\u003C/i> 264, 1113&#x02013;1123.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=8450455\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+Duan&#x00026;author=B.+Fermini&#x00026;author=S.+Nattel+&#x00026;publication_year=1993&#x00026;title=Potassium+channel+blocking+properties+of+propafenone+in+rabbit+atrial+myocytes&#x00026;journal=J.+Pharmacol.+Exp.+Ther.&#x00026;volume=264&#x00026;pages=1113-1123\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a> Dumaine, R., and Antzelevitch, C. (2006). Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome? \u003Ci>J. Mol. Cell. Cardiol.\u003C/i> 41, 421&#x02013;423. doi: 10.1016/j.yjmcc.2006.06.070\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16863649\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.yjmcc.2006.06.070\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Dumaine&#x00026;author=C.+Antzelevitch+&#x00026;publication_year=2006&#x00026;title=Disopyramide%3A+although+potentially+life-threatening+in+the+setting+of+long+QT,+could+it+be+life-saving+in+short+QT+syndrome%3F&#x00026;journal=J.+Mol.+Cell.+Cardiol.&#x00026;volume=41&#x00026;pages=421-423\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a> Edrich, T., Wang, S.-Y., and Wang, G. K. (2005). State-dependent block of human cardiac hNav1.5 sodium channels by propafenone. \u003Ci>J. Membr. Biol.\u003C/i> 207, 35&#x02013;43. doi: 10.1007/s00232-005-0801-4\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16463141\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00232-005-0801-4\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=T.+Edrich&#x00026;author=S.+-Y.+Wang&#x00026;author=G.+K.+Wang+&#x00026;publication_year=2005&#x00026;title=State-dependent+block+of+human+cardiac+hNav1.5+sodium+channels+by+propafenone&#x00026;journal=J.+Membr.+Biol.&#x00026;volume=207&#x00026;pages=35-43\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a> Enriquez, A., Antzelevitch, C., Bismah, V., and Baranchuk, A. (2016). Atrial fibrillation in inherited cardiac channelopathies: from mechanisms to management. \u003Ci>Heart Rhythm\u003C/i>. 13, 1878&#x02013;1884. doi: 10.1016/j.hrthm.2016.06.008\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27291509\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.hrthm.2016.06.008\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Enriquez&#x00026;author=C.+Antzelevitch&#x00026;author=V.+Bismah&#x00026;author=A.+Baranchuk+&#x00026;publication_year=2016&#x00026;title=Atrial+fibrillation+in+inherited+cardiac+channelopathies%3A+from+mechanisms+to+management&#x00026;journal=Heart+Rhythm&#x00026;volume=13&#x00026;pages=1878-1884\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a> Fei, L., Gill, J. S., McKenna, W. J., and Camm, A. J. (1993). Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig. \u003Ci>Br. J. Pharmacol.\u003C/i> 109, 178&#x02013;182. doi: 10.1111/j.1476-5381.1993.tb13550.x\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=8388297\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/j.1476-5381.1993.tb13550.x\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=L.+Fei&#x00026;author=J.+S.+Gill&#x00026;author=W.+J.+McKenna&#x00026;author=A.+J.+Camm+&#x00026;publication_year=1993&#x00026;title=Effects+of+propafenone+on+calcium+currents+in+single+ventricular+myocytes+of+guinea-pig&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=109&#x00026;pages=178-182\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a> Franqueza, L., Valenzuela, C., Delp&#x000F3;n, E., Longobardo, M., Caballero, R., and Tamargo, J. (1998). Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels. \u003Ci>Br. J. Pharmacol.\u003C/i> 125, 969&#x02013;978. doi: 10.1038/sj.bjp.0702129\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9846634\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.bjp.0702129\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=L.+Franqueza&#x00026;author=C.+Valenzuela&#x00026;author=E.+Delp&#x000F3;n&#x00026;author=M.+Longobardo&#x00026;author=R.+Caballero&#x00026;author=J.+Tamargo+&#x00026;publication_year=1998&#x00026;title=Effects+of+propafenone+and+5-hydroxy-propafenone+on+hKv1.5+channels&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=125&#x00026;pages=969-978\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a> Frea, S., Giustetto, C., Capriolo, M., Scrocco, C., Fornengo, C., Benedetto, S., et al. (2015). New echocardiographic insights in short QT syndrome: more than a channelopathy? \u003Ci>Heart Rhythm\u003C/i>. 12, 2096&#x02013;2105. doi: 10.1016/j.hrthm.2015.05.024\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26001507\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.hrthm.2015.05.024\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+Frea&#x00026;author=C.+Giustetto&#x00026;author=M.+Capriolo&#x00026;author=C.+Scrocco&#x00026;author=C.+Fornengo&#x00026;author=S.+Benedetto+&#x00026;publication_year=2015&#x00026;title=New+echocardiographic+insights+in+short+QT+syndrome%3A+more+than+a+channelopathy%3F&#x00026;journal=Heart+Rhythm&#x00026;volume=12&#x00026;pages=2096-2105\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a> Gaita, F., Giustetto, C., Bianchi, F., Schimpf, R., Haissaguerre, M., Cal,&#x000F2;, L., et al. (2004). Short QT syndrome: pharmacological treatment. \u003Ci>J. Am. Coll. Cardiol.\u003C/i> 43, 1494&#x02013;1499. doi: 10.1016/j.jacc.2004.02.034\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15093889\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.jacc.2004.02.034\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F.+Gaita&#x00026;author=C.+Giustetto&#x00026;author=F.+Bianchi&#x00026;author=R.+Schimpf&#x00026;author=M.+Haissaguerre&#x00026;author=L.+Cal,&#x000F2;+&#x00026;publication_year=2004&#x00026;title=Short+QT+syndrome%3A+pharmacological+treatment&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=43&#x00026;pages=1494-1499\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a> Giustetto, C. (2006). &#x0201C;Quinidine to treat short QT syndrome: a real alternative to ICD?,&#x0201D; in \u003Ci>Cardiac Arrhythmias 2005\u003C/i>, ed. A. R. MD (Milan: Springer), 333&#x02013;335.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Giustetto+&#x00026;publication_year=2006&#x00026;title=&#x0201C;Quinidine+to+treat+short+QT+syndrome%3A+a+real+alternative+to+ICD%3F,&#x0201D;&#x00026;pages=333-335\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a> Giustetto, C., Schimpf, R., Mazzanti, A., Scrocco, C., Maury, P., Anttonen, O., et al. (2011). Long-term follow-Up of patients with short QT syndrome. \u003Ci>J. Am. Coll. Cardiol.\u003C/i> 58, 587&#x02013;595. doi: 10.1016/j.jacc.2011.03.038\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21798421\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.jacc.2011.03.038\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Giustetto&#x00026;author=R.+Schimpf&#x00026;author=A.+Mazzanti&#x00026;author=C.+Scrocco&#x00026;author=P.+Maury&#x00026;author=O.+Anttonen+&#x00026;publication_year=2011&#x00026;title=Long-term+follow-Up+of+patients+with+short+QT+syndrome&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=58&#x00026;pages=587-595\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a> Gross, G. J., and Castle, N. A. (1998). Propafenone inhibition of human atrial myocyte repolarizing currents. \u003Ci>J. Mol. Cell. Cardiol.\u003C/i> 30, 783&#x02013;793. doi: 10.1006/jmcc.1998.0643\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9602427\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1006/jmcc.1998.0643\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=G.+J.+Gross&#x00026;author=N.+A.+Castle+&#x00026;publication_year=1998&#x00026;title=Propafenone+inhibition+of+human+atrial+myocyte+repolarizing+currents&#x00026;journal=J.+Mol.+Cell.+Cardiol.&#x00026;volume=30&#x00026;pages=783-793\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a> Hancox, J. C., and Mitcheson, J. S. (1997). Inhibition of L-type calcium current by propafenone in single myocytes isolated from the rabbit atrioventricular node. \u003Ci>Br. J. Pharmacol.\u003C/i> 121, 7&#x02013;14. doi: 10.1038/sj.bjp.0701086\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9146880\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.bjp.0701086\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+C.+Hancox&#x00026;author=J.+S.+Mitcheson+&#x00026;publication_year=1997&#x00026;title=Inhibition+of+L-type+calcium+current+by+propafenone+in+single+myocytes+isolated+from+the+rabbit+atrioventricular+node&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=121&#x00026;pages=7-14\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a> Hancox, J. C., Whittaker, D. G., Du, C., Stuart, A. G., and Zhang, H. (2018). Emerging therapeutic targets in the short QT syndrome. \u003Ci>Expert Opin. Ther. Targets\u003C/i> 22:439&#x02013;51. doi: 10.1080/14728222.2018.1470621\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29697308\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1080/14728222.2018.1470621\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+C.+Hancox&#x00026;author=D.+G.+Whittaker&#x00026;author=C.+Du&#x00026;author=A.+G.+Stuart&#x00026;author=H.+Zhang+&#x00026;publication_year=2018&#x00026;title=Emerging+therapeutic+targets+in+the+short+QT+syndrome&#x00026;journal=Expert+Opin.+Ther.+Targets&#x00026;volume=22&#x00026;pages=439-51\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B32\" id=\"B32\">\u003C/a> Harmer, A. R., Abi-Gerges, N., Easter, A., Woods, A., Lawrence, C. L., Small, B. G., et al. (2008). Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks\u003Csup>TM\u003C/sup>. \u003Ci>J. Pharmacol. Toxicol. Methods\u003C/i> 57, 30&#x02013;41. doi: 10.1016/j.vascn.2007.09.002\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17980627\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.vascn.2007.09.002\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+R.+Harmer&#x00026;author=N.+Abi-Gerges&#x00026;author=A.+Easter&#x00026;author=A.+Woods&#x00026;author=C.+L.+Lawrence&#x00026;author=B.+G.+Small+&#x00026;publication_year=2008&#x00026;title=Optimisation+and+validation+of+a+medium-throughput+electrophysiology-based+hNav1.5+assay+using+IonWorksTM&#x00026;journal=J.+Pharmacol.+Toxicol.+Methods&#x00026;volume=57&#x00026;pages=30-41\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B33\" id=\"B33\">\u003C/a> Hong, K., Bjerregaard, P., Gussak, I., and Brugada, R. (2005). Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. \u003Ci>J. Cardiovasc. Electrophysiol.\u003C/i> 16, 394&#x02013;396. doi: 10.1046/j.1540-8167.2005.40621.x\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15828882\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1046/j.1540-8167.2005.40621.x\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K.+Hong&#x00026;author=P.+Bjerregaard&#x00026;author=I.+Gussak&#x00026;author=R.+Brugada+&#x00026;publication_year=2005&#x00026;title=Short+QT+syndrome+and+atrial+fibrillation+caused+by+mutation+in+KCNH2&#x00026;journal=J.+Cardiovasc.+Electrophysiol.&#x00026;volume=16&#x00026;pages=394-396\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B34\" id=\"B34\">\u003C/a> Hu, D., Li, Y., Zhang, J., Pfeiffer, R., Gollob, M. H., Healey, J., et al. (2017). The phenotypic spectrum of a mutation hotspot responsible for the short QT syndrome. \u003Ci>JACC. Clin. Electrophysiol.\u003C/i> 3, 727&#x02013;43. doi: 10.1016/j.jacep.2016.11.013\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29759541\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.jacep.2016.11.013\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+Hu&#x00026;author=Y.+Li&#x00026;author=J.+Zhang&#x00026;author=R.+Pfeiffer&#x00026;author=M.+H.+Gollob&#x00026;author=J.+Healey+&#x00026;publication_year=2017&#x00026;title=The+phenotypic+spectrum+of+a+mutation+hotspot+responsible+for+the+short+QT+syndrome&#x00026;journal=JACC.+Clin.+Electrophysiol.&#x00026;volume=3&#x00026;pages=727-43\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B35\" id=\"B35\">\u003C/a> Katoh, H., Shinozaki, T., Baba, S., Satoh, S., Kagaya, Y., Watanabe, J., et al. (2005). Monophasic action potential duration at the crista terminalis in patients with sinus node disease. \u003Ci>Circ. J.\u003C/i> 69, 1361&#x02013;1367. doi: 10.1253/circj.69.1361\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16247212\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1253/circj.69.1361\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H.+Katoh&#x00026;author=T.+Shinozaki&#x00026;author=S.+Baba&#x00026;author=S.+Satoh&#x00026;author=Y.+Kagaya&#x00026;author=J.+Watanabe+&#x00026;publication_year=2005&#x00026;title=Monophasic+action+potential+duration+at+the+crista+terminalis+in+patients+with+sinus+node+disease&#x00026;journal=Circ.+J.&#x00026;volume=69&#x00026;pages=1361-1367\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B36\" id=\"B36\">\u003C/a> Kim, B.-S., Kim, Y.-H., Hwang, G.-S., Pak, H.-N., Lee, S. C., Shim, W. J., et al. (2002). Action potential duration restitution kinetics in human atrial fibrillation. \u003Ci>J. Am. Coll. Cardiol.\u003C/i> 39, 1329&#x02013;1336. doi: 10.1016/S0735-1097(02)01760-6\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=11955851\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/S0735-1097(02)01760-6\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=B.+-S.+Kim&#x00026;author=Y.+-H.+Kim&#x00026;author=G.+-S.+Hwang&#x00026;author=H.+-N.+Pak&#x00026;author=S.+C.+Lee&#x00026;author=W.+J.+Shim+&#x00026;publication_year=2002&#x00026;title=Action+potential+duration+restitution+kinetics+in+human+atrial+fibrillation&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=39&#x00026;pages=1329-1336\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B37\" id=\"B37\">\u003C/a> Koumi, S., Sato, R., Katori, R., Hisatome, I., Nagasawa, K., and Hayakawa, H. (1992). Sodium channel states control binding and unbinding behaviour of antiarrhythmic drugs in cardiac myocytes from the guinea pig. \u003Ci>Cardiovasc. Res.\u003C/i> 26, 1199&#x02013;1205. doi: 10.1093/cvr/26.12.1199\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=1337728\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/cvr/26.12.1199\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+Koumi&#x00026;author=R.+Sato&#x00026;author=R.+Katori&#x00026;author=I.+Hisatome&#x00026;author=K.+Nagasawa&#x00026;author=H.+Hayakawa+&#x00026;publication_year=1992&#x00026;title=Sodium+channel+states+control+binding+and+unbinding+behaviour+of+antiarrhythmic+drugs+in+cardiac+myocytes+from+the+guinea+pig&#x00026;journal=Cardiovasc.+Res.&#x00026;volume=26&#x00026;pages=1199-1205\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B38\" id=\"B38\">\u003C/a> Krueger, M. W., Schmidt, V., Tob&#x000F3;n, C., Weber, F. M., Lorenz, C., Keller, D. U. J., et al. (2011). &#x0201C;Modeling atrial fiber orientation in patient-specific geometries: a semi-automatic rule-based approach,&#x0201D; in \u003Ci>Functional Imaging and Modeling of the Heart Lecture Notes in Computer Science.\u003C/i> (Springer, Berlin, Heidelberg), 223&#x02013;232.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+W.+Krueger&#x00026;author=V.+Schmidt&#x00026;author=C.+Tob&#x000F3;n&#x00026;author=F.+M.+Weber&#x00026;author=C.+Lorenz&#x00026;author=D.+U.+J.+Keller+&#x00026;publication_year=2011&#x00026;title=&#x0201C;Modeling+atrial+fiber+orientation+in+patient-specific+geometries%3A+a+semi-automatic+rule-based+approach,&#x0201D;&#x00026;pages=223-232\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B39\" id=\"B39\">\u003C/a> Kumagai, K., Ogawa, M., Noguchi, H., Yasuda, T., Nakashima, H., and Saku, K. (2004). Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. \u003Ci>J. Am. Coll. Cardiol.\u003C/i> 43, 2281&#x02013;2289. doi: 10.1016/j.jacc.2004.01.051\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15193694\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.jacc.2004.01.051\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K.+Kumagai&#x00026;author=M.+Ogawa&#x00026;author=H.+Noguchi&#x00026;author=T.+Yasuda&#x00026;author=H.+Nakashima&#x00026;author=K.+Saku+&#x00026;publication_year=2004&#x00026;title=Electrophysiologic+properties+of+pulmonary+veins+assessed+using+a+multielectrode+basket+catheter&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=43&#x00026;pages=2281-2289\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B40\" id=\"B40\">\u003C/a> Lazar, S., Dixit, S., Marchlinski, F. E., Callans, D. J., and Gerstenfeld, E. P. (2004). Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. \u003Ci>Circulation\u003C/i> 110, 3181&#x02013;3186. doi: 10.1161/01.CIR.0000147279.91094.5E\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1161/01.CIR.0000147279.91094.5E\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+Lazar&#x00026;author=S.+Dixit&#x00026;author=F.+E.+Marchlinski&#x00026;author=D.+J.+Callans&#x00026;author=E.+P.+Gerstenfeld+&#x00026;publication_year=2004&#x00026;title=Presence+of+left-to-right+atrial+frequency+gradient+in+paroxysmal+but+not+persistent+atrial+fibrillation+in+humans&#x00026;journal=Circulation&#x00026;volume=110&#x00026;pages=3181-3186\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B41\" id=\"B41\">\u003C/a> Lee, G., Sanders, P., and Kalman, J. M. (2012). Catheter ablation of atrial arrhythmias: state of the art. \u003Ci>Lancet\u003C/i> 380, 1509&#x02013;1519. doi: 10.1016/S0140-6736(12)61463-9\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23101718\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/S0140-6736(12)61463-9\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=G.+Lee&#x00026;author=P.+Sanders&#x00026;author=J.+M.+Kalman+&#x00026;publication_year=2012&#x00026;title=Catheter+ablation+of+atrial+arrhythmias%3A+state+of+the+art&#x00026;journal=Lancet&#x00026;volume=380&#x00026;pages=1509-1519\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B42\" id=\"B42\">\u003C/a> Lemery, R., Birnie, D., Tang, A. S., Green, M., Gollob, M., Hendry, M., et al. (2007). Normal atrial activation and voltage during sinus rhythm in the human heart: an endocardial and epicardial mapping study in patients with a history of atrial fibrillation. \u003Ci>J. Cardiovasc. Electrophysiol.\u003C/i> 18, 402&#x02013;408. doi: 10.1111/j.1540-8167.2007.00762.x\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17394455\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/j.1540-8167.2007.00762.x\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Lemery&#x00026;author=D.+Birnie&#x00026;author=A.+S.+Tang&#x00026;author=M.+Green&#x00026;author=M.+Gollob&#x00026;author=M.+Hendry+&#x00026;publication_year=2007&#x00026;title=Normal+atrial+activation+and+voltage+during+sinus+rhythm+in+the+human+heart%3A+an+endocardial+and+epicardial+mapping+study+in+patients+with+a+history+of+atrial+fibrillation&#x00026;journal=J.+Cardiovasc.+Electrophysiol.&#x00026;volume=18&#x00026;pages=402-408\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B43\" id=\"B43\">\u003C/a> Loewe, A., Lutz, Y., Wilhelms, M., Sinnecker, D., Barthel, P., Scholz, E. P., et al. (2014a). \u003Ci>In-silico\u003C/i> assessment of the dynamic effects of amiodarone and dronedarone on human atrial patho-electrophysiology. \u003Ci>Europace\u003C/i> 16, iv30&#x02013;iv38. doi: 10.1093/europace/euu230\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25362168\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/europace/euu230\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Loewe&#x00026;author=Y.+Lutz&#x00026;author=M.+Wilhelms&#x00026;author=D.+Sinnecker&#x00026;author=P.+Barthel&#x00026;author=E.+P.+Scholz+&#x00026;publication_year=2014a&#x00026;title=In-silico+assessment+of+the+dynamic+effects+of+amiodarone+and+dronedarone+on+human+atrial+patho-electrophysiology&#x00026;journal=Europace\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B44\" id=\"B44\">\u003C/a> Loewe, A., Wilhelms, M., Fischer, F., Scholz, E. P., D&#x000F6;ssel, O., and Seemann, G. (2014b). Arrhythmic potency of human ether-&#x000E0;-go-go-related gene mutations L532P and N588K in a computational model of human atrial myocytes. \u003Ci>Europace\u003C/i> 16, 435&#x02013;443. doi: 10.1093/europace/eut375\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=24569898\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/europace/eut375\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Loewe&#x00026;author=M.+Wilhelms&#x00026;author=F.+Fischer&#x00026;author=E.+P.+Scholz&#x00026;author=O.+D&#x000F6;ssel&#x00026;author=G.+Seemann+&#x00026;publication_year=2014b&#x00026;title=Arrhythmic+potency+of+human+ether-&#x000E0;-go-go-related+gene+mutations+L532P+and+N588K+in+a+computational+model+of+human+atrial+myocytes&#x00026;journal=Europace&#x00026;volume=16&#x00026;pages=435-443\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B45\" id=\"B45\">\u003C/a> Mandapati, R., Skanes, A., Chen, J., Berenfeld, O., and Jalife, J. (2000). Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. \u003Ci>Circulation\u003C/i> 101, 194&#x02013;199. doi: 10.1161/01.CIR.101.2.194\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=10637208\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1161/01.CIR.101.2.194\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Mandapati&#x00026;author=A.+Skanes&#x00026;author=J.+Chen&#x00026;author=O.+Berenfeld&#x00026;author=J.+Jalife+&#x00026;publication_year=2000&#x00026;title=Stable+microreentrant+sources+as+a+mechanism+of+atrial+fibrillation+in+the+isolated+sheep+heart&#x00026;journal=Circulation&#x00026;volume=101&#x00026;pages=194-199\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B46\" id=\"B46\">\u003C/a> McLeod, A. A., Stiles, G. L., and Shand, D. G. (1984). Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies. \u003Ci>J. Pharmacol. Exp. Ther.\u003C/i> 228, 461&#x02013;466.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=6141285\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+A.+McLeod&#x00026;author=G.+L.+Stiles&#x00026;author=D.+G.+Shand+&#x00026;publication_year=1984&#x00026;title=Demonstration+of+beta+adrenoceptor+blockade+by+propafenone+hydrochloride%3A+clinical+pharmacologic,+radioligand+binding+and+adenylate+cyclase+activation+studies&#x00026;journal=J.+Pharmacol.+Exp.+Ther.&#x00026;volume=228&#x00026;pages=461-466\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B47\" id=\"B47\">\u003C/a> McPate, M. J., Duncan, R. S., Hancox, J. C., and Witchel, H. J. (2008). Pharmacology of the short QT syndrome N588K-hERG K&#43; channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. \u003Ci>Br. J. Pharmacol.\u003C/i> 155, 957&#x02013;966. doi: 10.1038/bjp.2008.325\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18724381\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/bjp.2008.325\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+J.+McPate&#x00026;author=R.+S.+Duncan&#x00026;author=J.+C.+Hancox&#x00026;author=H.+J.+Witchel+&#x00026;publication_year=2008&#x00026;title=Pharmacology+of+the+short+QT+syndrome+N588K-hERG+K&#43;+channel+mutation%3A+differential+impact+on+selected+class+I+and+class+III+antiarrhythmic+drugs&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=155&#x00026;pages=957-966\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B48\" id=\"B48\">\u003C/a> McPate, M. J., Duncan, R. S., Milnes, J. T., Witchel, H. J., and Hancox, J. C. (2005). The N588K-HERG K\u003Csup>&#43;\u003C/sup> channel mutation in the &#x02018;short QT syndrome&#x00027;: mechanism of gain-in-function determined at 37 &#x000B0;C. \u003Ci>Biochem. Biophys. Res. Commun.\u003C/i> 334, 441&#x02013;449. doi: 10.1016/j.bbrc.2005.06.112\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16011830\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.bbrc.2005.06.112\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+J.+McPate&#x00026;author=R.+S.+Duncan&#x00026;author=J.+T.+Milnes&#x00026;author=H.+J.+Witchel&#x00026;author=J.+C.+Hancox+&#x00026;publication_year=2005&#x00026;title=The+N588K-HERG+K&#43;+channel+mutation+in+the+&#x02018;short+QT+syndrome&#x00027;%3A+mechanism+of+gain-in-function+determined+at+37+&#x000B0;C&#x00026;journal=Biochem.+Biophys.+Res.+Commun.&#x00026;volume=334&#x00026;pages=441-449\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B49\" id=\"B49\">\u003C/a> Mizobuchi, M., Enjoji, Y., Yamamoto, R., Ono, T., Funatsu, A., Kambayashi, D., et al. (2008). Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties. \u003Ci>Pacing Clin. Electrophysiol.\u003C/i> 31, 1229&#x02013;1232. doi: 10.1111/j.1540-8159.2008.01169.x\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18834480\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/j.1540-8159.2008.01169.x\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Mizobuchi&#x00026;author=Y.+Enjoji&#x00026;author=R.+Yamamoto&#x00026;author=T.+Ono&#x00026;author=A.+Funatsu&#x00026;author=D.+Kambayashi+&#x00026;publication_year=2008&#x00026;title=Nifekalant+and+disopyramide+in+a+patient+with+short+QT+syndrome%3A+evaluation+of+pharmacological+effects+and+electrophysiological+properties&#x00026;journal=Pacing+Clin.+Electrophysiol.&#x00026;volume=31&#x00026;pages=1229-1232\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B50\" id=\"B50\">\u003C/a> Moreno, J. D., Lewis, T. J., and Clancy, C. E. (2016). Parameterization for \u003Ci>in-silico\u003C/i> modeling of ion channel interactions with drugs. \u003Ci>PLoS ONE\u003C/i> 11:e0150761. doi: 10.1371/journal.pone.0150761\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=26963710\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0150761\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+D.+Moreno&#x00026;author=T.+J.+Lewis&#x00026;author=C.+E.+Clancy+&#x00026;publication_year=2016&#x00026;title=Parameterization+for+in-silico+modeling+of+ion+channel+interactions+with+drugs&#x00026;journal=PLoS+ONE&#x00026;volume=11&#x00026;pages=e0150761\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B51\" id=\"B51\">\u003C/a> Nakajima, T., Kurachi, Y., Ito, H., Takikawa, R., and Sugimoto, T. (1989). Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: mediation by different molecular mechanisms. \u003Ci>Circ. Res.\u003C/i> 64, 297&#x02013;303. doi: 10.1161/01.RES.64.2.297\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=2912601\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1161/01.RES.64.2.297\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=T.+Nakajima&#x00026;author=Y.+Kurachi&#x00026;author=H.+Ito&#x00026;author=R.+Takikawa&#x00026;author=T.+Sugimoto+&#x00026;publication_year=1989&#x00026;title=Anti-cholinergic+effects+of+quinidine,+disopyramide,+and+procainamide+in+isolated+atrial+myocytes%3A+mediation+by+different+molecular+mechanisms&#x00026;journal=Circ.+Res.&#x00026;volume=64&#x00026;pages=297-303\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B52\" id=\"B52\">\u003C/a> Nenov, N. I., Crumb, W. J., Pigott, J. D., Harrison, L. H., and Clarkson, C. W. (1998). Quinidine interactions with human atrial potassium channels. \u003Ci>Circ. Res.\u003C/i> 83, 1224&#x02013;1231. doi: 10.1161/01.RES.83.12.1224.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=9851939\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1161/01.RES.83.12.1224\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=N.+I.+Nenov&#x00026;author=W.+J.+Crumb&#x00026;author=J.+D.+Pigott&#x00026;author=L.+H.+Harrison&#x00026;author=C.+W.+Clarkson+&#x00026;publication_year=1998&#x00026;title=Quinidine+interactions+with+human+atrial+potassium+channels&#x00026;journal=Circ.+Res.&#x00026;volume=83&#x00026;pages=1224-1231\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B53\" id=\"B53\">\u003C/a> Ni, H., Whittaker, D. G., Wang, W., Giles, W. R., Narayan, S. M., and Zhang, H. (2017). Synergistic anti-arrhythmic effects in human atria with combined use of sodium blockers and acacetin. \u003Ci>Front. Physiol.\u003C/i> 8:946. doi: 10.3389/fphys.2017.00946\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29218016\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fphys.2017.00946\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H.+Ni&#x00026;author=D.+G.+Whittaker&#x00026;author=W.+Wang&#x00026;author=W.+R.+Giles&#x00026;author=S.+M.+Narayan&#x00026;author=H.+Zhang+&#x00026;publication_year=2017&#x00026;title=Synergistic+anti-arrhythmic+effects+in+human+atria+with+combined+use+of+sodium+blockers+and+acacetin&#x00026;journal=Front.+Physiol.&#x00026;volume=8&#x00026;pages=946\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B54\" id=\"B54\">\u003C/a> Nof, E., Burashnikov, A., and Antzelevitch, C. (2010). Cellular basis for atrial fibrillation in an experimental model of short QT1: Implications for a pharmacological approach to therapy. \u003Ci>Heart Rhythm\u003C/i> 7, 251&#x02013;257. doi: 10.1016/j.hrthm.2009.10.017\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=20042373\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.hrthm.2009.10.017\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=E.+Nof&#x00026;author=A.+Burashnikov&#x00026;author=C.+Antzelevitch+&#x00026;publication_year=2010&#x00026;title=Cellular+basis+for+atrial+fibrillation+in+an+experimental+model+of+short+QT1%3A+Implications+for+a+pharmacological+approach+to+therapy&#x00026;journal=Heart+Rhythm&#x00026;volume=7&#x00026;pages=251-257\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B55\" id=\"B55\">\u003C/a> O&#x00027;Hara, T., Vir&#x000E1;g, L., Varr,&#x000F3;, A., and Rudy, Y. (2011). Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. \u003Ci>PLoS Comput. Biol.\u003C/i> 7:e1002061. doi: 10.1371/journal.pcbi.1002061\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21637795\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pcbi.1002061\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=T.+O&#x00027;Hara&#x00026;author=L.+Vir&#x000E1;g&#x00026;author=A.+Varr,&#x000F3;&#x00026;author=Y.+Rudy+&#x00026;publication_year=2011&#x00026;title=Simulation+of+the+undiseased+human+cardiac+ventricular+action+potential%3A+model+formulation+and+experimental+validation&#x00026;journal=PLoS+Comput.+Biol.&#x00026;volume=7&#x00026;pages=e1002061\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B56\" id=\"B56\">\u003C/a> Patel, C., and Antzelevitch, C. (2008). Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome. \u003Ci>Heart Rhythm\u003C/i> 5, 585&#x02013;590. doi: 10.1016/j.hrthm.2008.01.022\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=18362027\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.hrthm.2008.01.022\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Patel&#x00026;author=C.+Antzelevitch+&#x00026;publication_year=2008&#x00026;title=Cellular+basis+for+arrhythmogenesis+in+an+experimental+model+of+the+SQT1+form+of+the+short+QT+syndrome&#x00026;journal=Heart+Rhythm&#x00026;volume=5&#x00026;pages=585-590\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B57\" id=\"B57\">\u003C/a> Pau, D., Workman, A. J., Kane, K. A., and Rankin, A. C. (2007). Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. \u003Ci>J. Mol. Cell. Cardiol.\u003C/i> 42, 54&#x02013;62. doi: 10.1016/j.yjmcc.2006.08.007\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16989857\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.yjmcc.2006.08.007\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+Pau&#x00026;author=A.+J.+Workman&#x00026;author=K.+A.+Kane&#x00026;author=A.+C.+Rankin+&#x00026;publication_year=2007&#x00026;title=Electrophysiological+and+arrhythmogenic+effects+of+5-hydroxytryptamine+on+human+atrial+cells+are+reduced+in+atrial+fibrillation&#x00026;journal=J.+Mol.+Cell.+Cardiol.&#x00026;volume=42&#x00026;pages=54-62\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B58\" id=\"B58\">\u003C/a> Paul, A. A., Witchel, H. J., and Hancox, J. C. (2002). Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. \u003Ci>Br. J. Pharmacol.\u003C/i> 136, 717&#x02013;729. doi: 10.1038/sj.bjp.0704784\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=12086981\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.bjp.0704784\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+A.+Paul&#x00026;author=H.+J.+Witchel&#x00026;author=J.+C.+Hancox+&#x00026;publication_year=2002&#x00026;title=Inhibition+of+the+current+of+heterologously+expressed+HERG+potassium+channels+by+flecainide+and+comparison+with+quinidine,+propafenone+and+lignocaine&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=136&#x00026;pages=717-729\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B59\" id=\"B59\">\u003C/a> Redpath, C. J., Rankin, A. C., Kane, K. A., and Workman, A. J. (2006). Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. \u003Ci>J. Mol. Cell. Cardiol.\u003C/i> 40, 717&#x02013;724. doi: 10.1016/j.yjmcc.2006.01.012\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16603181\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.yjmcc.2006.01.012\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+J.+Redpath&#x00026;author=A.+C.+Rankin&#x00026;author=K.+A.+Kane&#x00026;author=A.+J.+Workman+&#x00026;publication_year=2006&#x00026;title=Anti-adrenergic+effects+of+endothelin+on+human+atrial+action+potentials+are+potentially+anti-arrhythmic&#x00026;journal=J.+Mol.+Cell.+Cardiol.&#x00026;volume=40&#x00026;pages=717-724\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B60\" id=\"B60\">\u003C/a> Roden, D. M. (2014). Pharmacology and toxicology of Nav1.5-class 1 anti-arrhythmic drugs. \u003Ci>Card. Electrophysiol. Clin.\u003C/i> 6, 695&#x02013;704. doi: 10.1016/j.ccep.2014.07.003\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25395995\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.ccep.2014.07.003\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+M.+Roden+&#x00026;publication_year=2014&#x00026;title=Pharmacology+and+toxicology+of+Nav1.5-class+1+anti-arrhythmic+drugs&#x00026;journal=Card.+Electrophysiol.+Clin.&#x00026;volume=6&#x00026;pages=695-704\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B61\" id=\"B61\">\u003C/a> Schimpf, R., Veltmann, C., Giustetto, C., Gaita, F., Borggrefe, M., and Wolpert, C. (2007). \u003Ci>In vivo\u003C/i> effects of mutant HERG K&#43; channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study. \u003Ci>J. Cardiovasc. Electrophysiol.\u003C/i> 18, 1157&#x02013;1160. doi: 10.1111/j.1540-8167.2007.00925.x\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=17711440\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/j.1540-8167.2007.00925.x\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Schimpf&#x00026;author=C.+Veltmann&#x00026;author=C.+Giustetto&#x00026;author=F.+Gaita&#x00026;author=M.+Borggrefe&#x00026;author=C.+Wolpert+&#x00026;publication_year=2007&#x00026;title=In+vivo+effects+of+mutant+HERG+K&#43;+channel+inhibition+by+disopyramide+in+patients+with+a+short+QT-1+syndrome%3A+a+pilot+study&#x00026;journal=J.+Cardiovasc.+Electrophysiol.&#x00026;volume=18&#x00026;pages=1157-1160\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B62\" id=\"B62\">\u003C/a> Schimpf, R., Wolpert, C., Gaita, F., Giustetto, C., and Borggrefe, M. (2005). Short QT syndrome. \u003Ci>Cardiovasc. Res.\u003C/i> 67, 357&#x02013;366. doi: 10.1016/j.cardiores.2005.03.026\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15890322\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.cardiores.2005.03.026\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Schimpf&#x00026;author=C.+Wolpert&#x00026;author=F.+Gaita&#x00026;author=C.+Giustetto&#x00026;author=M.+Borggrefe+&#x00026;publication_year=2005&#x00026;title=Short+QT+syndrome&#x00026;journal=Cardiovasc.+Res.&#x00026;volume=67&#x00026;pages=357-366\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B63\" id=\"B63\">\u003C/a> Seemann, G., H&#x000F6;per, C., Sachse, F. B., D&#x000F6;ssel, O., Holden, A. V., and Zhang, H. (2006). Heterogeneous three-dimensional anatomical and electrophysiological model of human atria. \u003Ci>Philos. Trans. R. Soc. Lond. Math. Phys. Eng. Sci.\u003C/i> 364, 1465&#x02013;1481. doi: 10.1098/rsta.2006.1781\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16766355\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1098/rsta.2006.1781\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=G.+Seemann&#x00026;author=C.+H&#x000F6;per&#x00026;author=F.+B.+Sachse&#x00026;author=O.+D&#x000F6;ssel&#x00026;author=A.+V.+Holden&#x00026;author=H.+Zhang+&#x00026;publication_year=2006&#x00026;title=Heterogeneous+three-dimensional+anatomical+and+electrophysiological+model+of+human+atria&#x00026;journal=Philos.+Trans.+R.+Soc.+Lond.+Math.+Phys.+Eng.+Sci.&#x00026;volume=364&#x00026;pages=1465-1481\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B64\" id=\"B64\">\u003C/a> Seki, A., Hagiwara, N., and Kasanuki, H. (1999). Effects of propafenone on K currents in human atrial myocytes. \u003Ci>Br. J. Pharmacol.\u003C/i> 126, 1153&#x02013;1162. doi: 10.1038/sj.bjp.0702428\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=10205003\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.bjp.0702428\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Seki&#x00026;author=N.+Hagiwara&#x00026;author=H.+Kasanuki+&#x00026;publication_year=1999&#x00026;title=Effects+of+propafenone+on+K+currents+in+human+atrial+myocytes&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=126&#x00026;pages=1153-1162\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B65\" id=\"B65\">\u003C/a> Slawsky, M. T., and Castle, N. A. (1994). K&#43; channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. \u003Ci>J. Pharmacol. Exp. Ther.\u003C/i> 269, 66&#x02013;74.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=8169853\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+T.+Slawsky&#x00026;author=N.+A.+Castle+&#x00026;publication_year=1994&#x00026;title=K&#43;+channel+blocking+actions+of+flecainide+compared+with+those+of+propafenone+and+quinidine+in+adult+rat+ventricular+myocytes&#x00026;journal=J.+Pharmacol.+Exp.+Ther.&#x00026;volume=269&#x00026;pages=66-74\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B66\" id=\"B66\">\u003C/a> Starmer, C. F., Grant, A. O., and Strauss, H. C. (1984). Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. \u003Ci>Biophys. J.\u003C/i> 46, 15&#x02013;27. doi: 10.1016/S0006-3495(84)83994-6\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=6331543\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/S0006-3495(84)83994-6\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+F.+Starmer&#x00026;author=A.+O.+Grant&#x00026;author=H.+C.+Strauss+&#x00026;publication_year=1984&#x00026;title=Mechanisms+of+use-dependent+block+of+sodium+channels+in+excitable+membranes+by+local+anesthetics&#x00026;journal=Biophys.+J.&#x00026;volume=46&#x00026;pages=15-27\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B67\" id=\"B67\">\u003C/a> Stephenson, R. S., Atkinson, A., Kottas, P., Perde, F., Jafarzadeh, F., Bateman, M., et al. (2017). High resolution 3-Dimensional imaging of the human cardiac conduction system from microanatomy to mathematical modeling. \u003Ci>Sci. Rep.\u003C/i> 7:7188. doi: 10.1038/s41598-017-07694-8\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=28775383\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41598-017-07694-8\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+S.+Stephenson&#x00026;author=A.+Atkinson&#x00026;author=P.+Kottas&#x00026;author=F.+Perde&#x00026;author=F.+Jafarzadeh&#x00026;author=M.+Bateman+&#x00026;publication_year=2017&#x00026;title=High+resolution+3-Dimensional+imaging+of+the+human+cardiac+conduction+system+from+microanatomy+to+mathematical+modeling&#x00026;journal=Sci.+Rep.&#x00026;volume=7&#x00026;pages=7188\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B68\" id=\"B68\">\u003C/a> ten Tusscher, K. H., and Panfilov, A. V. (2006). Alternans and spiral breakup in a human ventricular tissue model. \u003Ci>Am. J. Physiol. - Heart Circ. Physiol.\u003C/i> 291, H1088&#x02013;H1100. doi: 10.1152/ajpheart.00109.2006\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=16565318\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1152/ajpheart.00109.2006\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K.+H.+ten+Tusscher&#x00026;author=A.+V.+Panfilov+&#x00026;publication_year=2006&#x00026;title=Alternans+and+spiral+breakup+in+a+human+ventricular+tissue+model&#x00026;journal=Am.+J.+Physiol.+-+Heart+Circ.+Physiol.&#x00026;volume=291&#x00026;pages=H1088-H1100\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B69\" id=\"B69\">\u003C/a> Varela, M., Colman, M. A., Hancox, J. C., and Aslanidi, O. V. (2016). Atrial heterogeneity generates re-entrant substrate during atrial fibrillation and anti-arrhythmic drug action: mechanistic insights from canine atrial models. \u003Ci>PLOS. Comput. Biol.\u003C/i> 12:e1005245. doi: 10.1371/journal.pcbi.1005245.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=27984585\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pcbi.1005245\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Varela&#x00026;author=M.+A.+Colman&#x00026;author=J.+C.+Hancox&#x00026;author=O.+V.+Aslanidi+&#x00026;publication_year=2016&#x00026;title=Atrial+heterogeneity+generates+re-entrant+substrate+during+atrial+fibrillation+and+anti-arrhythmic+drug+action%3A+mechanistic+insights+from+canine+atrial+models&#x00026;journal=PLOS.+Comput.+Biol.&#x00026;volume=12&#x00026;pages=e1005245\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B70\" id=\"B70\">\u003C/a> Voigt, N., Trausch, A., Knaut, M., Matschke, K., Varr&#x000F3;, A., Wagoner, D. R. V., et al. (2010). Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillationclinical perspective. \u003Ci>Circ. Arrhythm. Electrophysiol.\u003C/i> 3, 472&#x02013;480. doi: 10.1161/CIRCEP.110.954636\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1161/CIRCEP.110.954636\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=N.+Voigt&#x00026;author=A.+Trausch&#x00026;author=M.+Knaut&#x00026;author=K.+Matschke&#x00026;author=A.+Varr&#x000F3;&#x00026;author=D.+R.+V.+Wagoner+&#x00026;publication_year=2010&#x00026;title=Left-to-right+atrial+inward+rectifier+potassium+current+gradients+in+patients+with+paroxysmal+versus+chronic+atrial+fibrillationclinical+perspective&#x00026;journal=Circ.+Arrhythm.+Electrophysiol.&#x00026;volume=3&#x00026;pages=472-480\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B71\" id=\"B71\">\u003C/a> Whittaker, D. G., Colman, M. A., Ni, H., Hancox, J. C., and Zhang, H. (2015). \u003Ci>In silico\u003C/i> investigation of short QT syndrome-linked potassium channel mutations on electro-mechanical function of human atrial cells. \u003Ci>Comput. Cardiol. Conference\u003C/i> 2015, 853&#x02013;856. doi: 10.1109/CIC.2015.7411045.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1109/CIC.2015.7411045\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+G.+Whittaker&#x00026;author=M.+A.+Colman&#x00026;author=H.+Ni&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2015&#x00026;title=In+silico+investigation+of+short+QT+syndrome-linked+potassium+channel+mutations+on+electro-mechanical+function+of+human+atrial+cells&#x00026;journal=Comput.+Cardiol.+Conference&#x00026;volume=2015&#x00026;pages=853-856\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B72\" id=\"B72\">\u003C/a> Whittaker, D. G., Colman, M. A., Ni, H., Hancox, J. C., and Zhang, H. (2018). Human atrial arrhythmogenesis and sinus bradycardia in KCNQ1-linked short QT syndrome: insights from computational modelling. \u003Ci>Front. Physiol.\u003C/i> 9:1402. doi: 10.3389/fphys.2018.01402\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=30337886\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fphys.2018.01402\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+G.+Whittaker&#x00026;author=M.+A.+Colman&#x00026;author=H.+Ni&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2018&#x00026;title=Human+atrial+arrhythmogenesis+and+sinus+bradycardia+in+KCNQ1-linked+short+QT+syndrome%3A+insights+from+computational+modelling&#x00026;journal=Front.+Physiol.&#x00026;volume=9&#x00026;pages=1402\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B73\" id=\"B73\">\u003C/a> Whittaker, D. G., Ni, H., Benson, A. P., Hancox, J. C., and Zhang, H. (2017a). Computational analysis of the mode of action of disopyramide and quinidine on hERG-linked short QT syndrome in human ventricles. \u003Ci>Front. Physiol.\u003C/i> 8:759. doi: 10.3389/fphys.2017.00759\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=29085299\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fphys.2017.00759\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+G.+Whittaker&#x00026;author=H.+Ni&#x00026;author=A.+P.+Benson&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2017a&#x00026;title=Computational+analysis+of+the+mode+of+action+of+disopyramide+and+quinidine+on+hERG-linked+short+QT+syndrome+in+human+ventricles&#x00026;journal=Front.+Physiol.&#x00026;volume=8&#x00026;pages=759\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B74\" id=\"B74\">\u003C/a> Whittaker, D. G., Ni, H., Harchi, A. E., Hancox, J. C., and Zhang, H. (2017b). Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: insights from virtual human atria. \u003Ci>PLOS. Comput. Biol.\u003C/i> 13:e1005593. doi: 10.1371/journal.pcbi.1005593\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=28609477\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pcbi.1005593\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+G.+Whittaker&#x00026;author=H.+Ni&#x00026;author=A.+E.+Harchi&#x00026;author=J.+C.+Hancox&#x00026;author=H.+Zhang+&#x00026;publication_year=2017b&#x00026;title=Atrial+arrhythmogenicity+of+KCNJ2+mutations+in+short+QT+syndrome%3A+insights+from+virtual+human+atria&#x00026;journal=PLOS.+Comput.+Biol.&#x00026;volume=13&#x00026;pages=e1005593\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B75\" id=\"B75\">\u003C/a> Wilhelms, M., Hettmann, H., Maleckar, M. M., Koivum&#x000E4;ki, J. T., D&#x000F6;ssel, O., and Seemann, G. (2013). Benchmarking electrophysiological models of human atrial myocytes. \u003Ci>Front. Physiol.\u003C/i> 3:487. doi: 10.3389/fphys.2012.00487\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=23316167\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fphys.2012.00487\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Wilhelms&#x00026;author=H.+Hettmann&#x00026;author=M.+M.+Maleckar&#x00026;author=J.+T.+Koivum&#x000E4;ki&#x00026;author=O.+D&#x000F6;ssel&#x00026;author=G.+Seemann+&#x00026;publication_year=2013&#x00026;title=Benchmarking+electrophysiological+models+of+human+atrial+myocytes&#x00026;journal=Front.+Physiol.&#x00026;volume=3&#x00026;pages=487\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B76\" id=\"B76\">\u003C/a> Workman, A. J., Smith, G. L., and Rankin, A. C. (2011). Mechanisms of termination and prevention of atrial fibrillation by drug therapy. \u003Ci>Pharmacol. Ther.\u003C/i> 131, 221&#x02013;241. doi: 10.1016/j.pharmthera.2011.02.002\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=21334377\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.pharmthera.2011.02.002\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+J.+Workman&#x00026;author=G.+L.+Smith&#x00026;author=A.+C.+Rankin+&#x00026;publication_year=2011&#x00026;title=Mechanisms+of+termination+and+prevention+of+atrial+fibrillation+by+drug+therapy&#x00026;journal=Pharmacol.+Ther.&#x00026;volume=131&#x00026;pages=221-241\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B77\" id=\"B77\">\u003C/a> Yuan, Y., Bai, X., Luo, C., Wang, K., and Zhang, H. (2015). The virtual heart as a platform for screening drug cardiotoxicity. \u003Ci>Br. J. Pharmacol.\u003C/i> 172, 5531&#x02013;5547. doi: 10.1111/bph.12996\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=25363597\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/bph.12996\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+Yuan&#x00026;author=X.+Bai&#x00026;author=C.+Luo&#x00026;author=K.+Wang&#x00026;author=H.+Zhang+&#x00026;publication_year=2015&#x00026;title=The+virtual+heart+as+a+platform+for+screening+drug+cardiotoxicity&#x00026;journal=Br.+J.+Pharmacol.&#x00026;volume=172&#x00026;pages=5531-5547\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B78\" id=\"B78\">\u003C/a> Zhang, H., and Hancox, J. C. (2004). \u003Ci>In silico\u003C/i> study of action potential and QT interval shortening due to loss of inactivation of the cardiac rapid delayed rectifier potassium current. \u003Ci>Biochem. Biophys. Res. Commun.\u003C/i> 322, 693&#x02013;699. doi: 10.1016/j.bbrc.2004.07.176\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15325285\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.bbrc.2004.07.176\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H.+Zhang&#x00026;author=J.+C.+Hancox+&#x00026;publication_year=2004&#x00026;title=In+silico+study+of+action+potential+and+QT+interval+shortening+due+to+loss+of+inactivation+of+the+cardiac+rapid+delayed+rectifier+potassium+current&#x00026;journal=Biochem.+Biophys.+Res.+Commun.&#x00026;volume=322&#x00026;pages=693-699\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003Cdiv class=\"References\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B79\" id=\"B79\">\u003C/a> Zhou, J., Augelli-Szafran, C. E., Bradley, J. A., Chen, X., Koci, B. J., Volberg, W. A., et al. (2005). Novel potent human ether-&#x000E0;-Go-Go-related gene (hERG) potassium channel enhancers and their \u003Ci>in vitro\u003C/i> antiarrhythmic activity. \u003Ci>Mol. Pharmacol.\u003C/i> 68, 876&#x02013;884. doi: 10.1124/mol.105.014035\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&#x00026;Cmd=ShowDetailView&#x00026;TermToSearch=15976038\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1124/mol.105.014035\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Zhou&#x00026;author=C.+E.+Augelli-Szafran&#x00026;author=J.+A.+Bradley&#x00026;author=X.+Chen&#x00026;author=B.+J.+Koci&#x00026;author=W.+A.+Volberg+&#x00026;publication_year=2005&#x00026;title=Novel+potent+human+ether-&#x000E0;-Go-Go-related+gene+(hERG)+potassium+channel+enhancers+and+their+in+vitro+antiarrhythmic+activity&#x00026;journal=Mol.+Pharmacol.&#x00026;volume=68&#x00026;pages=876-884\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\r\n\u003C/div>\r\n\u003Cdiv class=\"thinLineM20\">\u003C/div>\r\n\u003Cdiv class=\"AbstractSummary\">\r\n\u003Cp>\u003Cspan>Keywords:\u003C/span> arrhythmia, short QT syndrome, atrial fibrillation, hERG, class I anti-arrhythmics, human atria, potassium channels\u003C/p>\r\n\u003Cp>\u003Cspan>Citation:\u003C/span> Whittaker DG, Hancox JC and Zhang H (2019) \u003Ci>In silico\u003C/i> Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome. \u003Ci>Front. Physiol\u003C/i>. 9:1888. doi: 10.3389/fphys.2018.01888\u003C/p>\r\n\u003Cp id=\"timestamps\">\u003Cspan>Received:\u003C/span> 01 August 2018; \u003Cspan>Accepted:\u003C/span> 12 December 2018;\u003Cbr> \u003Cspan>Published:\u003C/span> 11 January 2019.\u003C/p>\r\n\u003Cdiv>\u003Cp>Edited by:\u003C/p> \u003Ca href=\"http://loop.frontiersin.org/people/24963/overview\">Olaf Doessel\u003C/a>, Karlsruhe Institute of Technology (KIT), Germany\u003C/div>\r\n\u003Cdiv>\u003Cp>Reviewed by:\u003C/p> \u003Ca href=\"http://loop.frontiersin.org/people/27699/overview\">Richard Gray\u003C/a>, United States Food and Drug Administration, United States\u003Cbr> \u003Ca href=\"http://loop.frontiersin.org/people/63899/overview\">Socrates Dokos\u003C/a>, University of New South Wales, Australia\u003C/div>\r\n\u003Cp>\u003Cspan>Copyright\u003C/span> &#x000A9; 2019 Whittaker, Hancox and Zhang. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY)\u003C/a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\r\n\u003Cp>\u003Cspan>*Correspondence:\u003C/span> Jules C. Hancox, \u003Ca id=\"encmail\">anVsZXMuaGFuY294QGJyaXN0b2wuYWMudWs=\u003C/a>\u003Cbr> Henggui Zhang, \u003Ca id=\"encmail\">aGVuZ2d1aS56aGFuZ0BtYW5jaGVzdGVyLmFjLnVr\u003C/a>\u003C/p>\r\n\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\r\n\r\n","\u003Cul class=\"flyoutJournal\">\r\n\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h2\">Introduction\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h3\">Methods\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h4\">Results\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h5\">Discussion\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h6\">Limitations\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h7\">Conclusions\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h8\">Author Contributions\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h9\">Funding\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h10\">Conflict of Interest Statement\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h11\">Acknowledgments\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h12\">Supplementary Material\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h13\">References\u003C/a>\u003C/li>\r\n\u003C/ul>",[698,703,709,712,718],{"name":699,"fileServerPackageEntryId":19,"fileServerId":700,"fileServerVersionNumber":442,"type":701},"EPUB.epub","417422/epub",{"code":702,"name":702},"EPUB",{"name":704,"fileServerPackageEntryId":705,"fileServerId":706,"fileServerVersionNumber":442,"type":707},"fphys-09-01888.pdf","fphys-09-01888/fphys-09-01888.pdf","417422/pubmed-zip",{"code":708,"name":708},"PDF",{"name":704,"fileServerPackageEntryId":19,"fileServerId":710,"fileServerVersionNumber":442,"type":711},"417422/publishers-proof/pdf",{"code":708,"name":708},{"name":713,"fileServerPackageEntryId":714,"fileServerId":706,"fileServerVersionNumber":442,"type":715},"fphys-09-01888.xml","fphys-09-01888/fphys-09-01888.xml",{"code":716,"name":717},"NLM_XML","XML",{"name":719,"fileServerPackageEntryId":19,"fileServerId":720,"fileServerVersionNumber":442,"type":721},"Provisional PDF.pdf","417422/provisional-pdf",{"code":708,"name":708},"v3",{"title":724,"link":725,"meta":729,"script":824},"Frontiers | In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome",[726],{"rel":727,"href":728},"canonical","https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/full",[730,733,736,738,741,745,748,752,755,758,761,763,765,767,769,771,774,777,779,782,785,787,790,793,796,799,802,806,810,813,816,819,821],{"hid":731,"property":731,"name":731,"content":732},"description","Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the human Ether--go-go-Related Gene (hERG), which encodes the  subunit of ch...",{"hid":734,"property":734,"name":735,"content":724},"og:title","title",{"hid":737,"property":737,"name":731,"content":732},"og:description",{"hid":739,"name":739,"content":740},"keywords","arrhythmia,short QT syndrome,Atrial Fibrillation,hERG, potassium channels,class I anti-arrhythmics,human atria",{"hid":742,"property":742,"name":743,"content":744},"og:site_name","site_name","Frontiers",{"hid":746,"property":746,"name":435,"content":747},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/417422/fphys-09-01888-HTML/image_m/fphys-09-01888-g001.jpg",{"hid":749,"property":749,"name":750,"content":751},"og:type","type","article",{"hid":753,"property":753,"name":754,"content":728},"og:url","url",{"hid":756,"name":756,"content":757},"twitter:card","summary_large_image",{"hid":759,"name":759,"content":760},"citation_volume","9",{"hid":762,"name":762,"content":116},"citation_journal_title",{"hid":764,"name":764,"content":744},"citation_publisher",{"hid":766,"name":766,"content":678},"citation_journal_abbrev",{"hid":768,"name":768,"content":679},"citation_issn",{"hid":770,"name":770,"content":587},"citation_doi",{"hid":772,"name":772,"content":773},"citation_firstpage","417422",{"hid":775,"name":775,"content":776},"citation_language","English",{"hid":778,"name":778,"content":588},"citation_title",{"hid":780,"name":780,"content":781},"citation_keywords","arrhythmia; short QT syndrome; Atrial Fibrillation; hERG, potassium channels; class I anti-arrhythmics; human atria",{"hid":783,"name":783,"content":784},"citation_abstract","Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the human Ether--go-go-Related Gene (hERG), which encodes the  subunit of channels carrying rapid delayed rectifier potassium current, IKr. In addition to QT interval shortening and ventricular arrhythmias, SQT1 is associated with increased risk of atrial fibrillation (AF), which is often the only clinical presentation. However, the underlying basis of AF and its pharmacological treatment remain incompletely understood in the context of SQT1. In this study, computational modelling was used to investigate mechanisms of human atrial arrhythmogenesis consequent to a SQT1 mutation, as well as pharmacotherapeutic effects of selected class I drugs  disopyramide, quinidine, and propafenone. A Markov chain formulation describing wild type (WT) and N588K-hERG mutant IKr was incorporated into a contemporary human atrial action potential (AP) model, which was integrated into one-dimensional (1D) tissue strands, idealised 2D sheets, and a 3D heterogeneous, anatomical human atria model. Multi-channel pharmacological effects of disopyramide, quinidine, and propafenone, including binding kinetics for IKr/hERG and sodium current, INa, were considered.Heterozygous and homozygous formulations of the N588K-hERG mutation shortened the AP duration (APD) by 53 and 86 ms, respectively, which abbreviated the effective refractory period (ERP) and excitation wavelength in tissue, increasing the lifespan and dominant frequency (DF) of scroll waves in the 3D anatomical human atria. At the concentrations tested in this study, quinidine most effectively prolonged the APD and ERP in the setting of SQT1, followed by disopyramide and propafenone. In 2D simulations, disopyramide and quinidine promoted re-entry termination by increasing the re-entry wavelength, whereas propafenone induced secondary waves which destabilised the re-entrant circuit. In 3D simulations, the DF of re-entry was reduced in a dose-dependent manner for disopyramide and quinidine, and propafenone to a lesser extent. All of the anti-arrhythmic agents promoted pharmacological conversion, most frequently terminating re-entry in the order quinidine > propafenone = disopyramide. Our findings provide further insight into mechanisms of SQT1-related AF and a rational basis for the pursuit of combined IKr and INa block based pharmacological strategies in the treatment of SQT1-linked AF. ",{"hid":786,"name":786,"content":602},"citation_article_type",{"hid":788,"name":788,"content":789},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/pdf",{"hid":791,"name":791,"content":792},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01888/xml",{"hid":794,"name":794,"content":795},"citation_fulltext_world_readable","yes",{"hid":797,"name":797,"content":798},"citation_online_date","2018/12/12",{"hid":800,"name":800,"content":801},"citation_publication_date","2019/01/11",{"hid":803,"name":804,"content":805},"citation_author_0","citation_author","Whittaker, Dominic G. ",{"hid":807,"name":808,"content":809},"citation_author_institution_0","citation_author_institution","Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, United Kingdom",{"hid":811,"name":804,"content":812},"citation_author_1","Hancox, Jules C. ",{"hid":814,"name":808,"content":815},"citation_author_institution_1","Biological Physics Group, School of Physics and Astronomy, The University of Manchester, United Kingdom",{"hid":817,"name":804,"content":818},"citation_author_2","Zhang, Henggui ",{"hid":820,"name":808,"content":815},"citation_author_institution_2",{"hid":822,"name":822,"content":823},"dc.identifier","doi:10.3389/fphys.2018.01888",[825,828,830,832,834],{"src":826,"body":13,"type":827,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":829,"body":13,"type":827,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":831,"body":13,"type":827,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":833,"body":13,"type":827,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fphys.2018.01888?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":835,"body":13,"type":827,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":837,"articleHubArticlesList":838,"canJournalHasArticleHub":395,"articleDoiList":839},{},[],[],{"title":19,"image":-1,"breadcrumbs":841,"linksCollection":842,"metricsCollection":844},[],{"total":439,"items":843},[],{"total":439,"items":845},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fphys.2018.01888?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>